These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Completed, but no date, and reported results 2004-000007-18 A Multicentre, Randomised, Double-Blind, Parallel Group, 24 Week Study to Compare the Effect of the Salmeterol/Fluticasone Propionate Combination Product (SERETIDE) 50/250mcg with Salmeterol 50mcg Bot... bad-data
Reported results 2004-000060-27 A Phase IIIB, Randomized, Open-Label, Multicenter Study of the Safety and Efficacy of GW433908 700mg BID plus ritonavir 100mg BID Versus Lopinavir/ritonavir 400mg/100mg BID when Administered in... 2007-11-27 due-trials
Ongoing, reported early 2004-000091-14 A Randomised, Double-Blind, Placebo-Controlled, Parallel Group, Multicentre, Long-Term Study to Evaluate the Safety of Once-Daily, Intranasal Administration of GW685698X Aqueous Nasal Spray 100mcg for... not-yet-due
Completed, but no date 2004-000106-41 A study to investigate the effect of GW406381 on methotrexate pharmacokinetics in patients treated with methotrexate for rheumatoid arthritis bad-data
Completed, but no date 2004-000336-81 GW433908 Expanded Access Program for HIV infected subjects non responding or intolerant to the previous antiretroviral treatments bad-data
Listed as ongoing, but also has a completion date and reported results 2004-000367-98 A double-blind, randomised, placebo-controlled, parallel group study to investigate the efficacy, safety, tolerability, pharmacokinetics and pharmacodynamics of SB-497115-GR, a thrombopoietin receptor... 2007-01-31 bad-data
Listed as ongoing, but also has a completion date and reported results 2004-000368-28 A Double-blind, Randomised, Multicentre, Placebo-controlled, Parallel Group, Dose Ranging Study to Assess the Efficacy, Safety, and Pharmacokinetics of an Oral Thrombopoietin Receptor Agonist (SB-4971... 2007-02-28 bad-data
Listed as ongoing, but also has a completion date and reported results 2004-000369-37 A multicentre, randomised, double-blind, placebo-controlled, parallel group study to evaluate the safety and efficacy of oral dosing with GW679769 (50 mg or 150 mg) for 3 consecutive days in conjuncti... 2005-12-16 bad-data
Listed as ongoing, but also has a completion date and reported results 2004-000370-31 A Multicentre, Randomised, Double-blind, Placebo-controlled, Dose-ranging, Parallel Group Phase II Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of the Oral Neurokinin-1 Receptor Antago... 2005-08-04 bad-data
Reported results 2004-000371-34 A Phase II Multicenter, Randomized, Double-Blind, Placebo and Active-Controlled, Dose-Ranging, Parallel Group Study of the Safety and Efficacy of The Oral Neurokinin-1 Receptor Antagonist, GW679769 Wh... 2006-01-18 due-trials
Reported results 2004-000374-31 A Randomised, Double-blind, Placebo-controlled, Parallel Group, Dose-Ranging Study to Investigate the Efficacy and Safety of Three Months administration of SB 683699 (150 - 1200mg twice daily) in Sub... 2006-07-21 due-trials
Listed as ongoing, but also has a completion date and reported results 2004-000406-51 A Prospective, Randomized, Double-blind, Placebo Controlled, Dose Ranging, Multi-Center Study of the Safety and Efficacy of Three Days Continuous Intravenous Infusion of GR270773 in the Treatment of S... 2007-05-31 bad-data
Listed as ongoing, but also has a completion date and reported results 2004-000482-35 A randomised, double-blind, placebo-controlled, parallel group study to investigate the anti-inflammatory and metabolic effects of rosiglitazone XR, 8mg once daily, in subjects with rheumatoid arthrit... 2006-12-08 bad-data
Ongoing, reported early 2004-000518-37 A phase III, double-blind, randomized, controlled study to evaluate the safety and immunogenicity of GlaxoSmithKline Biologicals? HPV-16/18 VLP/AS04 vaccine administered intramuscularly according to a... not-yet-due
Ongoing, reported early 2004-000576-13 A two-centre, randomised, double-blind, double-dummy, placebo-controlled, 3-period cross-over study to evaluate the effect of treatment with repeat doses of GW274150 on the allergen-induced late asthm... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2004-000610-39 A Dose Ranging Trial for the Evaluation of the Safety, Tolerability and Efficacy of Odiparcil in the Prevention of Venous Thromboembolism following Total Knee Replacement Surgery. 2006-09-15 bad-data
Reported results 2004-000754-24 An open-label, two-period, crossover, pharmacokinetic study of abacavir and its intracellular anabolite carbovir triphosphate following once-daily and twice-daily administration of abacavir in HIV-inf... 2006-05-22 due-trials
Completed, but no date, and reported results 2004-000784-97 A Randomized, Double-blind, Double-Dummy, Multicenter, Non-inferiority Phase III Study to Assess the Safety and Efficacy of Topical 1% SB-275833 Ointment, Applied Twice Daily, versus Oral Cephalexin, ... bad-data
Listed as ongoing, but also has a completion date and reported results 2004-000789-11 A 12-week, randomised, double-blind, placebo-controlled, parallel-group multicentre study to evaluate the anti-inflammatory activity of GW842470 4mg twice daily on pulmonary hyperinflation in patients... 2005-09-15 bad-data
Completed, but no date 2004-000805-23 A national, multicentric, randomised, controlled trial. Applications of a critical pathway using LEVOFLOXACIN for the management of patients with abnormal PSA bad-data
Ongoing, reported early 2004-000848-24 An Eight-Week, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Efficacy and Safety of Talnetant in Subjects with Irritable Bowel Syndrome not-yet-due
Reported results 2004-000882-36 A multi-centre, two-staged with interim analysis, parallel, randomised, double blind, placebo-controlled, dose ranging study of the safety, tolerability, and effects on plasma high-density lipoprotein... 2006-07-17 due-trials
Completed, but no date 2004-000929-30 A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Phase III Study to Evaluate Corticosteroid-reduction and -sparing Effects of Mepolizumab 750 mg Intravenous in Subjects with... bad-data
Completed, but no date, and reported results 2004-000930-35 An open-label extension study to study 100185, to evaluate long-term safety, efficacy and optimal dosing frequency of 750mg intravenous mepolizumab in subjects with hypereosinophilic syndrome. bad-data
Reported results 2004-000985-12 An open-label extension to study AVA100193, to assess the long-term safety and efficacy of rosiglitazone (extended release tablets) in subjects with mild to moderate Alzheimer's disease. 2006-04-10 due-trials
Listed as ongoing, but also has a completion date and reported results 2004-001020-20 A Phase II multicenter, randomized, double-blind, placebo-controlled, dose ranging, parallel group study of the safety and efficacy of the oral Neurokinin-1 Receptor Antagonist, GW679769, when adminis... 2005-12-27 bad-data
Completed, but no date, and reported results 2004-001021-22 A Multicentre, Randomised, Double-blind, Double-dummy, Placebo-controlled, Parallel Group, Phase II Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Oral (25 mg) and Intravenous (3 mg a... bad-data
Reported results 2004-001173-26 A phase III, double-blind, randomized study to assess the consistency of the immunogenicity of three consecutive production lots of GlaxoSmithKline Biologicals’ HPV-16/18 VLP/AS04 vaccine administered... 2009-01-06 due-trials
Listed as ongoing, but also has a completion date and reported results 2004-001175-19 A phase IIIb, double-blind, randomized, placebo-controlled, multi-country and multi-center study to assess the efficacy, safety and immunogenicity of two doses of GSK Biologicals' oral live attenuated... 2006-10-08 bad-data
Completed, but no date, and reported results 2004-001182-18 A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunct... bad-data
No trial status on register 2004-001223-37 Ensayo clínico abierto en fase IV, para evaluar la inmunogenicidad y reactogenicidad de la vacuna combinada DTPa (Infanrix) de GlaxoSmithKline Biologicals administrada como dosis de recuerdo a los 4 a... bad-data
Ongoing 2004-001249-14 A Phase III open, multicentre, booster vaccination study to assess the immunogenicity, safety and reactogenicity of a booster dose of GlaxoSmithKline (GSK) Biologicals’ Haemophilus influenzae type b-m... not-yet-due
Ongoing, reported early 2004-001325-14 Estudio en fase III, doble ciego, aleatorizado, controlado, multicéntrico para evaluar la eficacia de la vacuna HPV-16/18 VLP/AS04 de GlaxoSmithKline Biologicals comparada con la vacuna antihepatitis ... not-yet-due
Reported results 2004-001456-36 A phase III, randomized, open-label, multicenter study comparing GW572016 and Capecitabile (Xeloda) versus Capecitabile in women with refractory advanced or metastatic breast cancer. 2010-02-18 due-trials
Listed as ongoing, but also has a completion date and reported results 2004-001469-16 A double-blind, randomized, placebo-controlled, multi-centre, dose-ranging, parallel group, phase II study to assess efficacy, safety/tolerability, and pharmacokinetics of a thrombopoietin receptor ag... 2006-10-20 bad-data
Completed, but no date, and reported results 2004-001549-13 A pilot, randomized, double-blind, placebo-controlled, crossover study evaluating the efficacy and safety of Vardenafil versus placebo administered 12, 18 and 24 hours prior to initiation of sexual in... bad-data
Listed as ongoing, but also has a completion date and reported results 2004-001680-22 A randomised, double-blind, placebo-controlled, parallel group study to investigate the safety and efficacy of controlled-release ropinirole CR 1-24mg administered once daily for 12 weeks in subje... 2005-07-01 bad-data
Listed as ongoing, but also has a completion date and reported results 2004-001814-14 A Double-Blind, Placebo-Controlled, Multicenter Phase IIb Extension Study to Evaluate the Safety and Efficacy of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunctio... 2007-04-09 bad-data
Completed, but no date 2004-001823-39 An open, randomized, controlled, phase II study to evaluate the safety and immunogenicity of GlaxoSmithKline Biologicals’ 11-valent pneumococcal conjugate vaccine, when administered intramuscularly as... bad-data
Reported results 2004-001894-24 A Randomised, Double-Blind, Parallel-Group, Placebo-Controlled Fixed Dose Study Comparing the Efficacy and Safety of GW597599/Paroxetine combination or Paroxetine monotherapy to Placebo in Patients wi... 2005-09-19 due-trials
Listed as ongoing, but also has a completion date and reported results 2004-001905-93 A Phase II study to evaluate the efficacy, safety and pharmacodynamics of lapatinib in combination with paclitaxel as neoadjuvant therapy in patients with newly diagnosed inflammatory breast cancer 2006-11-01 bad-data
Ongoing, reported early 2004-001906-29 Phase II study to evaluate the efficacy, safety and pharmacodynamics of lapatinib in patients with relapsed or refractory inflammatory breast cancer not-yet-due
Completed, but no date, and reported results 2004-001999-40 A randomised, multicentre, double-blind, placebo-controlled, 2-arm, Phase III study of oral GW572016 in combination with paclitaxel in subjects previously untreated for advanced or metastatic breast c... bad-data
Completed, but no date, and reported results 2004-002362-37 A multicentre, randomised, double-blind, placebo-controlled, dose ascending, four way crossover study to examine efficacy (FEV1),safety, tolerability, pharmacodynamics and pharmacokinetics of single ... bad-data
Reported results 2004-002605-77 A Proof-of-Principle Study to Evaluate a Combination Therapy for the Treatment of Migraine 2005-05-16 due-trials
Reported results 2004-002676-41 Blinded, randomised, controlled, multicenter study to evaluate the clinical efficacy against varicella disease of GlaxoSmithKline Biologicals’ live attenuated varicella vaccine (Varilrix) given on a o... 2016-12-15 due-trials
Listed as ongoing, but also has a completion date and reported results 2004-002769-18 A 28-day, randomised, double-blind, placebo-controlled study to assess the safety, tolerability, anti-inflammatory effect and steadystate pharmacokinetics of SB-681323 7.5 mg per day in patients with ... 2006-03-02 bad-data
Ongoing, reported early 2004-002872-41 A Study to Validate Key Therapeutic Targets and Biomarkers during Allergen Exposure in Subjects with Allergic Rhinitis not-yet-due
Ongoing, reported early 2004-002873-21 A study to assess disease pathology and key therapeutic targets in severe asthma not-yet-due
Reported results 2004-003619-22 A placebo-controlled study to investigate the efficacy of a combination analgesic treatment compared to its individual components in primary dysmenorrhoea. 2005-06-23 due-trials
Reported results 2004-003768-32 A Phase II, open (partially double-blind), randomized, controlled dose-range study to evaluate the immunogenicity, reactogenicity and safety of four different formulations of GlaxoSmithKline (GSK) Bio... 2006-03-03 due-trials
Ongoing 2004-003769-33 A phase III open (partially double-blind), controlled, multicenter, multicountry primary & booster vaccination study to demonstrate the non-inferiority of the meningococcal serogroup C response of Gla... not-yet-due
Completed, but no date, and reported results 2004-003803-19 A Multi-Centre, Randomised, Double-Blind, Parallel-Group, Placebo- and Active- Controlled, Flexible Dose Study Evaluating the Efficacy, Safety and Tolerability of Extended-Release Bupropion Hydrochlor... bad-data
Listed as ongoing, but also has a completion date and reported results 2004-003827-10 A Phase III, Randomized, Controlled, Open-label, Multicentre, Three Arm Study to Compare the Efficacy and Safety of a Dual-boosted HIV-1 Protease Inhibitor (PI) regimen of Fosamprenavir (FPV)/ Lopinav... 2007-04-27 bad-data
Listed as ongoing, but also has a completion date and reported results 2004-003865-33 A Phase IIb, 96 week, randomized, open-label, multicenter, parallel group, repeat dose study to evaluate the safety, tolerability, pharmacokinetics and antiviral effect of different doses and regimens... 2006-07-12 bad-data
Listed as ongoing, but also has a completion date and reported results 2004-003866-13 A phase IIb, 96 week, randomised, partially,double-blinded,multicentre,parallel group, repeat dose study to evaluate the safety, tolerability, pharmacokinetics and antiviral effect of GW873140 in comb... 2006-07-21 bad-data
Ongoing 2004-003928-35 A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase III Study Comparing GW572016 and Letrozole versus Letrozole in Subjects with Estrogen/Progesterone Receptor-Positive Advanced or Meta... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2004-004090-29 A Phase III, 18 Month, Multicenter, Randomized, Double-Blind, Active-Controlled Clinical Trial to Compare Rosiglitazone versus Glipizide on the Progression of Atherosclerosis in Subjects with Type 2 D... 2008-08-15 bad-data
Reported results 2004-004193-91 A 12-Week, Parallel-Group, Double-Blind, Randomized, Placebo-Controlled, Multicenter, Dose Ranging Study to Evaluate the Efficacy, Safety and Tolerability of GW823093 (2.5mg, 7.5mg, 15mg, 30mg and 45m... 2006-07-21 due-trials
Reported results 2004-004247-22 A 28-day, Randomised, Double-Blind, Active Comparator, Controlled Study to Assess the Effects of Rosiglitazone, Inhaled Corticosteroid, Theophylline and Theophylline Plus Inhaled Corticosteroid on Inf... 2007-06-06 due-trials
Completed, but no date, and reported results 2004-004248-37 A phase II open (partially double-blind), randomized, controlled, primary vaccination study to assess the immunogenicity, safety and reactogenicity of one intramuscular dose of four different formulat... bad-data
Completed, but no date, and reported results 2004-004342-41 A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects with Partial Seizures bad-data
Reported results 2004-004343-21 A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects with Primary Generalized Tonic-Clonic Seizures 2008-05-13 due-trials
Ongoing 2004-004370-85 A phase III, multicentric open study to evaluate the immunological memory induced by a 3-dose primary vaccination followed by a booster dose with GSK Biologicals’ 11-valent conjugate pneumococcal vacc... not-yet-due
Completed, but no date, and reported results 2004-004371-11 A phase IIIB, partially blind, randomized study to evaluate the immunogenicity and safety of GlaxoSmithKline Biologicals’ measles-mumps-rubella-varicella vaccine (MeMuRu-OKA) given to healthy children... bad-data
Listed as ongoing, but also has a completion date and reported results 2004-004378-10 Multi-center, open-label, non-randomised phase II study to evaluate the activity and tolerability of GW786034 in patients with advanced and/or metastatic soft tissue sarcoma who have relapsed followin... 2014-02-11 bad-data
Completed, but no date, and reported results 2004-004406-24 A Randomised, Double-blind, Multicentre, Superiority Placebo-controlled, Phase III Study to Assess the Efficacy and Safety of Topical 1 SB-275833 Ointment versus Placebo Ointment Applied Twice Daily ... bad-data
Ongoing, reported early 2004-004409-24 A Multi-Centre, Randomised, Double-Blind, Parallel-Group, Placebo-Controlled, Flexible Dose Study to Evaluate the Efficacy, Safety and Tolerability of Extended-Release Bupropion Hydrochloride (150mg-3... not-yet-due
Completed, but no date, and reported results 2004-004434-14 A randomised, double-blind, placebo controlled, parallel group, multicentre two week study to evaluate the efficacy and safety of once-daily, intranasal administration of GW685698X aquenous nasal spra... bad-data
Reported results 2004-004439-70 A Randomised, Observer-blind, Multicentre, Non-inferiority, Comparative, Phase III Study of the Safety and Efficacy of Topical 1% SB-275833 Ointment, Applied Twice Daily for 5 Days, versus Topical 2% ... 2005-09-09 due-trials
Listed as ongoing, but also has a completion date and reported results 2004-004743-22 A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Once-Daily, Intranasal Administration of GW685698X Aqueous Nasal Spray 100mcg f... 2006-01-16 bad-data
Listed as ongoing, but also has a completion date and reported results 2004-004744-43 A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Once-Daily, Intranasal Administration of GW685698X Aqueous Nasal Spray 100mcg f... 2005-12-30 bad-data
Reported results 2004-004745-18 A randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate the safety and efficacy of once-daily, intranasal administration of GW685698X Aqueous Nasal Spray 50mcg an... 2005-11-23 due-trials
Reported results 2004-004749-17 A randomized, double-blind, placebo-controlled, 2-week crossover, knemometric assessment of the effect of once daily GW685698X Aqueous Nasal Spray 100 mcg on short term growth in children ages 6 - 11 ... 2006-01-31 due-trials
Listed as ongoing, but also has a completion date and reported results 2004-004984-32 A Randomised, Double-Blind, Double-Dummy, Parallel-Group, Placebo-Controlled, Forced Dose Titration Study Evaluating the Efficacy and Safety of GW679769 and Paroxetine in Subjects with Major Depressiv... 2006-08-16 bad-data
Ongoing 2004-005024-40 A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP STUDY TO EVALUATE THE SAFETY AND EFFICACY OF LAMOTRIGINE 200-400MG/DAY COMPARED WITH PLACEBO IN SUBJECTS WITH PAINFUL DIABET... not-yet-due
Not reported 2004-005058-30 A randomised, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of 500µg of GW799943X administered once-daily in the morning, 500µg of GW799943X administered ... 2006-04-06 due-trials
Listed as ongoing, but also has a completion date and reported results 2004-005115-29 A randomised, placebo-controlled, parallel group single dose study of SB681323 in patients with active RA to investigate the CRP dose response relationship 2006-08-03 bad-data
Completed, but no date, and reported results 2004-005123-18 A phase III, partially blind, randomised, primary vaccination study to assess the immunogenicity and safety of three different lots of GlaxoSmithKline (GSK) Biologicals’ live attenuated measles-mumps-... bad-data
Listed as ongoing, but also has a completion date 2004-005213-11 A multi-centre, randomised, double-blind, parallel group study assessing the efficacy and safety of IV nesiritide versus placebo, in addition to background care, in the treatment of subjects with acut... 2006-06-01 bad-data
Completed, but no date, and reported results 2004-005262-20 A phase IV, single-blinded, randomized, single centre study to demonstrate the non-inferiority of immunogenicity elicited by GSK Biologicals’ hepatitis B vaccine, Engerix-B in multidose presentation t... bad-data
Completed, but no date 2004-005263-19 A phase III, blinded, randomised, controlled study to evaluate the immunogenicity and safety of three production lots of GlaxoSmithKline Biologicals’ combined measles-mumps-rubella-varicella (MeMuRu-O... bad-data
Reported results 2005-000149-12 A Phase III, 12-week, Multicentre, Double-blind, Double-dummy, Randomised, Placebo- and Active Comparator-Controlled, Parallel Group study to investigate the Efficacy and Safety of GW406381 1mg, 5mg, ... 2005-12-01 due-trials
Listed as ongoing, but also has a completion date and reported results 2005-000158-61 A Phase III, 12-Week, Multicentre, Double-Blind, Randomised, Placebo- and Active Comparator-Controlled, Parallel Group Study to Investigate the Efficacy and Safety of GW406381, 5mg, 10mg, 25mg, and ... 2006-09-14 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-000184-25 A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release XR Tablets Compared with Ropinirole Immediate R... 2006-12-15 bad-data
Reported results 2005-000374-48 A randomized, open label comparative study to determine the proportion of asthma patients on Seretide Diskus 50/250 mcg b.i.d. achieving total control when given medication and compli-ance enhancement... 2007-05-29 due-trials
Completed, but no date, and reported results 2005-000449-12 A phase II, double-blind, randomized, placebo controlled study to compare the immunogenicity, reactogenicity and safety of two different formulations of GlaxoSmithKline (GSK) Biologicals’ live attennu... bad-data
Reported results 2005-000836-25 Seretide vs Flixotide in mild persistent asthma (GINAII) 2007-07-29 due-trials
Completed, but no date 2005-000846-35 GlaxoSmithKline Study EGF100161 – An open-label, multicenter, 2 Part, Phase I/II dose escalation study of oral lapatinib in combination with docetaxel (Taxotere) plus trastuzumab (Herceptin) in subjec... bad-data
Not reported 2005-000848-83 Teilverblindete, randomisierte, Placebo-kontrollierte, multizentrische Studie zur Wirksamkeit von Dickextrakt aus Kürbissamen (Kürbissamen-Extrakt) und Kürbissamen bei Patienten mit benigner Prostatah... 2009-10-28 due-trials
Not reported 2005-000867-24 A PHASE 2b, RANDOMIZED, MULTI-CENTER, ACTIVE-CONTROLLED, OPEN-LABEL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ALBUFERON (RECOMBINANT HUMAN ALBUMIN-INTERFERON ALFA FUSION PROTEIN) IN COMBINATION WI... 2007-05-10 due-trials
Ongoing 2005-000902-30 A Study of the Pharmacodynamic Effects of Prednisolone on Whole Blood Protein and Gene Expression in Rheumatoid Arthritis Patients not-yet-due
Completed, but no date, and reported results 2005-000965-21 A phase II open (partially double-blind), randomized, controlled, primary vaccination study to assess the immunogenicity, safety and reactogenicity of one intramuscular dose of four different formulat... bad-data
Ongoing, reported early 2005-000979-18 A phase IIa/b double-blind, randomised, placebo-controlled, linear trend design dose-ranging study to investigate the effects of 24 weeks of monotherapy with SB-742457 on cognition in subjects with mi... not-yet-due
Reported results 2005-000995-41 A double-blind, randomized, placebo-controlled multi-centre, phase II parallel dose-ranging study to assess the antifibrotic activity of GI262570 in chronic hepatitis C subjects with hepatic fibrosis ... 2008-02-29 due-trials
Completed, but no date 2005-001010-41 An outpatient, randomised, double-blind, placebo controlled, parallel group exploratory study to evaluate safety, tolerability and efficacy of GW679769 in patients with Fibromyalgia syndrome comorbid ... bad-data
Not reported 2005-001122-87 A Randomized Double-Blind Placebo-Controlled, Parallel-Group, Multicenter, Study to Evaluate the Efficacy and Safety of GW685698X Inhalation Powder 200mcg, 400mcg, 600mcg and 800mcg Administered Once ... 2006-01-13 due-trials
Completed, but no date 2005-001123-11 A Randomized Double-Blind Placebo-Controlled, Parallel-Group, Multicenter, Study to Evaluate the Efficacy and Safety of GW685698X Inhalation Powder 25mcg, 50mcg, 100mcg, and 200mcg Administered Once D... bad-data
Completed, but no date 2005-001124-36 A Randomized Double-Blind Placebo-Controlled, Parallel-Group, Multicenter, Study to Evaluate the Efficacy and Safety of GW685698X Inhalation Powder 100mcg, 200mcg, 300mcg and 400mcg Administered Once ... bad-data
Reported results 2005-001150-24 A Phase IIB, Randomized, Multicenter, Parallel Group Study to Evaluate the Short-Term Safety, Pharmacokinetics and Antiviral Activity of Four Blinded Dosing Regimens of GW640385/Ritonavir Therapy Comp... 2007-09-11 due-trials
Listed as ongoing, but also has a completion date and reported results 2005-001246-16 A Phase III, randomized, double-blind, placebo-controlled, multicenter, parallel group study to compare the efficacy and safety of GW873140 400mg BID in combination with a ritonavir-containing optimiz... 2007-06-27 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-001247-39 A Phase III, randomised, double-blind, placebo-controlled, multicentre, parallel group study to compare the efficacy and safety of GW873140 400mg BID in combination with a ritonavir-containing optimis... 2007-08-28 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-001256-20 A randomized, double blind, double dummy, parallel group, placebo controlled study to evaluate the pharmacodynamic and pharmacokinetic response and safety and tolerability of SB424323 250mg, 375mg an... 2006-12-28 bad-data
Reported results 2005-001288-73 A Phase II, open (partially double-blind), randomized, controlled dose-range study to evaluate the immunogenicity, reactogenicity and safety of four different formulations of GlaxoSmithKline (GSK) Bio... 2008-02-13 due-trials
Listed as ongoing, but also has a completion date and reported results 2005-001335-30 A Multicentre, Two-Part, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy, Tolerability and Pharmacokinetics of the iNOS Inhibitor GW274150 Administered up t... 2007-09-11 bad-data
Ongoing, reported early 2005-001384-60 An exploratory, observational cohort study investigating commercially available treatments which may reduce the scab stage of recurrent herpes labialis not-yet-due
Ongoing, reported early 2005-001555-38 Open Immunization Study to Determine the Reactogenicity and Immunogenicity of Fluarix/ Influsplit SSW 2005/2006 in Persons as of 18 Years of Age not-yet-due
Listed as ongoing, but also has a completion date and reported results 2005-001556-20 Integrated Biomarker and Imaging Study – 2 (IBIS-2) 2007-08-28 bad-data
Ongoing, reported early 2005-001558-26 A RANDOMISED, DOUBLE-BLIND, PARALLEL GROUP, PLACEBO-CONTROLLED, MULTICENTRE STUDY TO EVALUATE THE SAFETY, TOLERABILITY AND EFFICACY OF ORAL GW677954 CAPSULES 2.5mg, 5mg, 10mg AND 20mg A DAY FOR 24 WEE... not-yet-due
Reported results 2005-001667-58 A phase III, double-blind, randomized study to assess the consistency of the immunogenicity of three consecutive production lots of GlaxoSmithKline Biologicals’ HPV-16/18 L1/AS04 vaccine administered ... 2007-03-01 due-trials
Listed as ongoing, but also has a completion date and reported results 2005-001723-10 A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate the Efficacy and Safety of Alvimopan 0.5mg Once Daily and 0.5mg Twice Daily for 12 Weeks for the Treatment of Opio... 2006-05-26 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-001724-37 A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate the Efficacy and Safety of Alvimopan 0.5mg Once Daily and 0.5mg Twice Daily for 12 Weeks for the Treatment of Opio... 2006-06-29 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-001725-28 A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate the Long-Term Safety of Alvimopan 0.5mg Twice Daily for 12 Months for the Treatment of Opioid-Induced Bowel Dysfun... 2007-02-16 bad-data
Completed, but no date, and reported results 2005-001771-35 Randomized, Open Label, Active Controlled (Mometasone Furoate Aqueous Nasal Spray [Nasonex®] 200mcg QD), Parallel Group, Multi-Centre, 52-Week Study to Assess the Long Term Safety of GW685698X Aqueous... bad-data
Ongoing 2005-001841-40 A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of GW685698X Inhalation Powder 200mcg Twice-Daily, GW685698X Inhalation Powder 200... not-yet-due
Completed, but no date, and reported results 2005-001928-37 A phase I/II, open, controlled study in order to evaluate the reactogenicity and the immunogenicity of GlaxoSmithKline Biologicals influenza candidate vaccine containing the adjuvant AS25 (FluAS25) in... bad-data
Listed as ongoing, but also has a completion date and reported results 2005-001974-28 A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunct... 2006-05-09 bad-data
Ongoing, reported early 2005-001977-82 A randomised, double-blind, placebo-controlled, parallel group study to investigate the safety, tolerability, pharmacokinetics and effect on synovial thickness and vascularity of 28 days repeat dosing... not-yet-due
Reported results 2005-002044-26 A randomized, double-blind, placebo-controlled, post-marketing phase III Study to evaluate the efficacy of GSK Biologicals’ influenza vaccine (Fluarix™) administered intramuscularly in adults 2006-05-31 due-trials
Listed as ongoing, but also has a completion date and reported results 2005-002212-13 A Phase II Study of GW786034 Using a Randomized Discontinuation Design in Subjects with Locally Recurrent or Metastatic Clear-Cell Renal Cell Carcinoma 2013-09-10 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-002219-26 A randomised, parallel group, placebo-controlled, double blind study to assess the safety and tolerability of SB-681323 at 7.5mg daily dose for 28 days and its effect on the levels of serum C-reactive... 2006-10-18 bad-data
Completed, but no date 2005-002261-37 A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Flexible-Dose Study Evaluating the Efficacy, Safety, and Tolerability of Radafaxine Extended-Release (100-140mg/day) Compar... bad-data
No trial status on register 2005-002352-18 A phase III, randomized, multinational study, double-blinded for the immunogenicity and consistency evaluation of 3 Hib-MenCY-TT vaccine lots and single-blinded and controlled for the evaluation of sa... bad-data
Completed, but no date, and reported results 2005-002360-28 An open, randomized phase I/II study to demonstrate the non inferiority in term of cellular mediated immune response between GlaxoSmithKline Biologicals influenza candidate vaccines containing various... bad-data
Ongoing, reported early 2005-002485-11 A Randomized, Single Blind, Placebo-controlled, Multi-centre, Phase II Study of Lapatinib in Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck not-yet-due
Listed as ongoing, but also has a completion date and reported results 2005-002546-20 A phase III, double-blind, randomized, controlled study to evaluate the safety, immunogenicity and efficacy of GlaxoSmithKline Biologicals’ HPV 16/18 L1/AS04 vaccine administered intramuscularly accor... 2014-01-29 bad-data
Reported results 2005-002883-27 A multi-centre, double blind, double-dummy, placebo-controlled, randomised, adaptive, dose-range study to evaluate the dafety and efficacy of SB-773812 administered once daily for 12 weeks in adults w... 2008-06-28 due-trials
Listed as ongoing, but also has a completion date and reported results 2005-002949-40 A multicentre, randomised, double-blind, double dummy, parallel group study to compare the salmeterol/fluticasone propionate combination SERETIDE at a dose of 50/100mcg twice daily and fluticasone ... 2006-10-26 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-002950-23 A multi-centre, randomised, double blind, stratified, and parallel group study to evaluate whether a treatment strategy based on aiming for ‘Total control’ results in better airway hyper-responsivenes... 2007-08-27 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-002969-37 A randomised, placebo-controlled, parallel group single dose study of GW856553 in patients with active RA to investigate the CRP dose response relationship. 2006-11-18 bad-data
Ongoing, reported early 2005-002976-14 A phase IIa, single-centre, randomised, placebo-controlled, double-blind, three-period crossover exploratory study investigating the effects on gut autonomic responses of single administrations of eit... not-yet-due
Reported results 2005-002978-30 A double-blind, randomized, placebo-controlled, repeat dose study to compare the safety, tolerability, pharmacokinetics and pharmacodynamics of GSK189075 with GW869682 in subjects with type 2 diabetes... 2006-05-24 due-trials
Completed, but no date 2005-003052-36 A phase II, multicentre booster study to evaluate booster vaccination with GSK Biologicals’ 10-valent pneumococcal conjugate vaccine or to evaluate the immune memory following the administration of a ... bad-data
Completed, but no date 2005-003299-40 A phase IIIa randomized, controlled study to assess the immunogenicity of GlaxoSmithKline (GSK) Biologicals’ 10-valent pneumococcal conjugate vaccine, when administered as a 3-dose primary immunizatio... bad-data
Not reported 2005-003300-11 A phase III randomised, controlled study to assess in a double blind manner the lot-to-lot consistency of three consecutive production lots of GlaxoSmithKline (GSK) Biologicals’ 10-valent pneumococcal... 2006-06-28 due-trials
Ongoing, reported early 2005-003319-64 A randomised, placebo-controlled, crossover study to measure the effect of alosetron on mucosal blood flow in female healthy volunteers and diarrhea-predominant IBS subjects not-yet-due
Reported results 2005-003400-11 An Eight-week, Multicenter, Randomized, Double-Blind, Placebo and Active-Controlled, Parallel Group, Fixed-Dose Study Evaluating the Efficacy, Safety, and Tolerability of GSK372475 (1.0 mg/day) or Par... 2008-06-24 due-trials
Listed as ongoing, but also has a completion date and reported results 2005-003401-87 A Ten-Week, Multicenter, Randomized, Double-Blind, Placebo and Active-Controlled, Parallel-Group, Flexible-Dose Study Evaluating the Efficacy, Safety, and Tolerability of GSK372475 (1.5 mg/day to 2.0 ... 2008-12-03 bad-data
Ongoing 2005-003432-22 A Randomized, Double Blind, Placebo-Controlled, Multicenter, Phase III Study Comparing the Activity of Paclitaxel Plus Trastuzumab Plus Lapatinib to Paclitaxel Plus Trastuzumab Plus Placebo in Women w... not-yet-due
Reported results 2005-003437-41 An open, randomized, phase IIIa study to evaluate the safety and immunogenicity of GlaxoSmithKline Biologicals’ 10-valent pneumococcal conjugate vaccine, when administered intramuscularly according to... 2007-01-17 due-trials
Listed as ongoing, but also has a completion date and reported results 2005-003590-24 Estudio multicéntrico, aleatorizado, doble ciego, controlado con placebo, de grupos paralelos, de determinación de dosis óptima de SB-480848, un inhibidor de la fosfolipasa A2 asociada a lipoproteínas... 2006-09-27 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-003767-23 A Randomized, Double-Blind, Placebo-Controlled, Multicentre, Phase II Study of Oral Lapatinib in combination with Concurrent Radiotherapy and Cisplatin versus Radiotherapy and Cisplatin alone, in Subj... 2014-01-21 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-003926-24 A Randomized, Multicenter Open-Label Phase III Study of Lapatinib in Combination with Trastuzumab versus Lapatinib Monotherapy in Subjects with Metastatic Breast Cancer whose disease has progressed on... 2010-10-29 bad-data
Completed, report not yet due 2005-003944-68 A Phase II Study of Lapatinib for Brain Metastases in Subjects with ErbB2-Positive Breast Cancer Following Trastuzumab based Systemic Therapy and Cranial Radiotherapy 2018-03-15 not-yet-due
Completed, but no date, and reported results 2005-003945-16 An open-label, single-arm, multicentre, Phase II study of oral lapatinib in combination with paclitaxel as first-line treatment for ErbB2-amplified metastatic breast cancer patients bad-data
Listed as ongoing, but also has a completion date and reported results 2005-004078-25 A Randomized, Double-blind, Placebo-controlled, Multi-center Phase III Study to Evaluate the Efficacy and Safety of Pazopanib (GW786034) Compared to Placebo in Patients with Locally Advanced and/or Me... 2014-12-29 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-004285-16 A 28-day, randomized, double-blind, placebo-controlled study to assess the safety, tolerability, anti-inflammatory effect and steady-state pharmacokinetics of SB-681323 (7.5 mg) in subjects with coron... 2007-08-03 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-004350-28 A Phase II, Open-Label, Randomized, Multicenter Trial of GW786034 (Pazopanib) in Combination with Lapatinib (GW572016) Compared to Lapatinib Alone as First Line Therapy in Subjects with Advanced or Me... 2015-03-17 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-004419-31 A multi-centre, randomised, double-blind, placebo-controlled, four-way incomplete block crossover study, to examine efficacy, safety, tolerability, pharmacodynamics and pharmacokinetics of single and ... 2007-01-11 bad-data
Ongoing, reported early 2005-004434-40 A randomised, double-blind, double dummy, 3 way cross-over study evaluating the effects of Seretide 50/500mcg twice daily plus tiotropium bromide 18mcg once daily compared with the individual treatmen... not-yet-due
Ongoing, reported early 2005-004480-37 A single blind, placebo controlled, multi-centre study to investigate the pharmacokinetics, safety, tolerability and pharmacodynamics of the TRPV1 antagonist SB-705498 against the pain of acute migrai... not-yet-due
Reported results 2005-004481-16 A multi-centre, randomised, single blind, placebo controlled, parallel group study to examine the effect of single doses of SB-705498, a TRPV1 receptor antagonist, on pain following third molar tooth ... 2007-10-02 due-trials
Reported results 2005-004493-25 A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicentre Study to Evaluate the Efficacy and Safety of Once-Daily Intranasal Administration of GW685698X Aqueous Nasal Spray 100mcg fo... 2006-06-23 due-trials
Completed, but no date, and reported results 2005-004497-24 Observer-blinded, randomised, controlled, phase I/II study, to evaluate the safety, reactogenicity and immunogenicity of GSK Biologicals’ candidate tuberculosis vaccines M72/AS01B and M72/AS02A when ... bad-data
Not reported 2005-004517-14 Open study to determine the immunogenicity and reactogenicity of Influsplit SSW 2005/2006 in children from 6 years until 13 years of age 2006-04-20 due-trials
Reported results 2005-004889-17 A randomized, double-blind, placebo-controlled, crossover study to evaluate the effects of morning administration of GW679769 (10mg and 30 mg) on polysomnograph sleep recordings, subjective sleep asse... 2007-07-13 due-trials
Ongoing, reported early 2005-005089-34 A double-blind, randomised, placebo-controlled, parallel-group study to investigate the effects of rosiglitazone (extended release tablets) on cerebral glucose utilisation and cognition in subjects wi... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2005-005186-10 A Randomized, Double-blind, Multicenter, Placebo-controlled Study of Adjuvant Lapatinib in Women with Early-Stage ErbB2 Overexpressing Breast Cancer 2013-08-05 bad-data
Ongoing, reported early 2005-005307-42 An evaluation of the 4 mg nicotine mint lozenge for the relief of cognitive impairment associated with nicotine withdrawal. not-yet-due
Listed as ongoing, but also has a completion date and reported results 2005-005329-68 A multi-centre, randomised, double-blind, placebo-controlled, four-way incomplete crossover study to examine efficacy, safety, tolerability, pharmacodynamics and pharmacokinetics of single and repeat ... 2007-01-24 bad-data
Reported results 2005-005336-27 The INPACT study Improving with Nadroparin the Prognosis in Advanced Cancer Treatment - A randomized, controlled trial to evaluate the effects of nadroparin on survival and disease progression in pa... 2009-09-07 due-trials
Reported results 2005-005339-83 A two-centre, randomised, double-blind, placebo-controlled, 2-period cross-over study to evaluate the effect of treatment with repeat doses of inhaled GSK256066 on the allergen-induced late asthmatic ... 2007-06-20 due-trials
Reported results 2005-005340-12 A 14 day, randomised, double blinded, placebo-controlled 2-way crossover trial of repeat doses of intranasal GSK256066 and placebo in an environmental exposition unit (Vienna Challenge Chamber) in sub... 2006-05-22 due-trials
Listed as ongoing, but also has a completion date and reported results 2005-005372-32 A randomised, double-blind, placebo-controlled, parallel group study to evaluate the efficacy and safety of ropinirole for 26 weeks and to further evaluate the incidence of augmentation and rebound fo... 2008-09-11 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-005421-59 Abbreviato A study in children to assess a 2-dose primary vaccination followed by a booster vaccination of GlaxoSmithKline Biologicals vaccine against Haemophilus influenzae type b and meningococcal... 2007-06-07 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-005423-34 A Randomised, Double-Blind, Double-Dummy, Parallel Group Comparison of 24 Weeks of Treatment with Ropinirole Immediate Release IR Tablets or Ropinirole Prolonged Release / Extended Release PR/XR T... 2007-08-23 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-005430-12 Randomised, double-blind, placebo-controlled study of topical GW842470X formulation in adult patients with moderate atopic dermatitis 2006-11-18 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-005431-97 An Eight-Week Randomized, Double-Blind, Placebo-Controlled, Parallel Group Proof of Concept Dose Ranging Study to Assess the Efficacy, Safety and Tolerability as well as the Pharmacokinetic Profile of... 2007-03-07 bad-data
Reported results 2005-005602-23 Evaluation of Novel Endpoints in Subjects with Chronic Obstructive Pulmonary Disease (COPD) in a Randomized, Double-Blind, Placebo-Controlled Study of Treatment with Fluticasone Propionate/Salmeterol ... 2007-02-13 due-trials
Listed as ongoing, but also has a completion date and reported results 2005-005682-11 A phase I/II, randomized, observer blinded study to evaluate and compare the safety, reactogenicity and immunogenicity of various formulations of the GlaxoSmithKline Biologicals’ adjuvanted 11-valent ... 2007-09-18 bad-data
Ongoing, reported early 2005-005703-42 A 12 week, randomised, double blind study evaluating the effects of low dose (10mg) and high dose (80mg) atorvastatin on macrophage activity and carotid plaque inflammation as determined by Ultra smal... not-yet-due
Completed, but no date 2005-005825-75 A phase II, open, randomised, comparative study to evaluate the immunogenicity and safety of GlaxoSmithKline s GSK Biologicals measles-mumps-rubella-varicella candidate vaccine MeMuRu-OKA and GSK... bad-data
Listed as ongoing, but also has a completion date and reported results 2005-005855-16 A Phase III Multicenter, Randomized, Double-blind, Parallel Group Study to Evaluate the Safety and Efficacy of the 30 mg Intravenous Formulation of the Neurokinin-1 Receptor Antagonist GW679769 for Pr... 2006-07-06 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-005856-42 A Phase III, Multicenter, Randomized, Double-blind, Parallel Group Study to Evaluate the Safety and Efficacy of 50 mg Oral Dosing with the Neurokinin-1 Receptor Antagonist GW679769 for the Prevention ... 2006-07-11 bad-data
Completed, reported early 2005-005943-24 A phase I/II, observer-blind, randomized, controlled study to assess the immunogenicity and safety of GlaxoSmithKline Biologicals’ HPV-16/18 L1/AS04 vaccine administered intramuscularly according to a... 2007-06-19 not-yet-due
Completed, but no date 2005-005944-22 Open, multicenter, randomised, controlled phase IIIb study evaluating the immunogenicity and safety of subcutaneous versus intramuscular administration of GlaxoSmithKline Biologicals’ combined measles... bad-data
Not reported 2005-006065-14 A phase II, open, randomised, comparative study to evaluate the immunogenicity and safety of GlaxoSmithKline GSK Biologicals measles-mumps-rubella-varicella candidate vaccine MeMuRu-OKA and GSK B... 2006-11-24 due-trials
No trial status on register 2005-006066-34 A phase III, single-blind, randomized, controlled, multinational study for the evaluation of safety of GSK Biologicals' Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-teta... bad-data
Ongoing, reported early 2005-006074-10 A randomized, double-blind, parallel group clinical trial to assess safety, tolerability, pharmacokinetics, and pharmacodynamics of intravenous mepolizumab (SB240563) (0.55mg/kg, 2.5mg/kg or 10mg/kg) ... not-yet-due
Reported results 2005-006118-17 A Randomized, Double-Blind, Placebo-Controlled, Crossover, Phase IIa Study to Evaluate Efficacy and Safety of the beta3-Adrenergic Receptor Agonist Solabegron in Subjects with Irritable Bowel Syndrome 2007-06-14 due-trials
Listed as ongoing, but also has a completion date and reported results 2005-006163-31 A single-arm, international, multi-center trial of HuMax-CD20, a fully human monoclonal anti-CD20 antibody, in patients with B-cell Chronic Lymphocytic Leukemia who have failed fludarabine and alemtuz... 2012-06-06 bad-data
Ongoing, reported early 2006-000143-26 A Phase II, Non-randomized, Multicenter Study to Evaluate the Safety and Efficacy of Pazopanib (GW786034) as Pre-Surgical Therapy in Treatment-Naïve Subjects with Stage IA or IB, Resectable Non Small ... not-yet-due
Reported results 2006-000215-22 A randomised, double blind, placebo controlled, two-way crossover, three phase, study, to investigate the trial models, Vienna Challenge Chamber, in and out of season, and Park Study in season and the... 2006-11-20 due-trials
Listed as ongoing, but also has a completion date and reported results 2006-000236-27 A Phase II, Open-Label, Randomized, Multicenter Trial of Pazopanib (GW786034) in Combination with Lapatinib (GW572016) Compared to Pazopanib Monotherapy and Lapatinib Monotherapy in Subjects with FIGO... 2011-07-21 bad-data
Reported results 2006-000253-21 Reaching asthma control with salmeterol/fluticasone 50 / 250µg bd combination in steroid naive or low dose JCS patients by using the asthma control test (ACT) as measurement. 2007-09-14 due-trials
Ongoing, reported early 2006-000442-39 An open, phase I/II study to evaluate the safety, reactogenicity and immunogenicity of GSK Biologicals’ 11PCV combined with adjuvant AS02V given as a 2-dose vaccination in adults aged 18-40 years old. not-yet-due
Listed as ongoing, but also has a completion date and reported results 2006-000468-95 A double-blind, randomised, placebo-controlled, parallel group study to investigate the effects of SB-742457, donepezil and placebo on cognition in subjects with mild to moderate Alzheimer's Disease 2007-06-12 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-000470-78 A randomized, double-blind, placebo-controlled phase III study, to evaluate the efficacy, safety and tolerability of eltrombopag olamine (SB-497115-GR), a thrombopoietin receptor agonist, administered... 2008-07-18 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-000471-14 EXTEND (Eltrombopag eXTENded Dosing Study): An extension study of eltrombopag olamine (SB-497115-GR) in adults, with idiopathic thrombocytopenic purpura (ITP), previously enrolled in an eltrombopag s... 2015-07-06 bad-data
Completed, but no date, and reported results 2006-000518-19 A Phase III, open, multicentre study to assess the long-term persistence of a booster dose of GSK Biologicals? Hib-MenC conjugate vaccine compared to a booster dose of Infanrix? hexa (combined diphthe... bad-data
Reported results 2006-000549-20 An open, phase IV, multicentre study to assess the long-term persistence of antibodies against hepatitis B and the immune response to a hepatitis B vaccine challenge in healthy children 7 to 9 years o... 2006-12-14 due-trials
Reported results 2006-000553-22 An open, phase IV, multicentre study to assess the long-term persistence of antibodies against hepatitis B and the immune response to a hepatitis B vaccine challenge in healthy children 4-6 years old,... 2006-11-27 due-trials
Reported results 2006-000554-46 A phase II, observer-blind, randomized study to evaluate the immunogenicity, safety and reactogenicity of GlaxoSmithKline (GSK) Biologicals’ combined DSSITGDPa-HBV-IPV/Hib vaccine containing diphtheri... 2007-05-31 due-trials
Reported results 2006-000556-41 An open, phase IV, single-group multicentre study to assess the long-term persistence of antibodies against hepatitis B and the immune response to a hepatitis B vaccine challenge in children at 4-5 ye... 2007-05-14 due-trials
No trial status on register 2006-000557-21 A phase IIIb randomized, double-blind, controlled study to assess the safety, reactogenicity and immunogenicity of GlaxoSmithKline (GSK) Biologicals’ 10-valent pneumococcal conjugate vaccine compared ... bad-data
Listed as ongoing, but also has a completion date and reported results 2006-000558-30 A phase IIIb randomised, open, controlled study to assess the safety, reactogenicity and immunogenicity of GlaxoSmithKline (GSK) Biologicals’ 10-valent pneumococcal conjugate vaccine when co-administe... 2007-10-24 bad-data
Ongoing, reported early 2006-000559-16 A phase IIIb randomized, open, controlled study to assess the effect of prophylactic antipyretic treatment on the rate of febrile reactions following concomitant administration of GlaxoSmithKline (GS... not-yet-due
Not reported 2006-000560-93 A phase IIIa, open, multicentre study to evaluate the immunological memory induced in healthy children following a 3-dose primary vaccination with either GSK Biologicals’ 10-valent pneumococcal conjug... 2006-12-08 due-trials
Ongoing 2006-000562-36 ALTTO (Adjuvant Lapatinib and/or Trastuzumab Treatment Optimisation) study. A randomised, multi-centre, open-label, phase III study of adjuvant lapatinib, trastuzumab, their sequence and their combina... not-yet-due
Ongoing 2006-000564-81 A randomised, multicenter open-label phase III study of neoadjuvant lapatinib, trastuzumab and their combination plus paclitaxel in women with HER2/ErbB2 positive primary breast cancer not-yet-due
Ongoing 2006-000635-94 A Phase II, randomized, double-blind, parallel group study to examine bone quality and bone mineral density changes following treatment with SB-462795 (40mg, 80mg, 120mg or 160mg), alendronate or plac... not-yet-due
Reported results 2006-000729-70 A randomised, double-blind, placebo-controlled parallel study to assess the safety, tolerability, pharmacodynamics and steady-state pharmacokinetics of repeated doses of GW856553 in patients with COPD... 2007-12-20 due-trials
Listed as ongoing, but also has a completion date and reported results 2006-000781-37 A Phase III, Multicenter, Randomized, Double-Blind, Active Controlled, Parallel Group Study of the Safety and Efficacy of the Intravenous and Oral Formulations of the Neurokinin-1 Receptor Antagonist... 2009-09-30 bad-data
Reported results 2006-000923-32 A randomised, double-blind, placebo-controlled, Bayesian adaptive dose finding study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of single and repeat intravenous inf... 2009-10-29 due-trials
Reported results 2006-000939-97 A phase IIb, controlled, randomised, multicenter, single blind study to demonstrate the Non-Inferiority of the low dose influenza vaccine with or without adjuvant AS03 compared with Fluarix™ (GlaxoSmi... 2006-12-19 due-trials
Ongoing, reported early 2006-000956-42 A multicenter, open-label, long-term, safety, tolerability and efficacy study of retigabine in adult epilepsy patients with partial-onset seizures (Extension of Study VRX-RET-E22-302) not-yet-due
Listed as ongoing, but also has a completion date and reported results 2006-001072-21 A double-blind placebo-controlled study of the efficacy and safety of the P38 Map Kinase inhibitor SB681323 in patients with neuropathic pain following nerve trauma 2008-04-23 bad-data
Ongoing, reported early 2006-001168-22 A phase II, randomized, open, partially controlled study to evaluate the safety and immunogenicity of different formulations of a pandemic influenza vaccine candidate (split virus formulation adjuvant... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2006-001169-40 A phase IIb, controlled, randomised, multicenter, observer blinded study to demonstrate the lot-to-lot consistency of three consecutive production lots of low dose of influenza vaccine adjuvanted with... 2006-12-18 bad-data
Ongoing, reported early 2006-001234-40 Estudio aleatorizado, doble ciego, controlado con placebo para investigar la seguridad, tolerabilidad y actividad clínica de dosis orales repetidas de 7,5 mg de GW856553 dos veces al día durante 28 d... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2006-001275-38 A Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group, Placebo-Controlled, Study To Evaluate Efficacy, Safety And Tolerability Of Oral GW677954 Capsules (2.5, 5, 10, 15 And 20 Mg Once ... 2006-10-20 bad-data
Not reported 2006-001276-20 A randomized, open-label, multicenter, parallel-group study to compare the efficacy, safety and resource utilization of a remifentanil/propofol analgosedation regimen versus a sufentanyl/propofol anal... 2007-06-14 due-trials
Ongoing, reported early 2006-001278-26 Phase I and II, Open-Label, Multi-Center Trials of Pazopanib in Combination with Lapatinib in Adult Patients with Relapsed Malignant Glioma not-yet-due
Listed as ongoing, but also has a completion date and reported results 2006-001281-16 A phase III, observer-blind, randomised study to evaluate the safety and immunogenicity of one and two administrations of pandemic monovalent (H5N1) influenza vaccine (split virus formulation containi... 2007-02-02 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-001402-92 A 54-week, double-blind, randomized, placebo-controlled, parallel-group study to investigate the effects of rosiglitazone (extended release tablets) as adjunctive therapy to acetylcholinesterase inhib... 2009-03-24 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-001403-11 A 54-week, double-blind, randomized, placebo-controlled, parallel-group study to investigate the effects of rosiglitazone extended release tablets as adjunctive therapy to donepezil on cognition and... 2009-01-28 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-001417-16 A randomized, double-blind, double-dummy, parallel group study evaluating the safety of fluticasone propionate/salmeterol 100/50mcg HFA (2 inhalations of 50/25mcg) twice daily compared with fluticason... 2008-01-25 bad-data
Reported results 2006-001419-30 A randomised, double-blind, placebo-controlled, dose ascending, 3 period crossover study to examine the safety, tolerability, pharmacodynamics and pharmacokinetics of repeat inhaled doses of GSK233705... 2007-04-03 due-trials
Listed as ongoing, but also has a completion date and reported results 2006-001433-17 A double-blind, randomized, two-dose-arm, parallel group, international, multi-center trial of HuMax-CD20, a fully human monoclonal anti-CD20 antibody, in patients with Follicular Lymphoma who are ref... 2013-05-23 bad-data
Reported results 2006-001481-17 A phase IIIb, open, controlled study to assess the effect of prophylactic antipyretic treatment on the rate of febrile reactions following concomitant booster administration of GlaxoSmithKline (GSK) B... 2009-02-17 due-trials
Reported results 2006-001482-42 A phase IIIb open, controlled study to evaluate the immunogenicity, safety and reactogenicity of GlaxoSmithKline (GSK) Biologicals’ 10-valent pneumococcal conjugate vaccine when given as a catch-up im... 2008-08-27 due-trials
Listed as ongoing, but also has a completion date and reported results 2006-001623-18 A Randomised, Double-Blind, Placebo-Controlled, Multi-centre, Phase III Study of Post-Operative Adjuvant Lapatinib or Placebo and Concurrent Chemoradiotherapy Followed by Maintenance Lapatinib or P... 2013-11-15 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-001628-38 A phase IIIa single-blind, controlled multicentre study to assess the safety, reactogenicity and immunogenicity of GSK Biologicals 10-valent pneumococcal conjugate vaccine or Prevenar when given as a ... 2007-11-06 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-001839-21 Chemotherapy plus Lapatinib (GW572016) or Trastuzumab or both in HER2+ Primary Breast Cancer. A Randomized Phase IIb study with Biomarker Evaluation 2012-06-21 bad-data
Completed, but no date 2006-001877-13 A randomised, double-blind, double-dummy, parallel-group, placebo-controlled study comparing correlates of brain functional activation before and after treatment with placebo, active comparator paroxe... bad-data
Completed, but no date 2006-001891-19 A multi-centre, randomised, dose-ascending, double-blind, placebo-controlled, four-way incomplete block crossover study, to examine efficacy, safety, tolerability, pharmacodynamics and pharmacokinetic... bad-data
Ongoing, reported early 2006-001907-13 Letrozole versus Letrozole plus lapatinib (GW572016) in hormone-sensitive, HER-2 negative operable breast cancer. A double blind randomized phase II study with biomarker evaluation not-yet-due
Reported results 2006-001918-33 A Phase III study for evaluation of immunogenicity and reactogenicity of Fluarix™ (Influspit SSW®) 2006/2007 in people aged 18 years or above 2006-08-28 due-trials
Reported results 2006-001934-42 A phase IIIa open, randomised, controlled study to assess the safety, reactogenicity and immunogenicity induced by a booster dose of GlaxoSmithKline (GSK) Biologicals 10-valent pneumococcal conjugate ... 2007-08-13 due-trials
Listed as ongoing, but also has a completion date and reported results 2006-002033-21 A Phase III Multicenter, Randomized, Double-Blind, Active-Controlled, Parallel Group Study of the Efficacy and Safety of the Intravenous and Oral Formulations of the Neurokinin-1 Receptor Antagonist, ... 2007-10-09 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-002038-39 A 24-week, double-blind, double-dummy, randomized, parallel-group study to investigate the effects of rosiglitazone (extended release tablets), donepezil, and placebo as monotherapy on cognition and ... 2008-10-01 bad-data
Reported results 2006-002074-22 A Randomized, Phase III, Open-Label Study of Oral Topotecan Plus Whole-Brain Radiation Therapy (WBRT) Compared with WBRT Alone in Patients with Brain Metastases from Non-Small Cell Lung Cancer. 2013-09-18 due-trials
Listed as ongoing, but also has a completion date 2006-002080-93 An Open-Label Expanded Access Study of Lapatinib and Capecitabine Therapy in Subjects with ErbB2 Overexpressing Locally Advanced or Metastatic Breast Cancer 2015-05-31 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-002088-18 An open label, dose escalation study with a double blind randomised placebo controlled withdrawal to examine the effects of the histamine H3 antagonist GSK189254 in patients with narcolepsy. 2007-12-10 bad-data
Ongoing, reported early 2006-002095-18 A phase II randomized, double-blind (observer blind), adjuvant justification study of RTS,S/AS01B and RTS,S/AS02A, candidate malaria vaccines, administered according to a 0, 1, 2 months schedule in ma... not-yet-due
Reported results 2006-002139-26 An open label, repeat dose, dose escalation study conducted in RLS patients to characterize pharmacokinetics and food effect of ropinirole controlled release for RLS 2006-12-12 due-trials
Not reported 2006-002157-79 “A Multi-Center, Double-Blind, Parallel-Group, Randomized, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Denagliptin in Subjects With Type 2 Diabetes Mellitus” 2006-12-18 due-trials
Listed as ongoing, but also has a completion date and reported results 2006-002381-18 An Open-Label Extension Study to Assess the Safety and Efficacy of Pazopanib in Subjects with Renal Cell Carcinoma previously enrolled on Protocol VEG105192 2013-12-20 bad-data
Reported results 2006-002407-14 Eptifibatide Versus Abciximab in primary PCI for Acute ST elevation Myocardial Infarction (EVA-AMI) 2007-12-04 due-trials
Ongoing, reported early 2006-002632-21 A double-blind, randomised, placebo controlled, single dose, two-period crossover study to investigate the therapeutic potential of the TRPV1 antagonist SB-705498 in treatment of subjects with rectal ... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2006-002633-20 Estudio aleatorizado, doble-ciego, controlado con placebo, de grupos paralelos, de definición de dosis, para investigar la eficacia mediante RM y la seguridad de la administración de firategrast (150 ... 2010-05-27 bad-data
Completed, but no date, and reported results 2006-002680-18 A phase II, controlled, randomized, single blind study to evaluate the immunogenicity, safety and reactogenicity of the low dose influenza vaccine adjuvanted with AS03 compared to Fluarix™ (GlaxoSmith... bad-data
Listed as ongoing, but also has a completion date and reported results 2006-002691-18 A multi-centre, randomised, single-blind, placebo-controlled, parallel group study to investigate the efficacy of single pre-emptive doses of GW842166X, a non-cannabinoid CB2 receptor agonist, on pain... 2007-03-29 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-002703-13 A Phase 3, Randomized, Multi-Center Study to Evaluate the Efficacy and Safety of Albumin Interferon Alfa-2b (alb-IFN) in Combination with Ribavirin Compared with Peginterferon Alfa-2a (PEGASYS or PEG-... 2009-02-13 bad-data
Listed as ongoing, but also has a completion date 2006-002704-34 A Phase 3, Randomized, Multi-Center Study to Evaluate the Efficacy and Safety of Albumin Interferon Alfa-2b (alb-IFN) in Combination with Ribavirin Compared with Peginterferon Alfa-2a (PEGASYS or PEG-... 2008-10-15 bad-data
Reported results 2006-002839-24 A randomized, double-blind, placebo-controlled, multi-country and multi-center, phase IV study to demonstrate the efficacy of GSK Biologicals’ influenza vaccine (Fluarix™) administered intramuscularly... 2007-06-07 due-trials
Reported results 2006-002897-23 An observational study to investigate the incidence of influenza and influenza-related complications, in adults between 50-64 years and elderly adults 65 years and over vaccinated with GSK Biologicals... 2007-06-18 due-trials
Ongoing, reported early 2006-002898-47 A phase IIIb open study to assess the safety and immunogenicity of GlaxoSmithKline (GSK) Biologicals´ 10-valent pneumococcal conjugate vaccine when co-administered with DTPa-HBV-IPV/Hib (Infanrix hexa... not-yet-due
Ongoing 2006-002911-28 A multicentre, randomized, double-blind, parallel-group, placebo-controlled, dose-ranging study to evaluate the efficacy, safety and tolerability of once daily oral dosing of GW501516 (2.5 mg, 5 mg an... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2006-002943-10 REPEAT. Repeated ExPosure To Eltrombopag in Adults with Idiopathic Thrombocytopenic Purpura. An Open-label repeat dosing study of eltrombopag olamine (SB-497115-GR) in adult subjects, with chronic ... 2008-06-24 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-002945-36 LENS – Long-term Eltrombopag ObservatioNal Study - A long term observational ocular safety study in adults who have received study medication (SB-497115-GR / eltrombopag olamine or placebo) in a phase... 2013-03-07 bad-data
Ongoing, reported early 2006-002946-13 A three part, staggered cohort, open-label and double blind, randomized, placebo controlled study to investigate the efficacy, safety, tolerability and pharmacokinetics of eltrombopag, a thrombopoieti... not-yet-due
Completed, but no date 2006-003023-37 A Randomised, Double-Blind, Placebo-Controlled, Multicentre Phase IV Study to Evaluate the Efficacy and Safety of Dutasteride 0.5mg Administered Orally Daily for 24 Weeks to Reduce the Risk of Acute U... bad-data
Completed, but no date, and reported results 2006-003236-30 A phase II, open, controlled study to evaluate the reactogenicity and the immunogenicity of GlaxoSmithKline Biologicals AS25 adjuvanted influenza vaccine (FluAS25) in elderly adults previously vaccin... bad-data
Completed, but no date, and reported results 2006-003237-32 A phase II, open, controlled study to evaluate the reactogenicity and the immunogenicity of GlaxoSmithKline Biologicals AS25 adjuvanted influenza vaccine (FluAS25) in elderly adults previously vaccin... bad-data
Listed as ongoing, but also has a completion date and reported results 2006-003238-14 A phase II/III, observer-blind, multicountry, multicentre, randomized study to demonstrate the superiority in terms of immunogenicity of AS25 adjuvanted influenza vaccine administered in adults aged 5... 2007-06-14 bad-data
Ongoing, reported early 2006-003239-61 A phase III, randomised study to evaluate the clinical consistency in terms of immunogenicity and reactogenicity of three production lots of the liquid formulation of GlaxoSmithKline (GSK) Biologicals... not-yet-due
Ongoing, reported early 2006-003295-36 Randomised double-blind, placebo-controlled, cross-over study comparing the effects of single dose and repeated dosing treatment for 14 days of vestipitant / paroxetine combination in an enriched popu... not-yet-due
Reported results 2006-003374-10 An Open-Label, Non-Comparative Study to Assess the Pharmacokinetics, Safety and Efficacy of Topical Retapamulin (SB-275833) Ointment, 1%, Twice Daily for Five Days in the Treatment of Uncomplicated Sk... 2008-09-26 due-trials
Listed as ongoing, but also has a completion date and reported results 2006-003500-19 A multi-centre, randomised, double-blind, double-dummy, placebo-controlled, 3-way crossover, incomplete block design study to investigate the efficacy, safety, tolerability, pharmacodynamics and pharm... 2007-05-31 bad-data
Reported results 2006-003597-10 Study CRH103390: A 12 Week Flexible Dose Study of GW876008, Placebo and Active Control (Paroxetine) in the Treatment of Social Anxiety Disorder (SocAD) 2007-08-30 due-trials
Completed, but no date, and reported results 2006-003602-26 A double-blind, two-period, placebo controlled cross-over study of the effects of the CB2 agonist GW842166 on pain and sensitisation in patients with osteoarthritis. bad-data
Listed as ongoing, but also has a completion date and reported results 2006-003762-33 A phase IIIb, double blind, randomised, placebo–controlled, multi–country, multicentre study to assess the safety, reactogenicity and immunogenicity of two doses of GlaxoSmithKline (GSK) Biologicals’ ... 2008-03-25 bad-data
Completed, but no date, and reported results 2006-003769-15 A phase II, controlled, randomized, single centre, single blind study to evaluate the immunogenicity, safety and reactogenicity of the low dose influenza vaccine with various doses of AS03 adjuvant co... bad-data
Completed, but no date, and reported results 2006-003796-12 A Phase I-II partially-blinded, randomized, dose- ranging study (10-30-90 mcg) to compare the safety and immunogenicity of GSK Biologicals’ candidate HIV vaccine F4co (p24-RT-Nef-p17), adjuvanted or n... bad-data
Listed as ongoing, but also has a completion date and reported results 2006-003807-38 A phase IIIb, randomized, open, multicentre study to evaluate the immunogenicity and safety of GlaxoSmithKline Biologicals’ HPV-16/18 L1 AS04 vaccine co-administered with GlaxoSmithKline Biologicals’ ... 2008-07-25 bad-data
Reported results 2006-003815-31 A phase IIb, controlled, randomized, multicenter, observer blinded study to evaluate the immunogenicity, safety and reactogenicity of a second vaccination with the low dose influenza vaccine adjuvante... 2007-02-05 due-trials
Completed, reported early 2006-004014-41 A randomised, single-blind, placebo-controlled study to investigate the safety, tolerability, immunogenicity, pharmacokinetics and pharmacodynamics of intravenous infusion of GSK933776A in patients wi... 2011-05-30 not-yet-due
Ongoing, reported early 2006-004033-15 A multicentre, randomised, placebo-controlled, double-blind, 4-arm parallel-group, 2-week study to evaluate the safety, tolerability, pharmacodynamics and pharmacokinetics of GW642444H (100 and 400mcg... not-yet-due
Reported results 2006-004041-42 A phase II, randomised, open study to evaluate the immunogenicity and safety of a single or double-dose of the pandemic influenza candidate vaccine split virus formulation adjuvanted with AS03 gi... 2008-03-05 due-trials
Listed as ongoing, but also has a completion date and reported results 2006-004152-20 A 52-week open-label extension study of the long-term safety and efficacy of rosiglitazone extended-release (RSG XR) as adjunctive therapy to acetylcholinesterase inhibitors in subjects with mild-to-m... 2009-05-30 bad-data
Completed, but no date, and reported results 2006-004204-39 A randomized, open label, multicentre study to compare the pharmaco-economic implications of an analgesia based regimen with remifentanil and a conventional sedation based regimen using propofol in me... bad-data
Ongoing, reported early 2006-004212-48 Estudio doble ciego, aleatorizado, controlado con placebo y alprazolam, de diseño cruzado con tres periodos y bloques incompletos, para comparar mediante Resonancia Magnética Funcional, las posibles ... not-yet-due
Completed, but no date, and reported results 2006-004236-70 A phase IIb, open, randomized, controlled primary vaccination study to evaluate the non-inferiority and the persistence of the immune response of GSK Biologicals’ meningococcal serogroup ACWY conjugat... bad-data
Reported results 2006-004694-97 A dose-ranging study of GSK189075 versus placebo in the treatment of Type 2 Diabetes in treatment naïve subjects. 2008-02-07 due-trials
Ongoing 2006-004695-12 A Dose-Ranging Study of GSK189075 versus Placebo in the treatment of Type 2 Diabetes Mellitus in Subjects taking Metformin. not-yet-due
Listed as ongoing, but also has a completion date and reported results 2006-004774-27 An International, Multicentre, Randomised, Double-blind, Placebo-controlled, Two-parallel Group, Phase III Study to Evaluate the Efficacy and Safety of ARIXTRA (2.5 mg subcutaneously) for the Treatmen... 2009-07-31 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-004777-10 A Phase I/II study to assess the safety and immunogenicity of recMAGE-A3+AS15 cancer immunotherapeutic given as adjuvant therapy, with or without adjuvant chemo(-radio)therapy, to patients with MAGE-A... 2013-08-08 bad-data
Ongoing, reported early 2006-004790-10 A Proof-of-Principle Analgesic Adjuvant Pilot Study in Post-Operative Dental Pain not-yet-due
Reported results 2006-004863-69 A phase II, single-blind, randomized, controlled, multicentre vaccination study to evaluate the safety and immune response of the GSK Biologicals Zoster vaccine, gE/AS01B, and to compare 3 doses of gE... 2014-07-14 due-trials
Listed as ongoing, but also has a completion date and reported results 2006-004946-17 ENABLE 1 (Eltrombopag to INitiate and Maintain Interferon Antiviral Treatment to Benefit Subjects with Hepatitis C related Liver DiseasE) Randomised, placebo-controlled, multi-centre study to assess t... 2011-04-08 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-005078-28 A 52-week open-label extension study of the long-term safety and efficacy of rosiglitazone extended-release (RSG XR) in subjects with mild-to-moderate Alzheimer's disease (REFLECT-5). 2009-02-12 bad-data
Listed as ongoing, but also has a completion date 2006-005177-21 A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled 76 week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006, LymphoStat-B™), a Fully Human Monoclonal Anti-BLyS Antibo... 2010-03-04 bad-data
Ongoing, reported early 2006-005227-42 A double-blind, placebo-controlled, parallel study to evaluate the effects of GW-856553 on endothelial function/ vascular compliance in subjects with dyslipidaemia. not-yet-due
Reported results 2006-005228-18 A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study to Evaluate the Efficacy and Safety of GW685698X 200mcg Twice Daily, GW685698X 200mcg and 400mcg Once Daily in the Mor... 2007-09-06 due-trials
Reported results 2006-005477-22 A phase II, open, randomized study in adults aged between 18 and 60 years designed to evaluate the reactogenicity and immunogenicity of a 1- and 2-dose prime-boost concept of pandemic monovalent (H5N1... 2008-10-20 due-trials
Reported results 2006-005578-39 A randomised, double-blind, placebo-controlled study to explore the antidepressant properties of the P38a kinase inhibitor GW856553X 15mg compared to placebo in subjects with Major Depressive Disorder... 2008-06-30 due-trials
Listed as ongoing, but also has a completion date and reported results 2006-005579-16 Study of Once-Daily Versus Twice-Daily Fosamprenavir plus Ritonavir, Administered with Abacavir/Lamivudine Once-Daily in Antiretroviral-Naïve HIV-1 Infected Adult Subjects. 2008-08-01 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-005733-38 A phase III, open, controlled study to assess the safety, reactogenicity and immunogenicity of GlaxoSmithKline (GSK) Biologicals’ 10-valent pneumococcal conjugate vaccine or Prevenar when given as a b... 2008-06-14 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-005807-32 A randomized, double-blind, placebo-controlled, dose ranging study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of GSK221149A administered intravenously and the pharm... 2011-06-16 bad-data
No trial status on register 2006-005891-41 A phase IIIb, observer-blind, controlled study to assess the safety, reactogenicity and immunogenicity of GlaxoSmithKline (GSK) Biologicals’ 10-valent pneumococcal conjugate vaccine or Prevenar when g... bad-data
Listed as ongoing, but also has a completion date and reported results 2006-005912-28 A Phase II Study of Lapatinib plus Topotecan or Lapatinib plus Capecitabine in the Treatment of Recurrent Brain Metastases from ErbB2-Positive Breast Cancer Following Cranial Radiotherapy 2010-03-17 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-005914-10 A Multicentre, Randomised, Double-blind, Placebo and Naproxen (500mg) BID controlled, Phase II Proof of Concept, Parallel Group Study to Assess the Efficacy and Safety of Oral GW842166 at Two Dose Lev... 2007-08-14 bad-data
Not reported 2006-005953-31 Inhibition of Dental Plaque Regrowth by an Ethanol-Free 0,2% Chlorhexidine Mouth Rinsing Solution 2007-08-24 due-trials
Ongoing 2006-005998-21 A multicentre randomised, double-blind, parallel-group study to compare the salmeterol xinafoate/fluticasone propionate combination (Seretide® Diskus® 50/100) 50/100 micrograms one inhalation twice da... not-yet-due
Reported results 2006-005999-41 A phase III, randomized, open, controlled, multicenter primary vaccination study to demonstrate the non inferiority of the immunogenicity of GSK Biologicals’ meningococcal serogroup ACWY conjugate vac... 2008-04-28 due-trials
Reported results 2006-006000-11 An 8 day, randomised, double blinded, placebo-controlled 2-way crossover trial of repeat doses of intranasal GSK256066 and placebo in the Vienna Challenge Chamber in subjects with seasonal allergic rh... 2008-02-04 due-trials
Listed as ongoing, but also has a completion date and reported results 2006-006015-72 Estudio CR9108963: Estudio de búsqueda de dosis optima de SB-751689 en mujeres posmenopáusicas con osteoporosis 2008-12-18 bad-data
Ongoing, reported early 2006-006083-33 A randomised, double-blind, placebo-controlled, dose ascending, 2-cohort, parallel group study to examine the safety, tolerability, pharmacokinetics and pharmacodynamics of twice-daily inhaled doses o... not-yet-due
Reported results 2006-006209-94 An open label, repeat dose, dose escalation study conducted in Parkinson’s Disease patients to characterize the pharmacokinetics and effect of food on ropinirole prolonged release (PR/CR) 12mg tablets... 2007-08-29 due-trials
Completed, reported early 2006-006240-63 A study to assess the pharmacokinetics of single escalating doses of inhaled GSK961081 DPI (a dual pharmacophore) in healthy subjects (Part 1) and a randomised, double-blind, double dummy, crossover (... 2008-05-23 not-yet-due
Ongoing, reported early 2006-006460-32 A phase IV, open, multicenter, multicountry study to assess the long-term antibody persistence of a booster dose of GlaxoSmithKline (GSK) Biologicals’ Haemophilus influenzae type b – meningococcal ser... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2006-006537-40 A Randomized, Multicenter, Phase III Study Comparing the Combination of Pazopanib and Lapatinib versus Lapatinib Monotherapy in Patients with ErbB2 over-expressing Inflammatory Breast Cancer 2011-12-20 bad-data
Ongoing, reported early 2006-006552-36 A phase IIIb open study to assess the long-term efficacy and safety of GlaxoSmithKline (GSK) Biologicals' oral live attenuated human rotavirus (HRV) vaccine approximately three years after vaccination... not-yet-due
Reported results 2006-006580-23 Immunogenicity & safety study of GSK Biologicals’ meningococcal vaccine GSK134612 when co-administered with GSK Biologicals’ MMRV vaccine (Priorix-Tetra™) in healthy 12 to 23-month-old children. 2008-03-26 due-trials
Listed as ongoing, but also has a completion date and reported results 2006-006680-23 A phase III, open, randomized, controlled study to demonstrate the immunogenicity, reactogenicity and safety of GSK Biologicals meningococcal serogroup ACWY conjugate vaccine (GSK134612, MenACWY-TT) c... 2008-10-27 bad-data
Reported results 2006-006710-15 A randomised, single blind, placebo-controlled 5-way crossover trial of single doses of intranasal GSK256066 in subjects with seasonal allergic rhinitis (SAR) 2007-05-16 due-trials
Listed as ongoing, but also has a completion date and reported results 2006-007057-42 An open-label study of leukocyte counts in the cerebrospinal fluid and blood of subjects with relapsing forms of multiple sclerosis following treatment with firategrast 2010-02-12 bad-data
Completed, but no date 2007-000097-23 Rationale for therapy with low dose steroids combined with long-acting beta2-agonists in patients with allergic asthma: redirecting innate immune responses by long-term treatment with high doses of in... bad-data
Completed, but no date, and reported results 2007-000115-28 A phase II, open, non-randomized study designed to evaluate the reactogenicity and immunogenicity of one or two booster administrations of an influenza pandemic candidate vaccine (GSK1562902A) in adul... bad-data
Reported results 2007-000187-25 A randomised, double blind, placebo-controlled, double dummy, 4-way cross-over, dose ascending study to assess the safety, tolerability, pharmacodynamics and pharmacokinetics of single inhaled doses o... 2007-10-15 due-trials
Listed as ongoing, but also has a completion date and reported results 2007-000243-10 An open-labeled, randomized, two-dose, parallel group trial of ofatumumab, a fully human monoclonal anti-CD20 antibody, in combination with fludarabine and cyclophosphamide, in patients with previous... 2013-05-21 bad-data
Reported results 2007-000244-27 An open-labeled, randomized, two-dose, parallel group trial of ofatumumab, a fully human monoclonal anti-CD20 antibody, in combination with CHOP, in patients with previously untreated Follicular Lymp... 2014-03-07 due-trials
Completed, but no date, and reported results 2007-000261-38 A phase IV, open, multicentric study to evaluate the immune response to a hepatitis B challenge dose in healthy subjects, 72 to 78 months after they received a primary vaccination course of GSK Biolog... bad-data
Listed as ongoing, but also has a completion date and reported results 2007-000292-42 ENABLE 2 (Eltrombopag to INitiate and Maintain Interferon Antiviral Treatment to Benefit Subjects with Hepatitis C related Liver DiseasE) Randomised, placebo-controlled, multi-centre study to assess t... 2011-08-23 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-000454-31 Study of Once-Daily Abacavir/Lamivudine versus Tenofovir/Emtricitabine, Administered with Efavirenz in Antiretroviral-Naive, HIV-1 Infected Adult Subjects 2009-11-26 bad-data
Ongoing, reported early 2007-000493-23 A Comparison of Two Analgesic Products for the Treatment of Headache not-yet-due
Listed as ongoing, but also has a completion date and reported results 2007-000548-29 A Multicenter, Randomized, Double-Blind, Triple-Dummy, Placebo-Controlled, Parallel Group, Four-Week Study Assessing the Efficacy of Fluticasone Propionate Aqueous Nasal Spray 200mcg OD versus Montelu... 2007-10-31 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-000596-42 A phase III open study to assess the safety, reactogenicity and immunogenicity following booster administration of GlaxoSmithKline (GSK) Biologicals´ 10-valent pneumococcal conjugate vaccine, co-admin... 2009-03-23 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-000683-24 Phase II, double blind, randomized, comparative study of the immunogenicity and safety of GlaxoSmithKline Biologicals’ modified formulation varicella vaccine and Varilrix™ given as a 2 dose course in ... 2008-04-29 bad-data
Not reported 2007-000779-40 A Phase II Trial of Pazopanib, a Pan Vascular Endothelial Growth Factor Receptor (VEGFR) Inhibitor, in Relapsed or Refractory Small Cell Lung Cancer (SCLC) 2008-09-29 due-trials
Other 2007-000838-39 A Compassionate Use Open-Label Study of Anti IL-5 (Mepolizumab) Treatment in Subjects with Hypereosinophilic Syndrome not-yet-due
Ongoing 2007-000929-22 A double-blind, randomised, placebo controlled, three-period crossover study to investigate the pharmacodynamic effect of two CRF-1 antagonists GSK561679 and GW876008 on meal induced cortisol response... not-yet-due
Ongoing, reported early 2007-001167-29 A phase IIIb multi-centre, open, controlled study to assess the immunogenicity, reactogenicity and safety of GlaxoSmithKline (GSK) Biologicals’ Haemophilus influenzae type b – meningococcal serogroup ... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2007-001283-73 A double-blind, randomized, placebo-controlled Phase III study to assess the efficacy of recMAGE-A3 + AS15 Antigen-Specific Cancer Immunotherapeutic as adjuvant therapy in patients with resectable MAG... 2014-09-23 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-001295-36 A parallel-group, double-blind, randomized, placebo-controlled, active comparator, multicenter study to evaluate the efficacy, safety, tolerability and pharmacokinetics of two doses of GSK232802 adm... 2008-07-30 bad-data
Reported results 2007-001345-18 A 19-week, randomized, double-blind, placebo-controlled, three-period, cross-over pilot study comparing the effect of salmeterol/fluticasone propionate 50/100mcg BID, fluticasone propionate 100mcg BID... 2008-07-23 due-trials
Reported results 2007-001391-37 A randomised, single-dose, dose ascending, double-blind, placebo controlled, four-way, incomplete block crossover study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics o... 2007-11-09 due-trials
Reported results 2007-001463-29 A Once-Daily Dose-Ranging Study of GSK189075 Versus Placebo In The Treatment of Type 2 Diabetes Mellitus in Treatment-Naïve Subjects 2008-06-05 due-trials
Ongoing, reported early 2007-001477-29 A proof-of-concept study of SB-751689 in male and female subjects with a fractured distal radius. not-yet-due
Listed as ongoing, but also has a completion date and reported results 2007-001703-38 A Randomised, Double-Blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Dutasteride (AVODART™) 0.5 mg in Extending the Time to PSA Doubling in Men with Prostate Cancer and Biochemica... 2011-03-15 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-001713-42 A randomised, double-blind, placebo-controlled, parallel group, dose ranging study evaluating the efficacy and safety of GW642444M administered once daily compared with placebo for 28 days in adolesce... 2008-09-10 bad-data
Reported results 2007-001731-55 A phase III/IV, community-randomized, controlled study to evaluate the effectiveness of two vaccination strategies using GlaxoSmithKline Biologicals’ HPV-16/18 L1 VLP AS04 vaccine in reducing the prev... 2014-12-17 due-trials
Reported results 2007-001828-12 A Phase III, open, non-randomized, multi-centric, single dose study to assess immunogenicity and safety of Fluarix™ (Influsplit SSW®) 2007/2008 injected intramuscularly in young adults (18 to 60 years... 2007-07-11 due-trials
Ongoing, reported early 2007-002155-17 A phase II open label, multicenter study to evaluate the efficacy and safety of daily dose of Lapatinib in advanced breast cancer patients with HER-2 non-amplified primary tumours and HER-2 positiv... not-yet-due
Reported results 2007-002221-76 An open, phase IV, single-group, multicentre study to assess the long-term persistence of antibodies against hepatitis B and the immune response to a hepatitis B (HBV) vaccine challenge in children ag... 2007-12-31 due-trials
Reported results 2007-002368-83 A phase III, observer-blind, multicountry, multicenter, study to evaluate the safety, reactogenicity and immunogenicity, of GlaxoSmithKline Biologicals AS25 adjuvanted influenza vaccine administered i... 2008-04-06 due-trials
Completed, but no date, and reported results 2007-002374-55 Simultaneous fMRI/EEG of the 4 mg nicotine lozenge in relief of cognitive impairment associated with nicotine withdrawal bad-data
Reported results 2007-002472-34 An open-label, Phase II randomised trial of Lapatinib (TYKERB™) + Pemetrexed (Alimta) versus Pemetrexed in the Second Line Treatment of advanced or metastatic Non Small Cell Lung Cancer 2009-06-30 due-trials
Completed, reported early 2007-002777-32 A phase I/II, partially blind, randomized, multicentre, age-stratified, dose-range study in healthy females aged 9 - 25 years to assess the safety and immunogenicity of GlaxoSmithKline Biologicals’ HP... 2013-03-18 not-yet-due
Completed, but no date, and reported results 2007-002783-10 A phase II, controlled, single centre, open study to evaluate the safety, reactogenicity and immunogenicity of a second vaccination with the low dose influenza vaccine adjuvanted with a reduced dose o... bad-data
Completed, but no date, and reported results 2007-002880-29 A phase II, open, controlled study to evaluate the reactogenicity and the immunogenicity of GlaxoSmithKline Biologicals AS25 adjuvanted influenza vaccine (FluAS25) in elderly adults (≥66 years) previo... bad-data
Completed, but no date, and reported results 2007-002881-36 A phase II, open, controlled study to evaluate the reactogenicity and the immunogenicity of GlaxoSmithKline Biologicals AS25 adjuvanted influenza vaccine (FluAS25) in elderly adults (≥67 years) previo... bad-data
Listed as ongoing, but also has a completion date and reported results 2007-002918-19 A Phase I/II, Open-Label, Multicenter, Two-Arm, Feasibility Study of Pazopanib, Carboplatin, and Paclitaxel in Women with Newly Diagnosed, Previously Untreated, Gynaecological Tumors 2008-04-15 bad-data
Reported results 2007-002950-42 A double-blind, randomized, placebo controlled, parallel group, multi-center, phase III trial of ofatumumab investigating clinical efficacy in adult patients with active rheumatoid arthritis who had a... 2015-07-15 due-trials
Ongoing, reported early 2007-002951-18 A double-blind, randomized, placebo controlled, parallel group, multi-center, phase III trial of ofatumumab investigating clinical efficacy in adult patients with active rheumatoid arthritis who had a... not-yet-due
Reported results 2007-003248-31 An open, phase IV, non-randomised, single-centre study with two study groups to assess the immunogenicity and reactogenicity of a booster dose of GlaxoSmithKline (GSK) Biologicals' combined reduced an... 2008-04-30 due-trials
Reported results 2007-003256-11 A phase IIIb open, randomized multi-center study to evaluate the immunogenicity and safety of GSK Biologicals HPV-16/18 L1 VLP AS04 vaccine when administered intramuscularly according to an alternativ... 2009-07-27 due-trials
Reported results 2007-003290-29 A phase II, observer-blind, multicountry, multicentre, randomized study to demonstrate the non-Inferiority of GlaxoSmithKline Biologicals’ one-container AS25 adjuvanted influenza vaccine compared to G... 2007-11-02 due-trials
Reported results 2007-003477-94 A phase IV, open, non-randomised, multicentre study to assess the reactogenicity and immunogenicity of a booster dose of GSK Biologicals’ combined reduced-antigen-content diphtheria-tetanus, acellular... 2008-07-08 due-trials
Reported results 2007-003597-25 A 12-month open-label, randomized parallel-group study to investigate the influence of salmeterol/fluticasone either in fixed combination (SFC500/50 µg bid) or seperately (SAL 50 µg and FP 500 µg bid)... 2009-06-25 due-trials
Listed as ongoing, but also has a completion date and reported results 2007-003776-18 A phase II, controlled, randomized, multicentre, single blind study to evaluate the immunogenicity, safety and reactogenicity of the low dose influenza vaccine with various doses of the AS03 adjuvant ... 2008-05-08 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-003802-86 A phase II, observer-blind, multicountry, multicentre, randomized study to evaluate the immunogenicity, safety and reactogenicity of the GlaxoSmithKline Biologicals’ influenza vaccine adjuvanted with ... 2008-06-10 bad-data
Ongoing, reported early 2007-004002-26 A phase III randomized, single-blind, controlled study to demonstrate the non-inferiority of co-administration of GSK Biologicals’ 10-valent pneumococcal conjugate vaccine with Pediacel™ versus co-ad... not-yet-due
Not reported 2007-004025-20 A randomised, double-blind, parallel-group, fixed-dose, placebo-controlled study comparing correlates of brain functional activation before and after treatment with placebo and Paroxetine in participa... 2007-11-29 due-trials
Listed as ongoing, but also has a completion date and reported results 2007-004033-42 A 12-week, randomised, double-blind, placebo-controlled study to assess the anti-inflammatory activity, efficacy and safety of GW856553 in subjects with chronic obstructive pulmonary disease (COPD). 2009-10-02 bad-data
Reported results 2007-004035-35 A multi-centre, randomized, double-blind, placebo-controlled, cross-over study to evaluate the effects of GW597599 and GR205171 on sleep continuity, PSG sleep recordings, subjective sleep assessment a... 2008-05-07 due-trials
Reported results 2007-004117-33 A single blind, placebo-controlled, randomised study in mild to moderate Alzheimer's disease patients to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of GSK239512, a selectiv... 2009-06-16 due-trials
Listed as ongoing, but also has a completion date and reported results 2007-004190-26 An open-label, single-arm, multi-center phase 2 trial with ofatumumab in patients with relapsed Diffuse Large B-Cell Lymphoma (DLBCL) ineligible for transplant or relapsed after autologous transplant 2014-08-19 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-004223-38 A double-blind, randomized, placebo-controlled, multicenter, dose-finding trial of ofatumumab in RRMS patients 2011-10-26 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-004347-30 A phase IIIb, randomized, open, multicentre study to evaluate the immunogenicity and safety of GlaxoSmithKline Biologicals’ HPV-16/18 L1 VLP AS04 vaccine co-administered with GlaxoSmithKline Biologica... 2009-04-28 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-004442-32 A Randomized Double-Blind, Double-Dummy, Placebo-Controlled, Parallel-Group, Multicenter, Dose Ranging Study to Evaluate the Efficacy and Safety of GW685698X Inhalation Powder Once Daily and Fluticaso... 2008-10-02 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-004458-98 A Randomized Double-Blind, Double Dummy, Placebo-Controlled, Parallel-Group, Multicenter Dose Ranging Study to Evaluate the Efficacy and Safety of GW685698X Inhalation Powder Once Daily and Fluticason... 2008-09-20 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-004459-13 A Randomized Double-Blind, Double-Dummy, Placebo-Controlled, Parallel-Group, Multicenter, Dose Ranging Study to Evaluate the Efficacy and Safety of GW685698X Inhalation Powder Once Daily and Fluticaso... 2008-11-24 bad-data
Listed as ongoing, but also has a completion date 2007-004568-27 A Randomised, Open-Label, Phase III Study of Taxane Based Chemotherapy with Lapatinib or Trastuzumab as First-Line Therapy for Women With HER2/neu Positive Metastatic Breast Cancer 2012-08-01 bad-data
Reported results 2007-004797-79 A Study to Assess the Pharmacologic Equivalence of Two Orlistat Dosage Forms 2007-11-24 due-trials
Reported results 2007-004807-37 Study B2C111045, A Dose-Finding Study of GW642444 versus Placebo in Patients with COPD 2008-10-24 due-trials
Listed as ongoing, but also has a completion date and reported results 2007-004878-31 An open-label, international, multi-center, phase II, extension trial investigating long-term efficacy and safety of repeated treatment courses of ofatumumab, a fully human monoclonal anti-CD20 antibo... 2013-03-19 bad-data
Reported results 2007-005082-34 A Proof of Principle Study to Investigate the Efficacy of a Medical Device and Topical Analgesic Combination for the Treatment of Pain and Performance Related Function in Osteoarthritis 2008-06-12 due-trials
Ongoing, reported early 2007-005148-26 A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Study to Evaluate the Effects of a One-Year Course of Fluticasone Furoate Nasal Spray 110mcg QD on Growth in Pre-Pubescent... not-yet-due
Not reported 2007-005153-32 A PHASE 2, RANDOMIZED, MULTI-CENTER, OPEN-LABEL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF MAPATUMUMAB ( [HGS1012], A FULLY HUMAN MONOCLONAL ANTIBODY TO TRAIL-R1) IN COMBINATION WITH CARBOPLATIN AND... 2012-03-29 due-trials
Listed as ongoing, but also has a completion date and reported results 2007-005169-36 A Study of Single Dose Intravenous Casopitant in Combination with Ondansetron and Dexamethasone for the Prevention of Oxaliplatin-Induced Nausea and Vomiting 2009-04-13 bad-data
Completed, but no date, and reported results 2007-005203-18 An open Phase II study of immunization with the recMAGE-A3 + AS01B Antigen-Specific Cancer Immunotherapeutic in patients with MAGE-A3-positive unresectable and progressive metastatic cutaneous melanom... bad-data
Reported results 2007-005301-22 An 8 day, randomised, double blind, 3-way crossover trial of repeat doses of intranasal GSK256066 and fluticasone propionate in the Vienna Challenge Chamber in subjects with seasonal allergic rhinitis... 2008-05-26 due-trials
Reported results 2007-005302-44 A randomised, double blind, 2-way crossover trial of 8 days repeat dosing with intranasal GSK256066 and azelastine hydrochloride in the Vienna Challenge Chamber in subjects with seasonal allergic rhin... 2008-05-21 due-trials
Ongoing, reported early 2007-005338-35 A double-blind, placebo-controlled, parallel group study to evaluate the effects of two regimens of GW856553, over a period of 3 months, on in-vivo macrophage activity, as assessed by FDG-PET/CT imagi... not-yet-due
Reported results 2007-005343-16 A phase II, open, study to assess the immunogenicity and reactogenicity of GlaxoSmithKline (GSK) Biologicals’ combined DTPa-HBV-IPV/Hib vaccine when administered as a booster dose to children aged 16-... 2008-08-18 due-trials
Ongoing, reported early 2007-005353-28 A randomised, double-blind, evaluation of the effects of paracetamol on the BOLD fMRI response to painful stimuli in subjects with osteoarthritis. not-yet-due
Reported results 2007-005392-34 A phase III long-term follow-up study to assess antibody persistence and immunological memory in children previously vaccinated with four doses of pneumococcal conjugate vaccine in primary vaccination... 2011-11-21 due-trials
Reported results 2007-005486-34 A Pilot Study to Evaluate the Relative Bioavailability of Diclofenac as Measured by Microdialysis After Repeated Doses of Two Topical Diclofenac Formulations 2008-07-21 due-trials
Completed, but no date, and reported results 2007-005520-32 An open label, 7-day repeat dose study to evaluate the pharmacodynamics of SB-656933-AAA in patients with Ulcerative Colitis. bad-data
Ongoing 2007-005725-29 A Phase III Study of ErbB2 Positive Advanced or Metastatic Gastric or Esophageal Or Gastroesophageal Junction Adenocarcinoma Treated with Capecitabine Plus Oxaliplatin with or without Lapatinib not-yet-due
Reported results 2007-005791-14 A randomised, placebo-controlled, incomplete block, three-way cross-over study to evaluate the effect of treatment with repeat inhaled doses of GW870086X on the allergen-induced early and late asthmat... 2009-11-03 due-trials
Listed as ongoing, but also has a completion date and reported results 2007-005851-40 A Randomised, Double-Blind, Placebo-Controlled, Multi-Centre Study to Evaluate the Safety and Efficacy of Eltrombopag to Reduce the Need for Platelet Transfusion in Thrombocytopenic Subjects with Chro... 2009-11-03 bad-data
Not reported 2007-005954-22 A randomized, double-blind, placebo-controlled, multicenter Phase II study to compare the efficacy and tolerability of pazopanib administered in combination with exemestane versus exemestane plus plac... 2008-07-10 due-trials
Reported results 2007-006073-84 A double-masked, randomized, parallel-group study to investigate the pharmacodynamics, safety, and systemic pharmacokinetics of pazopanib eye drops, administered for 28 days to adult subjects with cho... 2009-01-27 due-trials
Listed as ongoing, but also has a completion date and reported results 2007-006287-29 Dose ranging study for GSK233705B delivered once daily in subjects with COPD. 2009-02-06 bad-data
Reported results 2007-006562-15 A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Once-Daily Intranasal Administration of Fluticasone Furoate Nasal Spray 110mcg ... 2008-06-30 due-trials
Ongoing 2007-006651-39 A phase IV, randomized, open-label, controlled, post-licensure study to evaluate the safety of GlaxoSmithKline Biologicals’ HPV-16/18 L1 VLP AS04 vaccine (Cervarix®) when administered intramuscularly ... not-yet-due
Reported results 2007-007043-27 A phase II, double-blind, multicentre, randomized study to demonstrate the non-inferiority of GlaxoSmithKline Biologicals’ thiomersal-free adjuvanted influenza vaccine compared to GlaxoSmithKline Biol... 2008-04-11 due-trials
Listed as ongoing, but also has a completion date and reported results 2007-007648-85 A Multi-Center, Continuation Trial of Belimumab (HGS1006, LymphoStat-B), a Fully Human Monoclonal Anti-BLyS Antibody, in Subjects with Systemic Lupus Erythematosus (SLE) who Completed the Phase 3 Pr... 2016-12-09 bad-data
Reported results 2007-007783-14 A phase IIIb, randomized, open, multicentre study to evaluate the immunogenicity and safety of GlaxoSmithKline Biologicals’ HPV-16/18 L1 VLP AS04 vaccine (Cervarix™) co-administrated with GlaxoSmithKl... 2010-01-08 due-trials
Listed as ongoing, but also has a completion date and reported results 2007-007837-38 A phase III, open, randomized, controlled, primary vaccination study to demonstrate non-inferiority of GlaxoSmithKline (GSK) Biologicals’ meningococcal serogroup ACWY conjugate vaccine compared to lic... 2009-01-08 bad-data
Ongoing, reported early 2007-007876-41 A phase IIIb, randomized, open study to evaluate the immunogenicity and safety of GlaxoSmithKline Biologicals’ Hepatitis B vaccine (Engerix-B™) when co-administered with GlaxoSmithKline Biologicals’ H... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2008-000367-42 “A phase III, randomized, observer-blind, placebo-controlled, multicentre, clinical vaccination trial to assess the prophylactic efficacy, safety, and immunogenicity of GSK Biologicals’ gE/AS01B vacci... 2015-07-27 bad-data
Completed, but no date, and reported results 2008-000369-44 A long-term, open follow-up of the immunogenicity and safety of GlaxoSmithKline Biologicals’ HPV-16/18 VLP/AS04 vaccine in healthy female subjects up to 10 years after administration of the first vacc... bad-data
Reported results 2008-000406-36 A randomised, double-blind, double-dummy, placebo-controlled, 3-way crossover study to evaluate potential next-day residual effects of a single evening dose of 3mg eszopiclone and 7.5mg zopiclone in h... 2008-10-30 due-trials
Ongoing, reported early 2008-000526-39 A phase IV, open, multicentre, multicountry study to evaluate the immune response to a challenge dose of GSK Biologicals’ Twinrix™ vaccine versus monovalent hepatitis A and B vaccines from different m... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2008-000660-17 TPL108392: An open-label, multi-centre rollover study to assess the safety and efficacy of eltrombopag in thrombocytopenic subjects with hepatitis C virus (HCV) infection who are otherwise eligible t... 2013-02-28 bad-data
Completed, report not yet due 2008-000673-38 A Randomized, Multicentre, Open-Label, Phase III Study of Lapatinib plus Capecitabine versus Trastuzumab plus Capecitabine in Patients with Anthracycline- or Taxane-Exposed ErbB2-positive Metastatic B... 2018-03-22 not-yet-due
Reported results 2008-000725-18 A randomised, double-blind, crossover study to investigate the bronchodilatation post-inhalation of GSK961081 alone and with the addition of cumulative doses of short acting bronchodilators (salbutamo... 2008-10-19 due-trials
Reported results 2008-000727-26 Study HZC111348, a repeat-dose study of GW685698/GW642444 Inhalation Powder versus placebo in the treatment of Chronic Obstructive Pulmonary Disease (COPD) 2009-02-25 due-trials
Listed as ongoing, but also has a completion date and reported results 2008-000789-22 SAFE-AF: Safety of Fondaparinux in electric cardioversion of atrial fibrillation. 2011-09-06 bad-data
Reported results 2008-000826-37 Study AZ3110865, a study comparing SB-742457 or donepezil versus placebo in subjects with mild-to-moderate Alzheimer’s disease 2010-03-09 due-trials
Reported results 2008-000827-25 Estudio AZ3110866: Estudio de dosis fija de SB-742457 frente a placebo, como tratamiento añadido a donepezilo, en sujetos con enfermedad de Alzheimer leve a moderada 2010-11-16 due-trials
Listed as ongoing, but also has a completion date and reported results 2008-000872-25 A randomized, observer-blind, active-controlled phase III study to demonstrate the superior efficacy of GSK Biologicals’ adjuvanted influenza candidate vaccine [GSK2186877A], administered intramuscula... 2010-12-09 bad-data
Reported results 2008-001095-77 A randomised, double-blind, placebo-controlled, dose ascending, 2-cohort, parallel group study to examine the safety, tolerability and pharmacokinetics of once-daily inhaled doses of GSK573719 formula... 2009-08-10 due-trials
Completed, but no date, and reported results 2008-001301-42 An open Phase II study to assess the clinical activity and safety of recMAGE-A3 + AS15 cancer immunotherapeutic in patients with metastatic cutaneous melanoma, and to explore its immunogenic propertie... bad-data
Completed, reported early 2008-001303-34 A phase I/II, randomized, single blind, controlled study in adults aged 18-60 years to evaluate the immunogenicity, safety and reactogenicity of an adjuvanted influenza vaccine candidate (GSK 2115160A... 2009-01-28 not-yet-due
Listed as ongoing, but also has a completion date and reported results 2008-001307-33 A randomized double blind phase III trial of pazopanib versus placebo in patients with soft tissue sarcoma whose disease has progressed during or following prior therapy. 2012-11-28 bad-data
Reported results 2008-001310-24 A Phase III, open, non-randomized, multi-centric, single dose study to assess immunogenicity and safety of Fluarix™ / Influsplit SSW® 2008/2009 injected intramuscularly in young adults (18 to 60 years... 2008-07-30 due-trials
Completed, but no date 2008-001445-26 A phase III, randomized, observer blind, multi-centre study to evaluate the immunogenicity, safety and reactogenicity of study vaccine GSK1557482A (FluLaval thiomersal-free), Fluarix and FluLaval thio... bad-data
Listed as ongoing, but also has a completion date and reported results 2008-001507-39 A single-arm, international, multi-center trial investigating the efficacy and safety of ofatumumab retreatment and maintenance treatment in patients with B-cell chronic lymphocytic leukemia who progr... 2013-06-20 bad-data
Reported results 2008-001567-10 A randomised, double-blind, placebo-controlled, 3-period crossover study to assess the efficacy and safety of single dose intranasal GSK1004723 compared with placebo in an allergen challenge chamber i... 2008-08-28 due-trials
Ongoing, reported early 2008-001918-25 An open Phase I/II study of immunization with the recMAGE-A3 + AS15 Antigen Specific Cancer Immunotherapeutic in association with dacarbazine in patients with MAGE-A3 positive unresectable and progres... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2008-002046-27 Clinical phase I/IIA study of subcutaneous administration of Ofatumumab in Rheumatoid Arthritis patients on stable dose Methotrexate 2011-04-22 bad-data
Reported results 2008-002101-39 An extension study to protocol MD7108240; pazopanib eye drops in subjects with neovascolar age-related macular degeneration 2009-09-09 due-trials
Ongoing 2008-002102-19 Estudio de pazopanib frente a sunitinib en el tratamiento de sujetos con carcinoma de células renales localmente avanzado y/o metastásico not-yet-due
Listed as ongoing, but also has a completion date and reported results 2008-002144-42 An open-label, multicentre, randomised phase II study of pazopanib in combination with pemetrexed in first-line treatment of subjects with predominantly non-squamous cell stage IIIBwet/IV non-small... 2011-03-01 bad-data
Listed as ongoing, but also has a completion date and reported results 2008-002205-40 DEFEND-1: Durable-Response Therapy Evaluation For Early- or New-Onset Type 1 Diabetes 2012-01-31 bad-data
Listed as ongoing, but also has a completion date and reported results 2008-002301-38 A 52 Week Randomized, Double-Blind, Multicenter, Mechanistic Study with a 24 Week Open-Label Follow-Up to Evaluate the Effect of AVANDIA™ on Bone in Postmenopausal Women with Type 2 Diabetes Mellitus 2010-09-17 bad-data
Listed as ongoing, but also has a completion date and reported results 2008-002360-33 A phase III, observer-blind, multicountry, multicentre study to evaluate the safety, reactogenicity and immunogenicity of GlaxoSmithKline Biologicals’ GSK2186877A influenza vaccine administered to adu... 2009-05-23 bad-data
Reported results 2008-002362-66 A phase III, observer-blind, multi-country, multi-centre study to evaluate the safety, reactogenicity and immunogenicity of GlaxoSmithKline (GSK) Biologicals FLU NG vaccine compared to the reference v... 2009-12-15 due-trials
Listed as ongoing, but also has a completion date and reported results 2008-002447-16 A double-blind placebo-controlled Phase III study to assess the efficacy of MAGE-A3 + AS15 ASCI as adjuvant therapy in patients with MAGE-A3 positive resected stage III melanoma 2016-02-17 bad-data
Reported results 2008-002580-13 A randomised, double-blind, placebo-controlled, 2-period cross-over study to evaluate the effect of treatment with GSK2190915 on the allergen-induced asthmatic response in subjects with mild asthma 2009-09-11 due-trials
Listed as ongoing, but also has a completion date and reported results 2008-002747-16 FondaparinUx Trial with UFH during Revascularization in Acute Coronary Syndromes (FUTURA) A prospective study evaluating the safety of two regimens of adjunctive intravenous UFH during PCI in high ... 2010-05-11 bad-data
Completed, but no date 2008-003318-81 A phase IV, open, randomized, controlled study to demonstrate the non-inferiority of co-administration of GSK Biologicals’ live attenuated measles-mumps-rubella-varicella vaccine and Baxter’s Neisseri... bad-data
Reported results 2008-003395-22 The Effects of Weight Reduction with Orlistat vs. Placebo on Changes in Body Composition 2009-07-22 due-trials
Reported results 2008-003741-87 A phase II, open-label, randomized, multicentre study to evaluate the feasibility of GSK Biologicals’ DTPa-IPV/Hib-MenC-TT vaccine co-administered with Prevenar compared with Pediacel co-administered ... 2010-12-09 due-trials
Reported results 2008-003772-21 A RANDOMISED, DOUBLE-BLIND, PLACEBO CONTROLLED, MULTI-CENTER STUDY TO INVESTIGATE THE USE OF MEPOLIZUMAB (SB-240563) IN REDUCING THE NEED FOR SURGERY IN SUBJECTS WITH SEVERE BILATERAL NASAL POLYPOSIS 2014-12-05 due-trials
Reported results 2008-003824-51 A phase III, open, multi-centre, controlled study to evaluate the long-term antibody persistence at 2 years, 3 years and 4 years after a single dose of GlaxoSmithKline (GSK) Biologicals’ meningococca... 2012-09-10 due-trials
Reported results 2008-003950-14 A phase III long-term follow-up study to assess the immune responses following vaccination at 36-46 months of age with a booster dose of GSK Biologicals’ 10-valent pneumococcal conjugate vaccine (10Pn... 2009-07-02 due-trials
Listed as ongoing, but also has a completion date and reported results 2008-004007-64 An open, single-arm trial to assess the clinical activity of recMAGE-A3 + AS15 in patients with unresectable MAGE-A3-positive metastatic cutaneous melanoma 2015-04-01 bad-data
Reported results 2008-004092-22 A randomised, double-blind, placebo-controlled, 4-period incomplete block crossover study of single oral dose GSK835726 (100mg, 50mg, 10mg), Cetirizine (10mg) and placebo to evaluate the efficacy and ... 2008-11-27 due-trials
Listed as ongoing, but also has a completion date and reported results 2008-004149-27 A Multi-Centre, Randomized, Double-Blind, Placebo-Controlled, Repeat-Dose study to evaluate the Efficacy and Safety of Intravenous GSK679586 in Patients with Severe Asthma 2010-08-01 bad-data
Ongoing 2008-004177-17 A Randomized, Open Label Study of Ofatumumab and Bendamustine Combination Therapy Compared with Bendamustine Monotherapy in Indolent B-cell Non-Hodgkin’s Lymphoma Unresponsive to Rituximab or a Ritux... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2008-004181-10 “A Multicentre, Randomised, Open-label, Controlled, Two-parallel-group, Phase III Study to Evaluate the Efficacy and Safety of Fondaparinux versus Low-molecular-Weight Heparin (Nadroparin), in Patient... 2011-07-04 bad-data
Reported results 2008-004455-29 A phase II, randomized, multicentre, observer-blind study to compare and characterize the immunoginicity and safety parameters induced by various GSK Biologicals’ Adjuvant Systems in combination with ... 2011-07-14 due-trials
Listed as ongoing, but also has a completion date 2008-004672-50 A Phase III Study to Evaluate the Efficacy and Safety of Pazopanib Monotherapy Versus Placebo in Women Who Have not Progressed after First Line Chemotherapy for Epithelial Ovarian, Fallopian Tube, or ... 2017-08-24 bad-data
Ongoing, reported early 2008-004711-35 Estudio de vacunación, fase III, observador ciego, aleatorizado (3:3:2), control activo, multinacional, multicéntrico para evaluar la respuesta inmune celular y humoral de la vacuna FLU NG de GSK Biol... not-yet-due
Reported results 2008-004866-15 A Longitudinal MRI Study of Changes in Regional Body Composition During Orlistat (60mg)-Assisted Dieting 2009-08-28 due-trials
Listed as ongoing, but also has a completion date and reported results 2008-004932-19 A phase III, open label, randomized, multicenter trial of Ofatumumab added to Chlorambucil vs. Chlorambucil Monotherapy in previously untreated patients with Chronic Lymphocytic Leukemia 2018-05-17 bad-data
Reported results 2008-004933-99 Study PXN110527: The investigation of the efficacy and pharmacokinetics of XP13512 in subjects with neuropathic pain associated with post-herpetic neuralgia (PHN) who have had an inadequate response t... 2009-07-27 due-trials
Listed as ongoing, but also has a completion date and reported results 2008-005030-73 Thiazolidinedione Intervention with vitamin D Evaluation (TIDE) A Multicenter Randomized Double-Blind Placebo-Controlled Trial of a Thiazolidinedione or Placebo and of Vitamin D or Placebo In People W... 2010-12-08 bad-data
Reported results 2008-005041-33 A Single-Blind Study of the Safety, Pharmacokinetics and Pharmacodynamics of Escalating Repeat Doses of GSK249320 in Patients With Stroke. 2011-01-31 due-trials
Reported results 2008-005053-38 An open-label study to investigate the pharmacodynamics of a repeat dose regimen of bevacizumab (10mg/kg q2w) and escalating repeat doses of pazopanib in renal cell carcinoma 2013-11-01 due-trials
Reported results 2008-005120-86 A phase II, observer-blind, randomised, placebo-controlled, adjuvant-dose selection, multicenter prophylactic vaccination study to evaluate the immunogenicity and safety of GSK Biologicals’ herpes zos... 2010-07-02 due-trials
Reported results 2008-005149-48 A phase III/IV, cluster-randomized, controlled study to evaluate the effectiveness of GlaxoSmithKline Biologicals’ 10-valent pneumococcal and non-typeable Haemophilus influenzae protein D conjugate va... 2013-10-05 due-trials
Reported results 2008-005205-19 A randomised, double-blind, placebo-controlled, 3-period cross-over study to evaluate the effect of two doses of GSK2190915 on the allergen-induced early asthmatic response in subjects with mild asthm... 2009-07-28 due-trials
Not reported 2008-005288-33 Methodology Study to develop Sinerem enhanced 3T MR Imaging of Atherosclerotic Plaques within the Carotid Arteries, and to compare Sinerem MRI to contrast enhanced ultrasound 2009-10-29 due-trials
Completed, but no date, and reported results 2008-005319-16 ``A double blind, parallel group, placebo controlled study to evaluate the effect of a single oral dose of GSK958108 on ejaculatory latency time (ELT) in male patients suffering from premature ejacula... bad-data
Listed as ongoing, but also has a completion date and reported results 2008-005575-96 A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) 2013-07-26 bad-data
Listed as ongoing, but also has a completion date 2008-005811-16 A Phase III, Open Label, Randomized Trial of Ofatumumab added to Fludarabine-Cyclophosphamide vs. Fludarabine-Cyclophosphamide Combination in Subjects with Relapsed Chronic Lymphocytic Leukemia 2017-10-25 bad-data
Reported results 2008-006083-11 An open multicentre, multicountry study to evaluate long-term antibody persistence and immune memory between Years 11 and 15 after the primary study HAB-084 in which healthy adolescents were vaccinate... 2014-07-18 due-trials
Completed, but no date, and reported results 2008-006124-64 A phase IIIb, open-label, randomised, multicentre study to evaluate the immunogenicity and safety of a booster dose of GlaxoSmithKline Biologicals’ dTpa-IPV vaccine (Boostrix Polio) compared with Sano... bad-data
Reported results 2008-006345-72 A 28-Day, Polysomnographic and Subjective Assessment of Vestipitant (15mg/day) for the Treatment of Primary Insomnia in Adult Outpatients. 2009-09-21 due-trials
Ongoing, reported early 2008-006365-91 A phase II, open-label, randomised, multicentre study to evaluate the safety and immunogenicity of GlaxoSmithKline Biologicals’ DTPa-HBV-IPV/Hib-MenC-TT vaccine, when given in healthy infants at 3, 5 ... not-yet-due
Reported results 2008-006551-51 A phase III double-blind, cluster-randomized, controlled study to evaluate the impact on nasopharyngeal carriage, acute otitis media, immunogenicity and safety of GSK Biologicals’ 10-valent pneumococc... 2011-12-22 due-trials
Reported results 2008-006768-13 Follow-up survey for comparing stable dosing with a symptom based “as needed-regimen” in moderate and severe persitent asthma. 2010-04-22 due-trials
Reported results 2008-006986-10 A Study to Assess the Pharmacologic Equivalence of Two Orlistat Dosage Forms 2009-03-31 due-trials
Reported results 2008-007244-33 The efficacy of orally administered GSK2190915 as an add-on to current therapy in subjects with moderate to severe asthma who have elevated sputum neutrophils 2010-06-02 due-trials
Reported results 2008-007605-37 A phase III, open, multicentre, extension study to assess the immune response following administration of an additional dose of GSK Biologicals’ 10-valent conjugate pneumococcal vaccine or Prevenar™ a... 2009-10-09 due-trials
Listed as ongoing, but also has a completion date and reported results 2008-007660-41 A Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group, Multicenter Study to Determine the Efficacy and Safety of Albiglutide When Used in Combination With Metformin Compared With ... 2013-03-21 bad-data
Ongoing, reported early 2008-007661-24 A Randomized, Open-Label, Parallel-Group, Multicenter Study to Determine the Efficacy and Long-Term Safety of Albiglutide Compared With Insulin in Subjects With Type 2 Diabetes Mellitus not-yet-due
Ongoing, reported early 2008-007662-37 A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Determine the Efficacy and Safety of Albiglutide When Used in Combination With Pioglitazone With or Without Metform... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2008-007664-42 A Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group, Multicenter Study to Determine the Efficacy and Safety of Albiglutide Administered in Combination With Metformin and Glimepi... 2013-03-25 bad-data
Ongoing, reported early 2008-007846-69 Estudio en fase III, abierto, multicéntrico para evaluar la persistencia de anticuerpos a a largo plazo en niños hasta los 6 años de edad, tras una pauta completa de vacunación (primaria y de recuerdo... not-yet-due
Reported results 2008-008104-41 A phase III long-term follow-up study to assess immunological memory induced following primary and booster vaccination with GSK Biologicals’ 10-valent pneumococcal conjugate vaccine (10Pn-PD-DiT), thr... 2010-10-27 due-trials
Listed as ongoing, but also has a completion date and reported results 2008-008124-33 A phase IIIb, open, multi centre gynaecological extension study for follow-up of a subset of 580299/008 study subjects who were either cervical cytology negative and oncogenic HPV positive or pregnant... 2014-01-20 bad-data
Reported results 2008-008175-34 A Multicenter, Double-Blind, Randomized Placebo-Controlled Phase II Study to Evaluate the Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Single Doses of the Oral Motilin Receptor Agon... 2010-11-19 due-trials
Reported results 2008-008254-23 A randomised, double-blind, placebo-controlled, 2-way crossover study to determine the efficacy of repeat inhaled doses of GW870086X on FEV1 in mild to moderate asthmatics 2009-12-18 due-trials
Listed as ongoing, but also has a completion date and reported results 2009-009256-20 Ofatumumab versus Rituximab Salvage Chemoimmunotherapy followed by ASCT in Relapsed or Refractory DLBCL 2015-11-21 bad-data
Reported results 2009-009885-15 A Phase II, Randomised, Multi-Centre Study Evaluating Lapatinib in Combination with Vinorelbine or Capecitabine in Women with ErbB2 Overexpressing Metastatic Breast Cancer 2016-03-01 due-trials
Listed as ongoing, but also has a completion date and reported results 2009-010091-17 A randomised, double blind study to evaluate the safety and efficacy of the p38 kinase inhibitor, GW856553, in subjects with neuropathic pain from peripheral nerve injury 2010-07-19 bad-data
Reported results 2009-010269-21 A Phase IIb study to select a once daily oral dose of GSK1349572 administered with either abacavir/lamivudine or tenofovir/emtricitabine in HIV-1 infected antiretroviral therapy naïve adult subjects. 2016-12-22 due-trials
Listed as ongoing, but also has a completion date and reported results 2009-010270-37 A Phase IIb pilot study to assess the antiviral activity of GSK1349572 containing regimen in antiretroviral therapy (ART)-experienced, HIV-1-infected adult subjects with raltegravir resistance 2015-01-23 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-010421-39 A longitudinal 2-year bone marrow study of eltrombopag olamine (SB-497115-GR) in previously treated adults, with chronic immune (idiopathic) thrombocytopenic purpura (ITP). 2014-05-06 bad-data
Ongoing, reported early 2009-010571-24 An open label, multicenter, Phase I/II study of pazopanib in combination with paclitaxel in first line treatment of subjects with stage IIIBwet/IV non-small cell lung cancer not-yet-due
Reported results 2009-010615-32 A randomized, double-blind, placebo-controlled study to evaluate the safety of 12 weeks of dosing with GW856553 and its effects on inflammatory markers, infarct size, and cardiac function in subjects ... 2012-03-06 due-trials
Reported results 2009-010811-34 A Phase III, open, non-randomized, multi-centric, single dose study to assess mmunogenicity and safety of Fluarix / Influsplit SSW® 2009/2010 injected intramuscularly in young adults (18 to 60 years) ... 2009-07-08 due-trials
Completed, but no date, and reported results 2009-011022-33 A phase II, double-blind study to evaluate the safety, reactogenicity and immunogenicity of two different formulations of GSK Biologicals’ pneumococcal protein candidate vaccine, when given as a boos... bad-data
Reported results 2009-011051-51 A phase III, double-blind, randomized study to demonstrate the non-inferiority of an aged lot of GlaxoSmithKline Biologicals' FLU NG vaccine in adults aged 65 years and above compared to a fresh lot o... 2009-10-05 due-trials
Listed as ongoing, but also has a completion date and reported results 2009-011150-17 AMBITION: A Randomised, Multicenter Study of First-Line Ambrisentan and Tadalafil Combination Therapy in Subjects with Pulmonary Arterial Hypertension 2014-09-11 bad-data
Reported results 2009-011200-39 A six week randomized, double-blind, multi-center, placebocontrolled, exploratory, adaptive design study to explore the antidepressant properties of the p38 MAP kinase inhibitor GW856553 compared to p... 2010-07-07 due-trials
Reported results 2009-011357-41 A long-term, open, follow-up of the immunogenicity and safety of GlaxoSmithKline Biologicals’ HPV-16/18 L1 VLP AS04 vaccine in healthy female subjects up to 10 years after administration of the first ... 2015-02-03 due-trials
Completed, but no date 2009-011418-68 Pilotstudie zur Anwendung eines pflanzlichen Kombinationspräparats bei Frauen mit Reizblase ("Overactive Bladder"-Syndrom). bad-data
Reported results 2009-011459-39 A randomised, double-blind, placebo-controlled 4-period crossover study to assess the efficacy and safety of repeat dose intranasal GSK1004723 (1000μg), oral GSK835726 (10mg) and cetirizine (10mg) in ... 2009-08-14 due-trials
Listed as ongoing, but also has a completion date and reported results 2009-011461-84 A Long-Term, Randomized, Double-Blind, Parallel Group Study of Fluticasone Furoate/GW642444 Inhalation Powder Once-Daily and Fluticasone Furoate Inhalation Powder Once- Daily in Subjects with Asthma 2011-09-15 bad-data
Reported results 2009-011608-51 A Double-Blind, Double-Dummy, Placebo- and Active-Controlled Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Anti-Inflammatory Effects of GSK1399686 in Patients with M... 2012-07-31 due-trials
Not reported 2009-011782-92 A randomized, double-blind, placebo-controlled, dose ranging study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of GSK221149A administered intravenously in healthy, p... 2011-05-03 due-trials
Completed, but no date, and reported results 2009-011855-40 A Phase II Study to Evaluate: Delay in Intravaginal Ejaculatory Latency Time (IELT), Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Two Oral Doses of GSK557296 in a Randomized, Double ... bad-data
Listed as ongoing, but also has a completion date and reported results 2009-012054-20 A Randomized, Double-Blind, Double Dummy, Active Comparator, Parallel Group, Multicenter Study to Evaluate the Safety of Once-Daily Fluticasone Furoate/GW642444 Inhalation Powder for 52 Weeks in Adole... 2011-05-12 bad-data
Listed as ongoing, but also has a completion date 2009-012055-19 "A randomized, single-blind, placebo-controlled, parallel-group study evaluating the anti-inflammatory activity of GSK315234 in synovial biopsy tissue obtained from subjects with rheumatoid arthritis" 2010-10-01 bad-data
Reported results 2009-012117-21 An open, phase IV, single-group, multicentre study to assess the long-term persistence of antibodies against hepatitis B and the immune response to a hepatitis B (HBV) vaccine challenge in adolescents... 2010-04-07 due-trials
Listed as ongoing, but also has a completion date and reported results 2009-012188-32 A phase III, observer-blind, multicountry, multicentre study to evaluate the safety, reactogenicity and immunogenicity of GlaxoSmithKline Biologicals’ GSK2186877A influenza vaccine administered to adu... 2010-10-27 bad-data
Ongoing, reported early 2009-012202-39 A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of GlaxoSmithKline Biologicals’ dTpa-IPV vaccine (Boostrix Polio) compared with Sanofi... not-yet-due
Completed, but no date 2009-012204-42 A randomized, double-blind, placebo-controlled, parallel group study to investigate the ability of GSK706769 to maintain clinical efficacy after withdrawal of Enbrel in patients with rheumatoid arthri... bad-data
Reported results 2009-012219-16 A phase IV, open-label, non-randomised, multicentre study to assess the immunogenicity and reactogenicity of a booster dose of GSK Biologicals’ combined reduced-antigen-content diphtheria-tetanus, ace... 2012-03-01 due-trials
Completed, but no date, and reported results 2009-012223-29 A phase II, open, single centre, exploratory study to evaluate the safety and immunogenicity of one booster dose of a GSK Biologicals’ Hepatitis B vaccine Engerix™-B or a of GSK Biologicals’ HIV candi... bad-data
Listed as ongoing, but also has a completion date 2009-012460-14 A phase II, open-label, randomised study to assess the safety and immunogenicity of a birth dose of GSK Biologicals’ reduced-antigen-content tri-component pertussis vaccine followed by routine paediat... 2010-04-23 bad-data
Listed as ongoing, but also has a completion date 2009-012518-39 A phase III, open label, randomized, multicenter trial of ofatumumab maintenance treatment versus no further treatment in subjects with relapsed chronic lymphocytic leukemia (CLL) who have responded t... 2018-06-26 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-012581-32 A Clinical Outcomes Study of Darapladib versus Placebo in Subjects Following Acute Coronary Syndrome to Compare the Incidence of Major Adverse Cardiovascular Events (MACE). (Short title: The Stabiliza... 2013-12-06 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-012614-48 A randomised, double-blind, placebo-controlled study to evaluate the efficacy and safety of the H3 receptor antagonist, GSK239512 in subjects with mild to moderate Alzheimer’s disease. 2010-11-08 bad-data
Reported results 2009-012701-19 A phase II, randomized, controlled, observer-blind study to assess the safety, reactogenicity and immunogenicity of GlaxoSmithKline (GSK) Biologicals’ Streptococcus pneumoniae protein containing vacci... 2011-03-02 due-trials
Listed as ongoing, but also has a completion date and reported results 2009-012836-33 A randomised, double blind study to evaluate the safety and efficacy of the p38 kinase inhibitor, GW856553, in subjects with neuropathic pain from lumbosacral radiculopathy 2010-08-23 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-013063-19 A 52-week efficacy and safety study to compare the effect of three dosage strengths of Fluticasone Furoate/GW642444 Inhalation Powder with GW642444 on the Annual Rate of Exacerbations in Subjects with... 2011-10-31 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-013064-40 A 52-week efficacy and safety study to compare the effect of three dosage strengths of Fluticasone Furoate/GW642444 Inhalation Powder with GW642444 on the Annual Rate of Exacerbations in Subjects with... 2011-10-17 bad-data
Reported results 2009-013065-25 A 24-Week Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder and the Individual Components Delivered Once Daily (AM) Via a Novel Dry Powder Inhaler Compar... 2011-02-02 due-trials
Reported results 2009-013067-19 A 24-Week Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder and the Individual Components Delivered Once Daily (AM) Via a Novel Dry Powder Inhaler Compar... 2011-03-08 due-trials
Completed, but no date, and reported results 2009-013710-27 A phase III, observer-blind, randomized trial to evaluate the safety and immunogenicity of a two-dose schedule of the A/California/7/2009 (H1N1)v-like candidate vaccine manufactured in Dresden adjuvan... bad-data
Ongoing, reported early 2009-013783-39 Estudio fase II, aleatorizado, abierto, multicéntrico para evaluar la seguridad e inmunogenicidad de la vacuna experimental adyuvada de gripe pandémica H1N1 administrada como primovacunación y booste... not-yet-due
Ongoing, reported early 2009-013785-52 Estudio fase III, no aleatorizado, abierto para evaluar la seguridad e inmunogenicidad de la vacuna H1N1 adyuvada con AS03A administrada como primovacunación y booster en sujetos entre 3 y 17 años de ... not-yet-due
Completed, but no date, and reported results 2009-013837-92 A phase III, open, randomized, trial to evaluate the immunogenicity and safety of a single or two-dose schedule of the A/California/7/2009 (H1N1)v-like candidate vaccine manufactured in Dresden adjuva... bad-data
Reported results 2009-013931-39 A phase II, observer-blind, randomized study to assess the immunogenicity, safety and reactogenicity of a two-dose schedule with GSK Biologicals’ A/California/7/2009 (H1N1)v-like vaccine containing th... 2010-09-23 due-trials
Listed as ongoing, but also has a completion date and reported results 2009-014249-10 A randomised double-blind cross-over patient preference study of pazopanib versus sunitinib in treatment naïve locally advanced or metastatic renal cell carcinoma. 2015-11-23 bad-data
Completed, but no date, and reported results 2009-014275-53 An open, single centre study to evaluate the long-term antibody persistence and immune memory between 16 and 20 years after the primary study HAB-028 (208127/021) in which healthy adults were vaccina... bad-data
Listed as ongoing, but also has a completion date and reported results 2009-014415-12 A multicentre, randomised, double-blind, placebo-controlled, parallel group, dose ranging study to determine the effect of mepolizumab on exacerbation rates in subjects with severe uncontrolled refrac... 2012-03-23 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-014419-11 A phase III, observer-blind, randomized, study in adults aged between 18 and 60 years to assess the immunological equivalence of the Quebec-manufactured A/California/7/2009 (H1N1)v-like antigen adjuva... 2010-11-04 bad-data
Completed, but no date, and reported results 2009-014448-13 A phase III, randomised, single-blind study to evaluate the immunogenicity and safety of sequential administration of a licensed seasonal trivalent vaccine and the pandemic H1N1 influenza candidate va... bad-data
Completed, but no date, and reported results 2009-014449-96 A phase II, observer-blind, randomized trial to evaluate the safety and immunogenicity of a two-dose schedule of the A/California/7/2009 (H1N1)v-like candidate vaccine manufactured in Dresden adjuvant... bad-data
Reported results 2009-014543-36 A Randomized, Double-Blind, Placebo-Controlled, 3-Way Cross-Over Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of GSK573719 Administered Once- and Twice-Daily in Subjects with COPD 2010-03-11 due-trials
Completed, but no date, and reported results 2009-014853-33 An open single centre study to evaluate the long-term antibody persistence and immune memory between 16 and 20 years after the primary study HAB-032 (208127/022) in which healthy adults were vaccinate... bad-data
Reported results 2009-014858-15 A Randomized, Blinded, Placebo-controlled, Two-Phase, Sequential Cohort, Dose Finding Study to Assess the Safety and Efficacy of an Oral Thrombopoietin Receptor Agonist, Eltrombopag (SB-497115-GR), Ad... 2015-03-16 due-trials
Ongoing, reported early 2009-015008-25 A phase III, open, non-randomized, trial to evaluate the immunogenicity and safety of a two-dose schedule of the A/California/7/2009 (H1N1)v-like candidate vaccine manufactured in Dresden adjuvanted w... not-yet-due
Completed, but no date, and reported results 2009-015011-41 Phase III, non-randomised, open-label study to evaluate the safety and immunogenicity of a prime-boost schedule of the H1N1 candidate vaccine adjuvanted with AS03B administered to subjects aged 3 to 1... bad-data
Listed as ongoing, but also has a completion date and reported results 2009-015014-22 A randomized, double-blind, placebo controlled, parallel group, multi-centre, 2-week treatment study to evaluate the safety and efficacy of fluticasone furoate nasal spray (FFNS) 110 mcg, administered... 2010-07-16 bad-data
Reported results 2009-015106-19 A Phase 2b Dose-Evaluation Study of Pazopanib Eye Drops versus Ranibizumab Intravitreal Injections for the Treatment of Neovascular Age-Related Macular Degeneration 2012-10-05 due-trials
Reported results 2009-015174-35 A phase II, randomised, open-label study to evaluate the safety and immunogenicity of the adjuvanted pandemic H1N1 influenza candidate vaccine following a 0-28 day or 0-4 month vaccination schedule in... 2010-03-25 due-trials
Listed as ongoing, but also has a completion date and reported results 2009-015297-36 A Phase II (BRF113710) single-arm, open-label study of dabrafenib (GSK2118436) in BRAF mutant metastatic melanoma 2016-06-17 bad-data
Reported results 2009-015298-11 A Phase III randomized, open-label study comparing GSK2118436 to DTIC in previously untreated subjects with BRAF mutation positive advanced (Stage III) or metastatic (Stage IV) melanoma. 2016-09-16 due-trials
Listed as ongoing, but also has a completion date and reported results 2009-015386-30 A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter Study to Determine the Safety and Efficacy of Albiglutide Administered in Combination With Insulin Glargine as Compared with th... 2011-12-14 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-015512-17 Study PMA112509, a Phase I/II Study of Eltrombopag in Thrombocytopenic Subjects with Advanced Myelodysplastic Syndrome (MDS) or secondary Acute Myeloid Leukemia after MDS (sAML/MDS) 2013-12-05 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-015791-94 “A phase III, randomized, observer-blind, placebo-controlled, multicentre, clinical vaccination trial to assess the prophylactic efficacy, safety and immunogenicity of GSK Biologicals’ gE/AS01B vaccin... 2015-07-27 bad-data
Reported results 2009-015914-23 Clinical efficacy of an experimental toothpaste 2010-05-18 due-trials
Reported results 2009-015960-32 A phase III, randomised, observer-blind, multicentre study to evaluate the immunogenicity and safety of a 2-dose vaccination with the new process manufactured adjuvanted pandemic H1N1 influenza candid... 2011-01-14 due-trials
Completed, but no date, and reported results 2009-015997-36 A phase III, double-blind, randomized, study in adults aged between 18 and 60 years to assess the immunological non-inferiority of two manufacturing processes of the A/California/7/2009 (H1N1)v-like a... bad-data
Reported results 2009-016012-21 A phase IV, open, non-randomized, multicentre study to assess the reactogenicity and immunogenicity of a booster dose of GSK Biologicals’ combined reduced-antigen-content diphtheria, tetanus and acell... 2012-05-08 due-trials
Listed as ongoing, but also has a completion date and reported results 2009-016035-35 An Open-Label, Multi-Center, Single Arm Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects with Confirmed ... 2015-02-13 bad-data
Completed, but no date, and reported results 2009-016078-33 A phase III, observer-blind, randomised trial to evaluate the safety and immunogenicity of a two-dose schedule of the A/California/7/2009 (H1N1)v-like candidate vaccine manufactured in Dresden adjuvan... bad-data
Reported results 2009-016268-35 A phase II, randomized, observer blind study to evaluate the safety and immunogenicity of three different vaccination schedules employing two formulations of the monovalent A/California/7/2009 (H1N1)v... 2011-05-10 due-trials
Reported results 2009-016581-80 A randomised, double-blind, placebo-controlled, three-way crossover, repeat dose pilot study comparing the effect of inhaled fluticasone furoate/GW642444M combination and fluticasone furoate on the al... 2010-10-12 due-trials
Listed as ongoing, but also has a completion date and reported results 2009-016635-36 A phase II, open-label, randomised, multicentre study to evaluate the safety and immunogenicity of GlaxoSmithKline Biologicals’ DTPa-HBV-IPV/Hib-MenC-TT vaccine, when given to healthy infants at 2, 4 ... 2011-10-11 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-016636-13 An open, dose-escalation Phase I/II study to assess the safety, immunogenicity and clinical activity of recPRAME + AS15 Antigen-Specific Cancer Immunotherapeutic as first-line treatment of patients wi... 2016-12-19 bad-data
Reported results 2009-016663-11 A 35-Day, Multi-Centre, Randomised, Parallel-Group, Double-Blind, Placebo-Controlled Proof of Concept Study to Investigate the Effects of GSK1521498 on Body Weight and Composition, Eating Behaviour an... 2011-05-27 due-trials
Reported results 2009-016690-15 A randomized, double-blind, parallel-group, placebo-controlled study to evaluate the efficacy and safety of GSK573719 delivered once-daily over 28 days in subjects with COPD 2010-07-05 due-trials
Listed as ongoing, but also has a completion date and reported results 2009-016841-24 A phase IIIB open, multicountry, randomized, controlled study to demonstrate the non-inferiority of the immune response of GSK Biologicals’ meningococcal serogroup A, C, W-135 and Y conjugate vaccine ... 2013-09-10 bad-data
Completed, but no date, and reported results 2009-016911-39 An open, phase IV, multicentre, study to assess the long-term persistence of antibodies against hepatitis B and the immune response to a hepatitis B vaccine challenge in healthy children aged 11-12 ye... bad-data
Listed as ongoing, but also has a completion date 2009-017282-35 A phase IIIb, open, multi-centre gynaecological extension study for the follow-up of a subset of HPV-015 study subjects 2017-09-20 bad-data
Reported results 2009-017376-25 An Open-Label, Dose-Escalation, Phase I/II Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of the MEK Inhibitor GSK1120212 in Subjects with Relapsed or Refrac... 2013-04-27 due-trials
Completed, but no date, and reported results 2009-017477-38 An Open-Label, Dose-Escalation, Phase IB/ II Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of the MEK Inhibitor GSK1120212 in Combination with Oral Everolim... bad-data
Reported results 2009-017669-44 A study of the Effects of Inhaled Fliticasone Furotate/GW642444 versus Placebo on HPA Axis of Adolescent and Adult Asthmatics. 2010-09-24 due-trials
Listed as ongoing, but also has a completion date and reported results 2009-017744-14 An Open-Label, Flexible-Dose Study of Retigabine Immediate Release (IR) as Adjunctive Therapy to Specified Monotherapy Antiepileptic Treatments in Adults with Partial-Onset Seizures 2013-04-12 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-017809-11 A phase I/IIa randomized, observer-blind, placebo-controlled, multicenter study to evaluate the safety and immunogenicity of the GSK Biologicals’ herpes zoster vaccine, gE/AS01B in comparison to place... 2013-05-14 bad-data
Reported results 2009-017951-87 A Phase III study to demonstrate the antiviral activity and safety 2015-05-25 due-trials
Completed, reported early 2009-018097-64 Long-term follow-up of study participants from GlaxoSmithKline (GSK) Biologicals’-sponsored clinical trials evaluating Human Immunodeficiency Virus vaccine [F4co (p24-RT-Nef-p17)/AS01B vaccine] (73246... 2014-05-19 not-yet-due
Listed as ongoing, but also has a completion date 2010-018389-22 A randomized, multicentre, open-label, Phase II study of the efficacy and safety of lapatinib plus epirubicin and cyclophosphamide (EC90-L) followed by weekly paclitaxel and lapatinib (PX-L) compared... 2011-01-20 bad-data
Ongoing, reported early 2010-018392-22 Estudio fase I, abierto, multicéntrico para evaluar la seguridad e inmunogenicidad de la vacuna antigripal estacional trivalente (GSK2186877A) adyuvada con varias dosis de AS03, administrada en niños ... not-yet-due
Listed as ongoing, but also has a completion date 2010-018412-32 A phase II, double blind, exploratory, parallel-group, placebo-controlled clinical study to assess two dosing regimens of GSK2402968 for efficacy, safety, tolerability and pharmacokinetics in ambulant... 2012-09-12 bad-data
Listed as ongoing, but also has a completion date and reported results 2010-018730-51 A phase IIIb, open, multi-centre, controlled study to assess the long-term persistence of antibodies after a single dose of GlaxoSmithKline (GSK) Biologicals’ meningococcal serogroup ACWY tetanus-toxo... 2014-05-17 bad-data
Reported results 2010-018738-27 A Randomized, Double Blind, Parallel Group, Placebo Controlled 28 Day Study to Investigate the Safety, Tolerability and Pharmacodynamics of SB-656933 in Patients with Cystic Fibrosis 2010-12-29 due-trials
Listed as ongoing, but also has a completion date and reported results 2010-018775-17 DEFEND 2: Durable-Response Therapy Evaluation For Early- or New-Onset Type 1 Diabetes 2012-03-31 bad-data
Reported results 2010-018780-42 Phase III Randomized, Open Label Study of Single Agent Ofatumumab Vs. Single Agent Rituximab in Follicular Lymphoma Releapsed After Rituximab-Containing Therapy 2017-01-19 due-trials
Ongoing, reported early 2010-019095-70 A Randomised Double-Blind, Double-Dummy, Placebo-Controlled, Stratified, Parallel-Group, Multicentre, Dose Ranging Study to Evaluate the Efficacy and Safety of GSK2190915 Tablets Administered Once Dai... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2010-019157-17 Evaluation of the safety and tolerability of re-dosing with intravenous (IV)otelixizumab in adult subjects with newly diagnosed type 1 diabetes mellitus. 2011-07-14 bad-data
Reported results 2010-019253-18 A phase II, open-label, multicentre study to evaluate the safety and immunogenicity of GSK Biologicals’ DTPa-HBV-IPV/Hib-MenC-TT vaccine as a booster dose in children aged 12 to 18 months, previously ... 2010-12-03 due-trials
Not reported 2010-019390-15 A Phase II, Randomized, Open-label Study of Lapatinib Plus Chemotherapy versus Trastuzumab Plus Chemotherapy as Firstline Treatment for Women with HER2-positive and p95HER2-positive Metastatic Breast ... 2011-08-01 due-trials
Reported results 2010-019465-28 A randomised, double-blind, placebo-controlled, four-way crossover, repeat dose study comparing the effect of inhaled fluticasone furoate/GW642444M combination, GW642444M and fluticasone furoate on th... 2011-05-31 due-trials
No trial status on register 2010-019466-81 A Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Five-Treatment, Four 6-Week Period Cross-Over, Multi-Center Study to Evaluate the Effect of Adding GSK2190915 100 mg, GSK2190915 300 mg, M... bad-data
Listed as ongoing, but also has a completion date 2010-019547-19 A randomized, open label study comparing safety and efficacy parameters for a high and a low dose of ambrisentan (adjusted for body weight) for the treatment of pulmonary arterial hypertension in pae... 2013-05-07 bad-data
Ongoing 2010-019577-16 A Phase III trial to compare the safety and efficacy of lapatinib plus trastuzumab plus an aromatase inhibitor (AI) versus trastuzumab plus an AI versus lapatinib plus an AI as first-line therapy in p... not-yet-due
Reported results 2010-019578-34 A Randomized, Double-Blind Placebo-Controlled Phase II Study of the MEK inhibitor GSK1120212 plus Gemcitabine vs. Placebo plus Gemcitabine in Subjects with Metastatic Pancreatic Cancer 2013-02-25 due-trials
Ongoing, reported early 2010-019589-10 A Randomised, Double-Blind, Double-Dummy, Parallel-Group, Multicentre Study to assess efficacy and safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder and Fluticasone Propionate FP)/Salmete... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2010-019590-15 HZA106827: A randomised, double-blind, placebo-controlled (with rescue medication), parallel group multicentre study of Fluticasone Furoate/GW642444 Inhalation Powder and Fluticasone Furoate Inhalatio... 2011-10-18 bad-data
Listed as ongoing, but also has a completion date and reported results 2010-019594-14 A randomised, double-blind, parallel group, multicentre study of Fluticasone Furoate/GW642444 Inhalation Powder, Fluticasone Furoate Inhalation Powder alone, and Fluticasone Propionate alone in the t... 2011-10-18 bad-data
Completed, but no date, and reported results 2010-019600-23 A Phase III, open, non-randomized, multi-centric, single dose study to assess immunogenicity and safety of Fluarix™ / Influsplit SSW® 2010/2011 injected intramuscularly in young adults (18 to 60 years... bad-data
Listed as ongoing, but also has a completion date and reported results 2010-019690-15 A Randomized, Open-Label, Parallel-Group, Multicenter Study to Determine the Efficacy and Safety of Albiglutide as Compared With Liraglutide in Subjects With Type 2 Diabetes Mellitus 2011-09-27 bad-data
Reported results 2010-019695-76 A Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-centre, Dose Ranging Study to Evaluate the Efficacy and Safety of Losmapimod (GW856553) Tablets Administered Twice Daily compared ... 2011-12-22 due-trials
Reported results 2010-019730-27 A phase II, randomized, controlled, observer-blind study to assess the safety, reactogenicity and immunogenicity of two formulations of GlaxoSmithKline (GSK) Biologicals’ Streptococcus pneumoniae prot... 2012-10-01 due-trials
Reported results 2010-019777-15 A Randomized, Double-Blind, Active-Controlled, Parallel-Group, Multicenter Study to Determine the Efficacy and Safety of Albiglutide as Compared With Sitagliptin in Subjects With Type 2 Diabetes Melli... 2012-05-30 due-trials
Reported results 2010-019832-11 An open-label study to evaluate the utility of the apoptosis imaging biomarker [18F]ML-10 to assess the response to chemotherapy in patients with non Hodgkin's lymphoma. 2012-02-06 due-trials
Listed as ongoing, but also has a completion date and reported results 2010-019909-42 A double-blind, randomized, placebo-controlled, Phase I/II Study evaluating the safety, immunogenicity and clinical activity of neoadjuvant treatment with WT1-A10 + AS15 Antigen-Specific Cancer Immuno... 2014-11-14 bad-data
Completed, but no date, and reported results 2010-019989-91 A Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Three-Treatment, Three 6-Week Period Cross-Over, Multi-Center Exploratory Study to Evaluate the Effect of Adding GSK2190915 300mg Tablets ... bad-data
Listed as ongoing, but also has a completion date 2010-020069-26 A phase III, randomized, double blind, placebo-controlled clinical study to assess the efficacy and safety of GSK2402968 in subjects with Duchenne muscular dystrophy 2013-08-28 bad-data
Listed as ongoing, but also has a completion date and reported results 2010-020144-34 A randomised, double-blind, double-dummy, placebo controlled (with rescue medication), multicenter study to evaluate the efficacy and safety of fluticasone furoate inhalation powder in the treatment o... 2012-01-16 bad-data
No trial status on register 2010-020154-33 RTG113388, a Long-term, Open-label Safety Extension Study of bad-data
Reported results 2010-020157-13 An open-label, non-randomized, pharmacokinetic and safety study of repeat doses of fluticasone furoate and GW642444M combination in healthy subjects and in subjects with mild, moderate or severe hepat... 2011-07-15 due-trials
Reported results 2010-020227-48 A phase IIIb, open-label, multi-centre immunization study to evaluate the safety of GlaxoSmithKline (GSK) Biologicals’ HPV-16/18 L1 VLP AS04 vaccine administered intramuscularly according to a 0, 1, 6... 2017-01-10 due-trials
Completed, but no date, and reported results 2010-020312-12 A phase IIa, observer-blind, multi-country, multicentre, randomised study to evaluate the immunogenicity, safety and reactogenicity of the GlaxoSmithKline Biologicals’ quadrivalent influenza vaccine (... bad-data
Completed, but no date, and reported results 2010-020313-81 A Phase IIIA, open, randomized study to assess immunogenicity and safety of Fluarix™/Influsplit SSW® 2010/2011 or Pandemrix™ vaccination in adults aged 18 years and above previously vaccinated with on... bad-data
Reported results 2010-020330-26 A phase IV, open label, randomized, multicountry study to evaluate immunogenicity and safety of GSK Biologicals' seasonal (2010-2011) influenza vaccine FluarixTM in children previously vaccinated with... 2011-05-26 due-trials
Reported results 2010-020331-39 A Phase IV, open label, randomized, monocentric study to evaluate immunogenicity and safety of GSK Biologicals' seasonal (2010-2011) influenza vaccine FluarixTM in adolescents previously vaccinated wi... 2011-07-07 due-trials
Reported results 2010-020352-59 A multi-center, placebo-controlled study to evaluate the safety of GSK716155 and its effects on myocardial metabolism, myocardial function, and exercise capacity in patients with NYHA Class II/III con... 2012-09-18 due-trials
Listed as ongoing, but also has a completion date and reported results 2010-020412-11 A randomized, double-blind, double-dummy, parallel-group, placebo controlled (on inhaled corticosteroid medication), multicenter study to evaluate the efficacy and safety of vilanterol inhalation powd... 2011-08-26 bad-data
Completed, but no date 2010-020798-17 A Randomized, Multi-Center, Blinded, Placebo-Controlled Study of Mapatumumab ([HGS1012], a Fully Human Monoclonal Antibody to TRAIL-R1) in Combination with Sorafenib as a First-Line Therapy in Subject... bad-data
Reported results 2010-020826-17 An open-label, non-randomized pharmacokinetic and safety study of repeat doses of fluticasone furoate and GW642444M combination in healthy subjects and in subjects with severe renal impairment 2011-03-22 due-trials
Ongoing 2010-020965-26 A randomized, double blind, placebo controlled phase III study to evaluate the efficacy and safety of pazopanib as adjuvant therapy for subjects with localized or locally advanced RCC following nephre... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2010-020993-41 A phase 2a study to evaluate the effect of rilapladib (SB-659032) 2013-02-18 bad-data
Listed as ongoing, but also has a completion date and reported results 2010-021032-34 A phase III, double-blind, randomized study to evaluate the immunogenicity and safety of GSK Biologicals’ quadrivalent influenza vaccine compared to GSK Biologicals’ trivalent influenza vaccine admin... 2011-06-15 bad-data
Listed as ongoing, but also has a completion date and reported results 2010-021034-63 A phase III randomized, partially-blind, controlled, multi-country, multi-centre study to evaluate the immunogenicity, reactogenicity and safety of GSK Biologicals’ quadrivalent influenza vaccine D-QI... 2011-06-06 bad-data
Listed as ongoing, but also has a completion date and reported results 2010-021059-25 A 12-Week Study to Evaluate the 24 Hour Pulmonary Function of Fluticasone Furoate (FF)/Vilanterol (VI) Inhalation Powder (FF/VI Inhalation Powder) Once Daily Compared with Salmeterol/Fluticasone Propi... 2011-10-19 bad-data
Ongoing, reported early 2010-021073-36 Estudio fase III, doble ciego aleatorizado para evaluar la inmunogenicidad y seguridad de la vacuna antigripal tetravalente de GSK Biologicals GSK2282512A (FLU Q-QIV) comparada con la vacuna antigripa... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2010-021356-26 A Phase IIb, randomized, observer-blind, placebo controlled, multicenter primary/booster therapeutic vaccination study to determine efficacy and safety of F4co/ AS01B vaccine, administered intramuscul... 2012-10-11 bad-data
Completed, reported early 2010-021569-58 A phase I/II, double-blind, randomized, multicentre study to evaluate the safety and immunogenicity of new formulations of GlaxoSmithKline Biologicals’ DTPa-HBV-IPV/Hib vaccine when administered to he... 2012-01-05 not-yet-due
Ongoing 2010-021572-29 An open-label, long term extension study for treatment of pulmonary arterial hypertension in paediatric patients aged 8 years up to 18 years who have participated in AMB112529 and in whom continued tr... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2010-021621-12 A Phase III international, randomized, double-blind, double-dummy study to evaluate the efficacy and safety of 300 mg or 600 mg of intravenous zanamivir twice daily compared to 75 mg of oral oseltamiv... 2015-03-18 bad-data
Listed as ongoing, but also has a completion date and reported results 2010-021638-72 A Clinical Outcomes Study to compare the effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg with placebo on Survival in Subjects with moderate Chronic Obstructive Pulmonary Disease (... 2015-07-15 bad-data
Reported results 2010-021642-22 A two part study to investigate the pharmacokinetics and pharmacodynamics of SB705498, a TRPV1 antagonist, in cough. Part A: an open label study in healthy subjects to determine the exposure to SB-705... 2012-01-19 due-trials
Reported results 2010-021798-34 To assess the subjective effect of two paracetamol preparations on the feeling of breathing in subjects with the common cold. 2010-12-08 due-trials
Reported results 2010-021800-72 A multicenter trial comparing the efficacy and safety of GSK573719/GW642444 with GW642444 and with tiotropium over 24 weeks in subjects with COPD. 2012-04-24 due-trials
Reported results 2010-021802-39 A multicenter trial comparing the efficacy and safety of GSK573719/GW642444 with GSK573719 with tiotropium over 24 weeks in subjects with COPD 2012-04-10 due-trials
Listed as ongoing, but also has a completion date and reported results 2010-022111-19 Comparative efficacy of DUODART tm plus lifestyle advice versus watchful waiting plus lifestyle advice with step-up therapy to tamsulosin in the management of treatment naive men with moderately sympt... 2014-01-16 bad-data
Reported results 2010-022248-19 An open, phase II long term extension study to evaluate the immune responses to and safety of GSK Biologicals’ candidate herpes zoster vaccine, (gE/AS01B), at Months 48, 60 and 72 post-vaccination in ... 2013-06-20 due-trials
Reported results 2010-022279-77 A Phase II Randomised, Double-Blind, Placebo-Controlled, Parallel Group, Multicentre Study to determine the efficacy and dose response of repeat inhaled doses of GW870086X on FEV1 in adults with Persi... 2011-08-19 due-trials
Reported results 2010-022280-35 A randomised, double-blind, placebo-controlled study of topical GW870086X formulation in subjects with moderate or severe atopic dermatitis. 2011-04-14 due-trials
Listed as ongoing, but also has a completion date and reported results 2010-022382-10 A Randomised, Double-blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects with Moderately-to Severely Active Crohn’s Disease 2013-09-04 bad-data
Listed as ongoing, but also has a completion date and reported results 2010-022383-12 A 52 week Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Maintenance of Remission in Subjects with Crohn’s Disease 2013-10-23 bad-data
Listed as ongoing, but also has a completion date and reported results 2010-022384-35 An Open-Label Extension Study to Assess the Safety of GSK1605786A in Subjects with Crohn’s Disease 2013-11-14 bad-data
Reported results 2010-022510-11 A multicenter, open-label, dose ranging study to determine the pharmacokinetics and pharmacodynamics of mepolizumab administered intravenously or subcutaneously to adult asthmatic subjects with elevat... 2012-03-07 due-trials
Reported results 2010-022538-10 An open, phase IV, multicentre study to assess the long-term persistence of antibodies against hepatitis B and the immune response to a hepatitis B (Engerix-B™ Kinder) vaccine challenge in children ag... 2011-09-28 due-trials
Completed, reported early 2010-022777-34 A Multicentre, Open-Label, Long-Term, Safety and Tolerability Study of Retigabine Immediate Release (IR) in Adults with Partial-Onset Seizures (Extension of Study RGB113905). 2017-09-13 not-yet-due
Reported results 2010-022796-62 A 4-week Dose-Ranging, Dose-Interval, Efficacy, Safety and Tolerability Study of GSK961081 in Subjects with COPD. 2011-09-02 due-trials
Listed as ongoing, but also has a completion date and reported results 2010-022838-85 A Phase III randomized, open-label study comparing GSK1120212 to chemotherapy in subjects with advanced or metastatic BRAF V600E/K mutation-positive melanoma 2016-12-16 bad-data
Listed as ongoing, but also has a completion date and reported results 2010-022843-39 Efficacy of oral alitretinoin treatment in patients with palmo-plantar pustulosis (PPP) inadequately responding to standard topical treatment 2014-04-16 bad-data
Reported results 2010-022857-41 Effects of a common cold treatment on cognitive function 2011-04-12 due-trials
Listed as ongoing, but also has a completion date 2010-023015-33 MEK114375: A Rollover Study to Provide Continued Treatment with GSK1120212 to Subjects with Solid Tumors and Leukemia 2018-01-23 bad-data
Listed as ongoing, but also has a completion date 2010-023066-52 An open label, multicenter study investigating the safety and efficacy of ofatumumab therapy versus physicians' choice in patients with bulky fludarabine refractory chronic lymphocytic leukaemia (CLL) 2017-04-27 bad-data
Listed as ongoing, but also has a completion date and reported results 2010-023091-10 A 24-week study to evaluate the effect of fluticasone furoate/ vilanterol 100/25 mcg Inhalation Powder delivered once-daily via a Novel Dry Powder Inhaler on arterial stiffness compared with placebo a... 2014-11-04 bad-data
Listed as ongoing, but also has a completion date and reported results 2010-023186-21 A Randomized, Double-Blind, Placebo-Controlled Multicenter Phase II Study to Evaluate the Safety and Efficacy and Dose Response of 28 Days of Once-Daily Dosing of the Oral Motilin Receptor Agonist GSK... 2013-02-26 bad-data
Reported results 2010-023348-33 A 24-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GSK573719/GW642444 Inhalation Powder and the Individual Components Delivered Once-Daily via a Nove... 2012-04-20 due-trials
Listed as ongoing, but also has a completion date and reported results 2010-023349-32 A 24-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GSK573719/GW642444 Inhalation Powder and the Individual Components Delivered Once-Daily via a Nove... 2012-05-04 bad-data
Reported results 2010-023417-54 A 52-Week, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Safety and Tolerability of GSK573719 125mcg once-daily alone and in combination with GW642444... 2012-07-23 due-trials
Listed as ongoing, but also has a completion date and reported results 2010-023418-29 HZC113109: A 12-Week Study to Evaluate the 24-Hour Pulmonary Function Profile of Fluticasone Furoate /Vilanterol (FF/VI) Inhalation Powder 100/25mcg Once Daily Compared with Fluticasone Propionate/Sal... 2011-12-13 bad-data
Reported results 2010-023419-33 HZC112352: A 12-Week Study to Evaluate the 24-Hour Pulmonary Function Profile of Fluticasone Furoate /Vilanterol (FF/VI) Inhalation Powder 100/25mcg Once Daily Compared with Fluticasone Propionate/Sal... 2012-01-24 due-trials
Reported results 2010-023442-75 An exercise endurance study to evaluate the effects of treatment of COPD patients with a dual bronchodilator: GSK573719/GW642444 2012-06-14 due-trials
Reported results 2010-023444-32 An exercise endurance study to evaluate the effects of treatment of COPD patients with a dual bronchodilator: GSK573719/GW642444. 2012-07-16 due-trials
Reported results 2010-023837-45 A Phase II Open-Label, Two-Cohort, Multicentre Study of GSK2118436 as a Single Agent in Treatment Na�ve and Previously Treated Subjects with BRAF Mutation-Positive Metastatic Melanoma to the Brain 2013-06-12 due-trials
Not reported 2010-024087-17 Study MAG104615, a Proof of Concept Study for GSK249320 2012-02-21 due-trials
Reported results 2010-024435-16 A 12-week study to evaluate the effect of fluticasone furoate (FF, GW685698)/vilanterol (VI, GW642444) 100/25 mcg Inhalation Powder delivered once daily via a Novel Dry Powder Inhaler (NDPI) on arteri... 2012-08-06 due-trials
No trial status on register 2010-024566-22 A double-blind, escalating dose, randomized, placebo-controlled study to assess the pharmacokinetics, safety and tolerability of single subcutaneous injections of GSK2402968 in non-ambulant subjects w... bad-data
Listed as ongoing, but also has a completion date and reported results 2011-000114-19 A Three-part Study of Eltrombopag in Thrombocytopenic Subjects with Myelodysplastic Syndromes or Acute Myeloid Leukemia (Part 1: open-label, Part 2: randomized, double-blind, Part 3: extension). ASPIR... 2015-12-21 bad-data
Reported results 2011-000115-11 A randomized, double-blind, placebo controlled, incomplete block, 3 way cross over study in subjects with allergic rhinitis to assess the effect of intranasal repeat doses of SB-705498 when administer... 2011-07-07 due-trials
Not reported 2011-000241-21 A clinical and mechanistic proof of efficacy study with belimumab in chronic immune thrombocytopenia (ITP) patients 2013-03-07 due-trials
Listed as ongoing, but also has a completion date 2011-000242-38 A 2 year study of efficacy and safety of intravenous belimumab versus placebo in subjects with idiopathic membranous nephropathy 2013-10-23 bad-data
Reported results 2011-000243-24 An open-label, phase 2a study to evaluate pazopanib eye drops 2012-04-16 due-trials
Ongoing 2011-000368-88 A Multi-center, Randomized Parallel Group, Placebo-Controlled Double-Blind Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of Belimumab, a Human Monoclonal Anti-BLyS Antibody, Plus Standa... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2011-000483-94 A multicenter, two-part, randomized, parallel group, placebo and sitagliptin-controlled study to evaluate the safety and efficacy of GSK256073 administered once or twice daily for 12 weeks in subjects... 2012-09-17 bad-data
Reported results 2011-000484-28 A randomised, double-blind, dose-finding, multicenter study of the safety, tolerability, and efficacy of GSK2251052 therapy compared to imipenem-cilastatin in the treatment of adult subjects with febr... 2012-03-05 due-trials
Reported results 2011-000485-35 A Study to Assess the Safety, Tolerability and Preliminary Efficacy of GSK2251052 in the treatment of complicated intra-abdominal infection in adults. 2012-03-05 due-trials
Listed as ongoing, but also has a completion date and reported results 2011-000634-11 A Phase II, Open-label, Multicenter, Randomized Study to Assess the Efficacy and Safety of GSK1120212 Compared with Docetaxel in 2nd Line Subjects with Targeted Mutations (KRAS, NRAS, BRAF, MEK1) in L... 2013-09-24 bad-data
Reported results 2011-000757-22 A Phase IIIb open-label, randomised, multi-centre primary immunization study to evaluate the immunogenicity and safety of GSK Biologicals’ HPV-16/18 L1 VLP AS04 vaccine when administered intramuscular... 2014-11-13 due-trials
Listed as ongoing, but also has a completion date and reported results 2011-000758-41 A phase III, observer-blind, randomized, multi-country, non-influenza vaccine comparator-controlled study to demonstrate the efficacy of GlaxoSmithKline Biologicals’ quadrivalent seasonal influenza ca... 2014-12-31 bad-data
Listed as ongoing, but also has a completion date and reported results 2011-000876-33 A phase II, double-blind, multicentre study to evaluate the safety and immunogenicity of a booster dose of new formulations of GlaxoSmithKline Biologicals’ combined DTPa-HBV-IPV/Hib vaccine in healthy... 2012-11-14 bad-data
Reported results 2011-000943-26 A phase IV, open-label, study to assess the antibody persistence in healthy 5-year-old children, previously vaccinated at 3, 5 and 11months of age with GSK Biologicals’ DTPa-HBV-IPV/Hib or DTPa-IPV/Hi... 2011-07-15 due-trials
Ongoing, reported early 2011-001161-41 A Phase II study of the BRAF inhibitor dabrafenib as a single agent and in combination with the MEK inhibitor trametinib in subjects with BRAF V600E mutation positive metastatic (stage IV) non-small c... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2011-001266-17 An open-label extension study of the long-term safety, 2014-03-17 bad-data
No trial status on register 2011-001508-37 Phase III randomized, open, controlled study to evaluate the immune response to the hepatitis B antigen of the RTS,S/AS01E candidate vaccine, when administered as primary vaccination integrated into a... bad-data
Reported results 2011-001581-18 Effects of bronchodilatation with salmeterol on the autonomic nervous system 2012-11-30 due-trials
Ongoing, reported early 2011-001608-37 Open, randomised, controlled, multicenter Phase IIIb study to evaluate the immune response and safety, after the administration of GlaxoSmithKline Biologicals live attenuated measles mumps rubella ... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2011-001643-79 A 6-month safety and benefit study of inhaled fluticasone propionate/ salmeterol combination versus inhaled fluticasone propionate in the treatment of 6,200 pediatric subjects 4-11 years old with pers... 2015-11-03 bad-data
Listed as ongoing, but also has a completion date and reported results 2011-001644-29 A Safety and Efficacy Study of Inhaled Fluticasone Propionate/Salmeterol Combination versus Inhaled Fluticasone Propionate in the Treatment of Adolescent and Adult Subjects with Asthma. 2015-06-04 bad-data
Reported results 2011-001645-33 AC4115408: A12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of GSK573719 Delivered Once-Daily via a Novel Dry Powder Inhaler in Subjects... 2012-02-13 due-trials
Reported results 2011-001900-36 FFA115285: A randomised, double-blind, double-dummy, placebo controlled multi-centre study to evaluate the efficacy and safety of fluticasone furoate inhalation powder and fluticasone propionate inhal... 2012-09-26 due-trials
Listed as ongoing, but also has a completion date and reported results 2011-002035-26 A Phase IIIb observer-blind, randomized, multicentre primary immunization study to evaluate the immunogenicity and safety of GSK Biologicals’ HPV-16/18 L1 VLP AS04 vaccine and Merck's Quadrivalent Hum... 2015-10-26 bad-data
Reported results 2011-002068-26 A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Belimumab in Subjects with Generalized Myasthenia Gravis (MG). 2015-10-27 due-trials
No trial status on register 2011-002076-16 Clinical Otitis Media and Pneumonia Study (COMPAS): a phase III , double-blind, randomized, controlled, multicentre study to demonstrate the efficacy of GlaxoSmithKline (GSK) Biologicals’ 10-valent pn... bad-data
No trial status on register 2011-002077-35 A phase III, open, controlled study in South Africa to assess the immunogenicity, safety and reactogenicity of GSK Biologicals’ 10-valent pneumococcal conjugate vaccine administered as a 3-dose (6, 10... bad-data
No trial status on register 2011-002140-27 A phase III, open study in children previously enrolled in study 10PN-PD-DIT-037 (111188) to assess the immunogenicity, safety and reactogenicity of GlaxoSmithKline (GSK) Biologicals’ 10-valent pneumo... bad-data
Listed as ongoing, but also has a completion date and reported results 2011-002184-17 A two part, double-blind, randomized, placebo-controlled and open-label study to investigate the efficacy, safety and tolerability of eltrombopag, a thrombopoietin receptor agonist, in pediatric patie... 2014-01-02 bad-data
Completed, but no date, and reported results 2011-002225-22 A phase I, randomized, controlled, double-blind study to assess safety, reactogenicity and immunogenicity of GSK Biologicals’ pneumococcal vaccine 2830930A when administered as a single dose in health... bad-data
Listed as ongoing, but also has a completion date and reported results 2011-002333-19 A Randomized, Double-blind, Placebo controlled, Parallel-Group, Dose-Ranging Study to Investigate the MRI Efficacy and Safety of Six Months’ administration of Ofatumumab in Subjects with Relapsing-Rem... 2015-06-10 bad-data
Ongoing, reported early 2011-002410-36 A phase III, open, controlled study to evaluate immunogenicity of GSK Biologicals’ MenACWY-TT conjugate vaccine administered intramuscularly to at risk subjects from 1 to less than 18 years and to an ... not-yet-due
Reported results 2011-002451-33 A 12-Week Study to Evaluate the 24-Hour Pulmonary Function Profile of Fluticasone Furoate /Vilanterol (FF/VI) Inhalation Powder 100/25mcg Once-Daily via a Novel Dry Powder Inhaler Compared with Tiotro... 2012-12-21 due-trials
Ongoing, reported early 2011-002452-13 A 12-month, open label, randomised, effectiveness study to evaluate fluticasone furoate (FF, GW685698)/vilanterol (VI, GW642444) Inhalation Powder delivered once daily via a Novel Dry Powder Inhaler (... not-yet-due
No trial status on register 2011-002629-23 Immunogenicity and protective efficacy of GlaxoSmithKline Biologicals’ rec-Hepatitis B vaccine (10 µg) in newborns of Hepa-titis B envelope antigen positive (HBeAg+) and Hepatitis B surface antigen po... bad-data
Reported results 2011-002817-12 A Randomised, Double-blind, Active Treatment Study to Induce Clinical Response and/or Remission with GSK1605786A in Subjects with Moderately-to-Severely Active Crohn’s Disease 2013-10-17 due-trials
Not reported 2011-002818-37 A phase II, 20-week, multi-centre, randomised, double-blind, placebo-controlled, parallel group proof of concept study to investigate the efficacy and safety of GSK1605786 for treatment of patients wi... 2013-01-17 due-trials
Reported results 2011-002827-17 A fixed dose, dose response study for ropinirole prolonged release (PR) in patients with early stage Parkinson’s Disease. 2014-04-30 due-trials
Reported results 2011-002828-41 A fixed dose, dose-response study of ropinirole prolonged release (PR) as adjunctive treatment to L-dopa in patients with advanced Parkinson's disease. 2015-03-17 due-trials
Completed, but no date, and reported results 2011-002943-92 A Single-arm, Open Label Study Evaluating the Impact on Lifestyle of a New Thermo Stable Formulation of FLOLAN™ in Subjects with Pulmonary Arterial Hypertension (PAH) bad-data
Reported results 2011-002944-28 A phase 2, multi-national, multi-centre, double masked, 2013-06-12 due-trials
No trial status on register 2011-002946-11 A phase IIIb, open label, randomized, multicenter study of the im-munogenicity and safety of a booster dose of Kinrix when co-administered with varicella vaccine (Varivax®, Merck and Company) and MMR ... bad-data
No trial status on register 2011-003167-30 A randomised, open-label study to assess the immunogenicity and reactogenicity of GSK Biologicals’ IPV vaccine administered as a three-dose primary vaccination course at 2-3-4 months of age in healthy... bad-data
Reported results 2011-003255-19 A phase IV, open-label, single-center study to evaluate long term immunogenicity up to 10 years after the first booster immunization with Tick Borne Encephalitis vaccine in adults who received 1 of 3 ... 2016-09-30 due-trials
Listed as ongoing, but also has a completion date and reported results 2011-003337-34 HZA106853: A dose-ranging study of vilanterol (VI) inhalation powder in children aged 5-11 years with asthma on a background of inhaled corticosteroid therapy. 2014-04-28 bad-data
Listed as ongoing, but also has a completion date and reported results 2011-003338-15 HZA106855: A dose-ranging study of fluticasone furoate (FF) inhalation powder in children aged 5-11 years with asthma. 2019-09-24 bad-data
No trial status on register 2011-003512-23 A phase II, randomized, observer blind, multicenter study to evaluate the safety and immunogenicity of a single low dose of AS03-adjuvanted, Quebec- or Dresden- manufactured monovalent A/California/7/... bad-data
Reported results 2011-003672-36 A Phase IIIA, observer-blind, randomized study to evaluate non-inferiority of a second dose of GSK Biologicals’ measles-mumps-rubella vaccine vs. a second dose of Merck & Co., Inc.’s MMR vaccine when ... 2015-09-18 due-trials
No trial status on register 2011-003710-16 A phase III, randomized, open, controlled study in healthy Japanese children to assess the immunogenicity, safety and reactogenicity of GlaxoSmithKline Biologicals’ 10-valent pneumococcal conjugate va... bad-data
No trial status on register 2011-003711-39 A phase III, open, single centre study to assess the safety, reac-togenicity and immunogenicity of GlaxoSmithKline (GSK) Biologicals’ 10-valent pneumococcal conjugate (10Pn-PD-DiT) vaccine (GSK 102485... bad-data
No trial status on register 2011-003731-63 A phase IV, open, multi-centre study to assess the immunogenicity, reactogenicity and safety of two doses of GSK Biologicals’ oral live attenuated human rotavirus (HRV) vaccine in healthy Taiwanese in... bad-data
Listed as ongoing, but also has a completion date and reported results 2011-003814-18 A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 52-Week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) Administered Subcutaneously (SC) to Subjects with System... 2015-10-01 bad-data
Reported results 2011-004436-61 A Four-Part, Open-Label Study to Evaluate the Effects of Repeat Dose GSK2118436 on the Single Dose Pharmacokinetics of Warfarin, the Effects of Repeat Dose Oral Ketoconazole and Oral Gemfibrozil on th... 2012-11-15 due-trials
Listed as ongoing, but also has a completion date and reported results 2011-004438-32 A randomized, double-blind, placebo-controlled, parallel group, dose ranging study to assess the effect of repeat doses of GSK962040 on the pharmacokinetics of levodopa in subjects with Parkinson’s di... 2014-05-01 bad-data
Reported results 2011-004466-14 Effects of two doses of a common cold treatment on cognitive function 2012-10-31 due-trials
No trial status on register 2011-004485-15 A Phase IIIb, open, randomized study to evaluate non-inferiority of GSK Biologicals’ measles-mumps-rubella-varicella vaccine versus co-administration of GSK Biologicals’ Priorix™ and Varilrix™ in heal... bad-data
Listed as ongoing, but also has a completion date and reported results 2011-004569-33 A Multi-Center, Multinational, Randomized, Double-Blind, Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) in Combination with Azathioprine for the Maintenance of Remission in Wegener’... 2017-02-06 bad-data
Ongoing 2011-004570-28 A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab plus Standard of Care versus Placebo plus Standard of Care in Adult Subjects with Active ... not-yet-due
No trial status on register 2011-004638-32 A Phase IIIA, observer-blind, randomized study to evaluate non-inferiority of a second dose of GSK Biologicals’ measles-mumps-rubella vaccine vs. a second dose of Merck & Co., Inc.’s MMR vaccine when ... bad-data
No trial status on register 2011-004644-22 A phase III, randomized, single-blind, controlled study to assess the immunogenicity, safety and reactogenicity of GlaxoSmithKline (GSK) Biologicals’ 10-valent pneumococcal conjugate vaccine as a 3-do... bad-data
No trial status on register 2011-004650-25 A phase III, randomized, open, controlled study to assess the immunogenicity, safety and reactogenicity of GlaxoSmithKline (GSK) Biologicals’ 10-valent pneumococcal conjugate vaccine as a 3-dose prima... bad-data
No trial status on register 2011-004734-33 A Phase II, non-randomised, open-label study to evaluate the safety and immunogenicity of the adjuvanted (pre-) pandemic H5N1 influenza candidate vaccine following a heterologous prime-boost schedule ... bad-data
No trial status on register 2011-004751-39 A phase III, randomized, open, active-controlled study to evaluate the safety and immunogenicity of a prime-boost schedule of the H5N1 candidate vaccine adjuvanted with AS03B administered to children ... bad-data
Listed as ongoing, but also has a completion date and reported results 2011-004800-40 An Open-Label Extension Study to Evaluate the Long Term Safety and Efficacy of Migalastat Hydrochloride Monotherapy in Subjects with Fabry Disease. 2016-02-17 bad-data
No trial status on register 2011-004879-36 Comparative study of the immunogenicity and protective efficacy of GlaxoSmithKline Biologicals’ rec-DNA Hepatitis B vaccine (10µg) with or without Hepatitis B immunoglobulin (HBIG) in newborns of Hepa... bad-data
Reported results 2011-004891-12 A phase IIIA, randomized, observer-blind, controlled, multinational consistency study to evaluate the immunogenicity and safety of GSK Biologicals' MMR vaccine (209762) (Priorix®) compared to Merck & ... 2015-04-16 due-trials
No trial status on register 2011-004901-25 An Open-Label, Two-Period, Randomized, Crossover Study to bad-data
Reported results 2011-004905-26 Immunogenicity and safety study of GSK Biologicals? Priorix® vaccine (209762) at an end of shelf-life potency compared to Merck & Co., Inc.?s MMR vaccine when both are given on a 2-dose schedule to he... 2015-08-18 due-trials
No trial status on register 2011-005032-26 A phase III, open, randomized, controlled, multi-centre study to demonstrate the non-inferiority of the meningococcal serogroup C and the Haemophilus influenzae type b immune response of GlaxoSmithKli... bad-data
Listed as ongoing, but also has a completion date and reported results 2011-005178-43 A Phase II, Multi-centre Study Investigating the Safety and Efficacy of Ofatumumab and Bendamustine Combination in Patients with Untreated or Relapsed Chronic Lymphocytic Leukaemia (CLL) 2015-11-25 bad-data
Reported results 2011-005216-28 A Multicenter, Randomized, Single-blind, Active-controlled, Parallel Group, Phase II Study to Evaluate the Efficacy, Safety, and Tolerability of a Single Intravenous (6 mg, 12 mg, 18 mg, 24 mg or 36 m... 2012-08-22 due-trials
Reported results 2011-005244-95 A multi-national, randomized, double-blind, placebo-controlled, 3-period crossover study with GSK 573719 as monotherapy in adult subjects with asthma 2013-02-05 due-trials
Ongoing, reported early 2011-005553-31 A 12-month, open label, randomised, effectiveness study to evaluate fluticasone furoate (FF, GW685698)/vilanterol (VI, GW642444) Inhalation Powder delivered once daily via a Novel Dry Powder Inhaler c... not-yet-due
No trial status on register 2011-005604-15 A phase III, randomised, controlled, single-blind study to evaluate the safety and immunogenicity of GlaxoSmithKline (GSK) Biologicals’ HPV-16/18 L1 VLP AS04 vaccine administered according to a 2-dose... bad-data
Ongoing 2011-005667-25 A Randomized, Double-Blind, Placebo-Controlled 52-Week Study to Assess Adverse Events of Special Interest in Adults with Active, Autoantibody-Positive Systemic Lupus Erythematosus Receiving Belimumab not-yet-due
Ongoing 2011-005672-42 A Phase 3/4, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 52-Week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) in Adult Subjects of Black Race With Systemic Lupus Er... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2011-005743-27 A phase II, randomized, controlled, partially-blind study to demonstrate immunogenicity and assess safety of GlaxoSmithKline (GSK) Biologicals’ 11-valent and 12-valent pneumococcal polysaccharide and ... 2014-01-22 bad-data
No trial status on register 2011-005860-31 Immunogenicity of GlaxoSmithKline Biologicals’ MMR vaccine (209762) vs. M-M-R® II, when co-administered with hepatitis A, varicella and pneumococcal conjugate vaccines to children 12-15 months of age bad-data
No trial status on register 2011-005868-25 A randomised, open-label study to assess the immunogenicity and reactogenicity of GSK Biologicals’ DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course at 2-3-4 or 3-4-5 months... bad-data
No trial status on register 2011-005881-38 A phase II, randomized, double-blind study of Priorix-Tetra (combined measles-mumps-rubella-varicella vaccine), one lot using new measles and rubella working seeds and one lot using old working seeds,... bad-data
No trial status on register 2011-005882-19 Non-inferiority of GSK Biologicals’ measles-mumps-rubella-varicella (MMRV) vaccine 208136 vs Priorix™ and Priorix™ coadministered with Varilrix™ (comparator) and to evaluate non-inferiority of Priorix... bad-data
Reported results 2011-005913-35 A Randomized, Double-Blind, 3-Way, Cross-Over Study to Evaluate Lung Function Response after Treatment with Umeclidinium 62.5mcg, Vilanterol 25mcg, and Umeclidinium/Vilanterol 62.5/25mcg Once-Daily in... 2013-06-11 due-trials
Reported results 2011-005914-12 A Randomized, Double-Blind, 3-Way, Cross-Over Study to Evaluate Lung Function Response after Treatment with Umeclidinium 62.5mcg, Vilanterol 25mcg, and Umeclidinium/Vilanterol 62.5/25mcg Once-Daily in... 2013-03-06 due-trials
Listed as ongoing, but also has a completion date and reported results 2011-006013-34 A phase III, open, controlled, multi-centric study to evaluate the immunogenicity, safety and reactogenicity of GSK Biologicals' 10-valent pneumococcal conjugate vaccine when administered to children ... 2015-06-29 bad-data
Ongoing 2011-006087-49 A Phase III, randomized, double-blinded study comparing the combination of the BRAF inhibitor, dabrafenib and the MEK inhibitor, trametinib to dabrafenib and placebo as first-line therapy in subjects ... not-yet-due
Other 2011-006088-23 A phase III, randomised, open-label study comparing the combination of the BRAF inhibitor dabrafenib and the MEK inhibitor trametinib to the BRAF inhibitor vemurafenib in subjects with unresectable (s... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2011-006161-18 A phase IIIA, randomized, observer-blind, controlled, multinational study to evaluate the safety and immunogenicity of GSK Biologicals' MMR vaccine (209762) (Priorix®) compared to Merck & Co., Inc.’s ... 2015-12-22 bad-data
Ongoing, reported early 2011-006215-56 BEL114424: A Phase 2 Pilot, Multicentered, Randomised, Double Blind, Placebo-Controlled Study to Evaluate the Potential for Efficacy and the Safety of Belimumab plus Standard of Care versus Placebo pl... not-yet-due
Ongoing, reported early 2012-000126-22 A Single Blind (Sponsor-unblinded), Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of GSK1070806 in the Treatment of Obese Subjects with T2DM. not-yet-due
Listed as ongoing, but also has a completion date and reported results 2012-000138-20 A phase III, randomised, observer-blind, placebo-controlled, multicentre, clinical trial to assess the prophylactic efficacy, safety, and immunogenicity of GSK Biologicals’ herpes zoster gE/AS01B cand... 2017-02-01 bad-data
No trial status on register 2012-000162-38 A phase III open-label study to assess the safety and reactogenicity of GlaxoSmithKline (GSK) Biologicals’ 10-valent pneumococcal conjugate vaccine when co-administered with GSK Biologicals’ Infanrix ... bad-data
No trial status on register 2012-000254-64 A phase III, open, controlled study to evaluate the immunogenicity, safety and reactogenicity of GSK Biologicals’ 10- valent pneumococcal conjugate vaccine administered to children with sickle cell di... bad-data
No trial status on register 2012-000282-20 A phase III, randomized, open, controlled, multicenter primary vaccination study to demonstrate the non inferiority of the immunogenicity of meningococcal vaccine GSK134612 given intramuscularly versu... bad-data
No trial status on register 2012-000283-23 A phase III, open, randomized, controlled primary vaccination study to demonstrate the non-inferiority of meningococcal vaccine GSK134612 given intramuscularly versus Mencevax™ ACWY given subcutaneous... bad-data
Reported results 2012-000384-24 A 4-Week Randomized Cross-Over Study to Evaluate Daily Lung Function Following the Administration of Albuterol/Salbutamol and Ipratropium in Subjects with Chronic Obstructive Pulmonary Disease 2012-10-22 due-trials
Ongoing, reported early 2012-000385-38 BEL116472. A 2 year mechanistic study of belimumab in not-yet-due
Reported results 2012-000523-40 A Phase II Multicenter, Parallel-Group, Randomized, Dose-Ranging Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Following 12 Weeks of Oral Administration of GSK2... 2014-07-16 due-trials
Reported results 2012-000524-18 A randomized, multi-center, double-blind, doubledummy, parallel group study to evaluate the efficacy and safety of umeclidinium bromide/vilanterol compared with fluticasone propionate/salmeterol over ... 2013-10-07 due-trials
Reported results 2012-000525-45 DB2114930: A randomized, multi-center, double-blind, doubledummy, parallel group study to evaluate the efficacy and safety of umeclidinium/vilanterol compared with fluticasone 2013-10-25 due-trials
No trial status on register 2012-000741-12 A Randomized, Double blind, Placebo controlled, Two-Way Crossover 7-day study to Investigate the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Repeat Dose Inhaled GW642444 25μg in Chi... bad-data
No trial status on register 2012-000753-31 A randomized, double-blind, placebo-controlled, two-way bad-data
No trial status on register 2012-000754-55 A randomized, double-blind, repeat dose, two period crossover study to bad-data
Completed, but no date, and reported results 2012-000789-39 A Phase III, open, non-randomized, multi-centre, single dose study to assess immunogenicity and safety of Fluarix/Influsplit SSW 2012/2013 injected intramuscularly in adults (18 to 60 years) and in el... bad-data
No trial status on register 2012-000819-82 A phase III, multi-centre, open study to assess antibody persistence after completion of the 3-dose primary vaccination course with GlaxoSmithKline (GSK) Biologicals’ 10-valent pneumococcal conjugate ... bad-data
No trial status on register 2012-000826-23 A phase III, open, single centre study to assess the safety, reac-togenicity and immunogenicity of GlaxoSmithKline (GSK) Biologicals’ 10-valent pneumococcal conjugate (10Pn-PD-DiT) vaccine (GSK 102485... bad-data
Ongoing, reported early 2012-000927-42 A Randomised, Double-Blind, Placebo-Controlled, Cross-Over, Single-Centre Study to Investigate the Acute Lung Deflation Effects of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg Once Daily... not-yet-due
No trial status on register 2012-001132-60 Open-label, multiple dose study to evaluate the bad-data
Listed as ongoing, but also has a completion date and reported results 2012-001230-34 A phase III, open-label, multicentre study to evaluate the immunogenicity, safety and reactogenicity of a revaccination dose of the GlaxoSmithKline Biologicals' quadrivalent seasonal influenza candida... 2013-06-05 bad-data
Listed as ongoing, but also has a completion date and reported results 2012-001251-40 A randomised, double-blind, double-dummy, placebo-controlled, parallel-group, multi-centre study of the efficacy and safety of mepolizumab adjunctive therapy in subjects with severe uncontrolled refra... 2014-01-18 bad-data
Ongoing 2012-001266-15 COMBI-AD: A phase III randomized double blind study of dabrafenib (GSK2118436) in COMBInation with trametinib (GSK1120212) versus two placebos in the ADjuvant treatment of high-risk BRAF V600 mutatio... not-yet-due
No trial status on register 2012-001305-25 A phase II, observer-blinded, multi-center, controlled study to assess the safety and immunogenicity of one dose of GlaxoSmithKline (GSK) Biologicals’ meningococcal serogroup ACWY tetanus toxoid conju... bad-data
Reported results 2012-001344-22 A phase II, randomised, single-blind study to develop read-outs aimed at detecting and characterising the early and adaptive immune responses and to evaluate the kinetics of the early response and rea... 2016-09-13 due-trials
No trial status on register 2012-001481-16 A phase I, double-blind, randomised, placebo-controlled study to assess the reactogenicity and safety of two doses of GlaxoSmithKline Biologicals’ (GSK) oral live attenuated liquid human rotavirus (HR... bad-data
Reported results 2012-001497-29 MEA115575: A Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study of Mepolizumab Adjunctive Therapy to Reduce Steroid Use in Subjects with Severe Refractory Asthma 2013-12-12 due-trials
Other 2012-001499-12 Phase I/IIa, 2-Part, Multi-Center, Single-Arm, Open-Label Study to Determine the Safety, Tolerability and Pharmacokinetics of Oral Dabrafenib in Children and Adolescent Subjects with Advanced BRAF V60... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2012-001642-17 An open-label extension study of the long-term safety, tolerability and efficacy of ambrisentan in subjects with inoperable chronic thromboembolic pulmonary hypertension (CTEPH) 2015-11-18 bad-data
Ongoing, reported early 2012-001643-51 MEA115666: A multi-centre, open-label, long term safety study of mepolizumab in asthmatic subjects who participated in the MEA112997 trial. not-yet-due
Reported results 2012-001644-21 MEA115661: A multi-centre, open-label, long-term safety study of mepolizumab in asthmatic subjects who participated in the MEA115588 or MEA115575 trials. 2015-03-16 due-trials
Listed as ongoing, but also has a completion date and reported results 2012-001645-41 An adaptive Phase II study to evaluate the efficacy, pharmacodynamics, safety and tolerability of GSK2586184 in patients with active systemic lupus erythematosus. 2014-04-04 bad-data
Reported results 2012-001646-18 A randomised, multicentre, double-blind, placebo-controlled study of ambrisentan in subjects with inoperable chronic thromboembolic pulmonary hypertension (CTEPH) 2015-03-30 due-trials
No trial status on register 2012-001683-29 A Phase 2/3, randomized, controlled, observer-blind, multi-center trial to evaluate the safety and immunogenicity of a two-dose primary vaccination series of monovalent A/Indonesia/5/2005 (H5N1) vacci... bad-data
Completed, but no date, and reported results 2012-001820-36 A phase II observer blind, randomised, controlled study to evaluate the safety, reactogenicity and immunogenicity of GSK Biologicals’ candidate tuberculosis vaccine GSK 692342 when administered to adu... bad-data
Reported results 2012-001871-35 AC4116136: A multicenter, randomized, double-blind, parallelgroup 2013-08-16 due-trials
Reported results 2012-001876-13 A Phase III, open, randomized, controlled, multicenter study to assess the immunogenicity and reactogenicity of GSK Biologicals’ meningococcal serogroups A, C, W-135, Y tetanus toxoid conjugate vaccin... 2014-04-29 due-trials
Reported results 2012-002047-26 FDC116115: A prospective study of sexual function in sexually active men treated for BPH 2016-04-05 due-trials
Reported results 2012-002156-16 A randomized, multi-center, double-blind, doubledummy, 2014-01-09 due-trials
Reported results 2012-002236-87 Clinical Study to Evaluate the Efficacy of Chlorhexidine Mouthwashes 2013-03-01 due-trials
No trial status on register 2012-002401-22 A Phase III, open, randomized, controlled, multicenter study to assess the safety and immunogenicity of GlaxoSmithKline’s Biologicals’ (GSK Biologicals) Neisseria meningitidis serogroups A, C, W-135, ... bad-data
No trial status on register 2012-002426-70 Phase III b, open, randomised, multicenter study to evaluate the immunogenicity and safety of GlaxoSmithKline Biologicals’ combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio... bad-data
No trial status on register 2012-002427-15 A phase III, partially double-blind clinical trial to evaluate the immu-nogenicity and reactogenicity of GlaxoSmithKline (GSK) Biologicals’ combined DTPa-HBV-IPV/Hib vaccine (new formulation) as compa... bad-data
No trial status on register 2012-002428-34 A phase IV, partially double-blind, multicentre study to assess the immunogenicity and reactogenicity of GlaxoSmithKline (GSK) Biologicals’ combined DTPa-HBV-IPV/Hib vaccine (new formulation) as compa... bad-data
No trial status on register 2012-002439-26 An open, multicentre, post-marketing surveillance (PMS) study to assess the safety and reactogenicity of GlaxoSmithKline Biologicals’ DTPa-IPV/Hib vaccine administered at 3 and 4 months of age and DTP... bad-data
Reported results 2012-002541-37 A Phase II, open label, mono-centric study to evaluate the kinetics of mRNA expression after two doses of GSK Biologicals’ candidate tuberculosis (TB) vaccine GSK 692342 in healthy BCG-primed, HIV-neg... 2013-05-24 due-trials
No trial status on register 2012-002575-34 A phase IIIb, open, multi-center study to evaluate the immunogenicity, reactogenicity and safety of a booster dose of GSK Biologicals’ MenACWY-TT vaccine administered at 6 years post-primary vaccinati... bad-data
No trial status on register 2012-002587-27 A phase II, double-blind, multicenter, randomized study to evaluate the immunogenicity and safety of GSK Biologicals’ quadrivalent influenza candidate vaccine GSK2321138A compared with GSK Biologicals... bad-data
No trial status on register 2012-002718-38 A phase II, open, controlled, multi-center study to evaluate the long-term antibody persistence at 1 year, 3 years and 5 years after the administration of one dose of GlaxoSmithKline (GSK) Biologicals... bad-data
No trial status on register 2012-002719-24 A phase II, open, multi-center study to evaluate the long-term anti-body persistence at 1 year, 3 years and 5 years after the administration of one or two doses of GlaxoSmithKline (GSK) Biologicals’ m... bad-data
No trial status on register 2012-002722-75 A phase IIb, open, randomised, controlled primary vaccination study to evaluate the non-inferiority and the persistence of the immune response of GSK Biologicals’ meningococcal serogroup ACWY conjugat... bad-data
No trial status on register 2012-002727-15 A phase II, randomized, controlled, observer-blind study to evaluate the impact of two formulations of GlaxoSmithKline (GSK) Biologicals’ combined 10-valent pneumococcal polysaccharide and non-typeabl... bad-data
Completed, but no date, and reported results 2012-002737-11 A Phase III, randomised, partially-blind, controlled, multi-centric, multi-country study to evaluate the immunogenicity, safety and reactogenicity of GSK Biologicals’ MenACWY-TT conjugate vaccine co-a... bad-data
Listed as ongoing, but also has a completion date and reported results 2012-002790-55 A double blind, randomized, placebo controlled phase II study to assess the efficacy of recPRAME +AS15 Antigen-Specific Cancer Immunotherapeutic as adjuvant therapy in patients with resected PRAME-pos... 2016-08-24 bad-data
Listed as ongoing, but also has a completion date and reported results 2012-002797-32 A Randomized, Double-Blind, Parallel Group, Multicenter Study of Fluticasone Furoate/Vilanterol 200/25 mcg Inhalation Powder, Fluticasone Furoate/Vilanterol 100/25 mcg Inhalation Powder, and Fluticaso... 2013-10-15 bad-data
Reported results 2012-002917-20 A multi-centre, randomised, double-blind, placebo-controlled, dose ranging study to evaluate the safety and efficacy of GSK2586184 in patients with chronic plaque psoriasis 2014-03-24 due-trials
Listed as ongoing, but also has a completion date and reported results 2012-002966-11 A phase II/III, randomised, observer-blind, placebo-controlled, multicentre, clinical trial to assess the immunogenicity and safety of GSK Biologicals’ herpes zoster HZ/su candidate vaccine when admin... 2016-05-20 bad-data
No trial status on register 2012-003025-25 A phase III, double-blind, randomized, controlled study to evaluate the immunogenicity and safety of GlaxoSmithKline (GSK) Biologicals’ HPV-16/18 L1 VLP AS04 vaccine administered intramuscularly accor... bad-data
Reported results 2012-003105-10 Study PTG116878, a Dose-Optimization Study of ezogabine/retigabine Immediate Release Tablets versus Placebo in the Adjunctive Treatment of Subjects with Partial-Onset Seizures. 2013-06-20 due-trials
Reported results 2012-003106-27 A 12-Week Study to Evaluate the 24-Hour Pulmonary Function Profile of Fluticasone Furoate /Vilanterol (FF/VI) Inhalation Powder 100/25mcg Once Daily Compared with Fluticasone Propionate/Salmeterol Inh... 2013-07-17 due-trials
No trial status on register 2012-003324-20 An open-label study to assess the immune persistence in healthy Chinese toddlers primed in infancy with three doses of GSK Biologicals’ DTPa-IPV/Hib vaccine, and to assess the safety and immunogenicit... bad-data
Listed as ongoing, but also has a completion date and reported results 2012-003349-13 Study NOG112264, a Phase II Study of Ozanezumab 2015-01-28 bad-data
Listed as ongoing, but also has a completion date and reported results 2012-003438-18 A Phase III, randomised, observer-blind, placebo-controlled, multicentre study to assess the safety and immunogenicity of GSK Biologicals’ Herpes Zoster HZ/su candidate vaccine when administered intra... 2017-01-06 bad-data
Listed as ongoing, but also has a completion date and reported results 2012-003627-38 Proof of Mechanism Study to Assess the Potential of GSK239512 to Remyelinate Lesions in Subjects with Relapsing Remitting Multiple Sclerosis 2014-09-12 bad-data
Reported results 2012-003937-41 Phase 2, Observer-Blind, Placebo-Controlled, Randomized, Multi-Center Extension Study to Evaluate the Safety and Immunogenicity of a Booster Dose of a MenABCWY Vaccine Administered 24 Months Following... 2015-12-27 due-trials
Reported results 2012-003950-10 An open, phase IV, single-group, multicentre study to assess the long-term persistence of antibodies against hepatitis B and the immune response to a challenge dose of Engerix™-B Kinder in adolescents... 2014-02-21 due-trials
Reported results 2012-003973-24 A Multicenter Trial Comparing the Efficacy and Safety of Umeclidinium/Vilanterol 62.5/25 mcg Once Daily with Tiotropium 18 mcg Once Daily over 24 Weeks in Subjects with Chronic Obstructive Pulmonary D... 2014-01-24 due-trials
No trial status on register 2012-004039-21 An open, multicentric, post-marketing surveillance study to evaluate the safety and reactogenicity of GlaxoSmithKline Biologicals’ live attenuated oral Human Rotavirus (HRV) vaccine, Rotarix when admi... bad-data
Listed as ongoing, but also has a completion date and reported results 2012-004049-34 A four-week, Phase IIa, randomized, active-controlled, parallel-group, multi-center study to evaluate the safety, efficacy and pharmacokinetics of switching subjects from a stable dose of recombinant ... 2013-05-30 bad-data
Reported results 2012-004050-29 A four-week Phase IIa, randomized, double-blind, placebocontrolled, parallel-group, multi-center study to evaluate the safety, efficacy and pharmacokinetics of GSK1278863 in subjects with anemia assoc... 2013-05-07 due-trials
No trial status on register 2012-004060-22 A phase II, open, controlled, multicenter study to evaluate the long-term antibody persistence at 1, 3 and 5 years after the administration of a four dose vaccination series of Hib-MenCY-TT vaccine co... bad-data
No trial status on register 2012-004137-16 A phase III, randomized, open-label, multicentre study to assess the immunogenicity, safety and reactogenicity of GlaxoSmithKline Biologicals’ combined DTPa-IPV/Hib vaccine administered as a three-dos... bad-data
No trial status on register 2012-004380-44 A Phase II, open-label, randomised controlled study to evaluate the safety, reactogenicity and immunogenicity of GSK Biologicals’ candidate tuberculosis (TB) vaccine (M72/AS01E) when administered intr... bad-data
Listed as ongoing, but also has a completion date and reported results 2012-004385-17 A Double-blind, Randomised, Placebo-controlled Study to Investigate the Efficacy and Safety of Mepolizumab in the Treatment of Eosinophilic Granulomatosis with Polyangiitis in Subjects Receiving Stand... 2016-09-05 bad-data
Reported results 2012-004456-11 A phase III, randomised, open-label, multicentre, clinical trial to assess the safety and immunogenicity of GSK Biologicals’ HZ/su vaccine when administered intramuscularly according to a 0,2-month sc... 2015-04-08 due-trials
Listed as ongoing, but also has a completion date and reported results 2012-004494-23 Study MAG104615, a Proof of Concept Study for GSK249320 versus placebo in Stroke Patients 2014-07-28 bad-data
No trial status on register 2012-004513-14 An open-label study to assess the immunogenicity and reactogenicity of GlaxoSmithKline (GSK) Biologicals’ IPV vaccine (Poliorix) administered as a booster dose at 18 months of age in healthy Chinese t... bad-data
Reported results 2012-004577-12 Phase II biomarker study evaluating the upfront combination of BRAF inhibitor dabrafenib with MEK inhibitor trametinib versus the combination after eight weeks of monotherapy with dabrafenib or tramet... 2017-01-19 due-trials
Completed, report not yet due 2012-004801-28 Multi-centre, randomized, double-blind, parallel-group study evaluating the effect of Fluticasone Furoate/ Vilanterol (FF/VI) Inhalation Powder once daily compared with Vilanterol (VI) Inhalation Powd... 2018-03-26 not-yet-due
Ongoing, reported early 2012-004891-20 A randomised, double-blind (sponsor-unblind), placebo controlled, cross-over study to investigate the efficacy, effect on cough reflex sensitivity, safety, tolerability and pharmacokinetics of inhaled... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2012-005007-41 A Randomised, Double Blind, Double Dummy, Parallel Group 2015-07-22 bad-data
Reported results 2012-005059-18 A Phase III, randomised, observer-blind, placebo-controlled, multicentre clinical study to assess the immunogenicity and safety of GSK Biologicals’ HZ/su candidate vaccine when administered intramuscu... 2017-04-13 due-trials
No trial status on register 2012-005200-18 A phase III, double-blind, randomised, placebo-controlled, multi-centre study to assess the efficacy, immunogenicity and safety of two doses of GSK Biologicals’ oral live attenuated liquid human rotav... bad-data
Reported results 2012-005314-19 A phase III, randomized, open-label, multicenter clinical trial to assess the immunogenicity and safety of GSK Biologicals’ Herpes Zoster vaccine GSK1437173A when co-administered with Pneumovax 23 in ... 2016-06-17 due-trials
No trial status on register 2012-005639-10 A phase IIIb, open, multi-center study to evaluate the long-term anti-body persistence at 6, 7, 8, 9 and 10 years after the administration of one dose of GlaxoSmithKline (GSK) Biologicals’ meningococc... bad-data
No trial status on register 2012-005641-21 A phase III, open, controlled study to assess the persistence of antibodies after one dose of GlaxoSmithKline Biologicals’ meningococcal serogroup ACWY conjugate vaccine (MenACWY-TT) given intramuscul... bad-data
Reported results 2012-005671-14 A phase III, randomised, open-label, multicentre clinical trial to assess the safety and immunogenicity of GSK Biologicals’ HZ/su candidate vaccine when administered subcutaneously as compared to intr... 2014-11-11 due-trials
No trial status on register 2012-005695-34 A Phase II randomized, open, controlled study of the safety and immunogenicity of GlaxoSmithKline Biologicals’ candidate Plasmodium falciparum malaria vaccine RTS,S/AS01E, when incorporated into an Ex... bad-data
No trial status on register 2012-005716-26 A phase III, double blind (observer-blind), randomized, controlled multi-center study to evaluate, in infants and children, the efficacy of the RTS,S/AS01E candidate vaccine against malaria disease ca... bad-data
No trial status on register 2012-005718-20 A phase 2, open, randomized, controlled, multi-center study to evaluate the safety and immunogenicity of 7 infant immunization schedules of the RTS,S/AS01E candidate vaccine against P. falciparum. bad-data
Reported results 2013-000372-15 A phase III, randomized, open-label, multicentre clinical trial to assess the immunogenicity and safety of GSK Biologicals’ Herpes Zoster vaccine GSK1437173A when co-administered with GSK Biologicals’... 2015-03-20 due-trials
Completed, but no date, and reported results 2013-000373-76 A phase III, randomized, double blind multicenter study, to evaluate consistency, immunogenicity, safety and reactogenicity of 3 lots of GSK Biologicals’ herpes zoster HZ/su candidate vaccine when adm... bad-data
Ongoing 2013-000445-39 A phase I/II open-label, dose escalation study to investigate the not-yet-due
Listed as ongoing, but also has a completion date 2013-000572-15 Investigation of immune mechanisms relating to lapatinib 2014-04-30 bad-data
Reported results 2013-000642-20 A Randomized, Blinded, Placebo-Controlled, Dose Finding 2017-01-25 due-trials
Listed as ongoing, but also has a completion date and reported results 2013-000657-50 A Clinical Outcomes Study to Compare the Incidence of Major Adverse Cardiovascular Events in Subjects Presenting with Acute Coronary Syndrome Treated with Losmapimod Compared to Placebo (PM1116197) 2015-12-08 bad-data
Completed, but no date, and reported results 2013-000855-42 A Phase III, open-label, non-randomised, multi-centre, single dose study to assess immunogenicity and safety of Fluarix / Influsplit SSW 2013/2014 injected intramuscularly in adults (18 to 60 years of... bad-data
Listed as ongoing, but also has a completion date and reported results 2013-000918-37 A randomized, double-blind, placebo-controlled, phase III, multi-centre study of eltrombopag or placebo in combination with azacitidine in subjects with IPSS intermediate-1, intermediate 2 and high-ri... 2016-04-28 bad-data
Reported results 2013-000992-33 A Clinical Study to Assess the Efficacy and Onset of Pain Relief of Topical MFC51123 Diclofenac-Menthol Gel versus Controls in Ankle Sprain 2015-03-22 due-trials
Completed, but no date, and reported results 2013-001094-25 A Phase III, open-label, non-randomised, multi-centre, single dose study to assess the immunogenicity and safety of GSK Biologicals' Quadrivalent Split Virion Influenza Vaccine (GSK2321138A) Influspli... bad-data
Listed as ongoing, but also has a completion date 2013-001370-20 OPV116910: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Investigate the Efficacy and Safety of Ofatumumab Injection for Subcutaneous Use in Subjects with Pemphigus Vulgaris 2016-12-01 bad-data
Ongoing 2013-001371-20 Study 200170: A Rollover Study to Provide Continued Treatment with Eltrombopag not-yet-due
Completed, but no date 2013-001699-39 A phase I, first time in human, open-label, dose escalation study to investigate the safety, pharmacokinetics, and pharmacodynamics of anti-HER3 monoclonal antibody GSK2849330 in subjects with advance... bad-data
Ongoing 2013-001705-87 A Phase II, Open-label, Study in Subjects with BRAF V600EMutated Rare Cancers with Several Histologies to Investigate the Clinical Efficacy and Safety of the Combination Therapy of Dabrafenib and Tram... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2013-001827-38 Study DB2116961, a multicentre, randomised, blinded, parallel 2015-05-04 bad-data
Completed, but no date 2013-001918-15 A phase IV, open-label, single-centre study to assess the long-term persistence of hepatitis A antibodies in healthy adults, primed 21 to 25 years earlier with GSK Biologicals’ hepatitis A vaccine Hav... bad-data
Reported results 2013-002238-19 A study to compare the addition of umeclidinium bromide 2014-04-01 due-trials
Reported results 2013-002239-44 A study to compare the addition of umeclidinium bromide (UMEC) to fluticasone furoate (FF)/vilanterol (VI), with placebo plus FF/VI in subjects with Chronic Obstructive Pulmonary Disease (COPD) -Study... 2014-04-21 due-trials
Reported results 2013-002418-11 A study to evaluate the effect of a 67% Sodium Bicarbonate containing toothpaste on Chlorhexidine Digluconate tooth staining 2013-11-20 due-trials
Reported results 2013-002451-15 A Phase 2b, Randomized, Controlled, Observer-Blind, Multi-Center Study Assessing the Immunogenicity and Safety of GSK Meningococcal ABCWY Vaccine Administered at Different Schedules Compared to GSK Me... 2016-11-03 due-trials
No trial status on register 2013-002537-37 A phase IIIb, open, multi-country, controlled, randomized study to demonstrate the immunogenicity and safety of GSK Biologicals' meningococcal conjugate vaccine, MenACWY-TT (GSK 134612) in healthy inf... bad-data
No trial status on register 2013-002538-18 A phase III, single-group, open-label, multicentre study to assess the safety and reactogenicity of GlaxoSmithKline Biologicals’ combined diphtheria-tetanus-acellular pertussis-inactivated poliovirus-... bad-data
Listed as ongoing, but also has a completion date and reported results 2013-002681-39 A 24-week, Phase 2B, randomized, active-controlled, parallel group, multi-center study to evaluate the safety and efficacy of GSK1278863 in subjects with anemia associated with chronic kidney disease ... 2015-06-03 bad-data
Listed as ongoing, but also has a completion date and reported results 2013-002682-19 A Phase 2B, randomized, blinded, dose-ranging, active-controlled, parallel-group, multi-center study to evaluate the dose response relationship of GSK1278863 over the first 4 weeks of treatment and ev... 2015-02-06 bad-data
No trial status on register 2013-002804-15 A phase IV, open-label, multicentre, non-comparative study to assess reactogenicity and safety of co-administration of GlaxoSmithKline (GSK) Biologicals’ inactivated poliomyelitis vaccine PoliorixTM a... bad-data
Reported results 2013-002821-41 Persistence of hepatitis B antibodies, immunogenicity and safety of GSK Biologicals’ hepatitis B vaccine EngerixTM-B Kinder (SKF103860) challenge dose in adolescents vaccinated with four doses of Infa... 2014-09-23 due-trials
Reported results 2013-002940-94 A randomised, double-blind, placebo-controlled, 3 way, incomplete block cross over study in subjects with allergic rhinitis to assess the effect of once daily single and repeat doses of intranasal Flu... 2014-02-20 due-trials
Listed as ongoing, but also has a completion date and reported results 2013-003062-13 A Phase II, randomised, observer-blind, placebo-controlled, multi-centre study to evaluate the safety, reactogenicity and immunogenicity of GSK Biologicals’ investigational vaccine GSK2838504A, when a... 2017-04-19 bad-data
Listed as ongoing, but also has a completion date and reported results 2013-003073-10 A Phase III, 24 week, randomized, double blind, double dummy, parallel group study (with an extension to 52 weeks in a subset of subjects) comparing the efficacy, safety and tolerability of the fixed ... 2016-04-07 bad-data
Listed as ongoing, but also has a completion date and reported results 2013-003075-35 A phase III, 52 week, randomized, double-blind, 3-arm parallel group study, comparing the efficacy, safety and tolerability of the fixed dose triple combination FF/UMEC/VI with the fixed dose dual com... 2017-07-17 bad-data
Reported results 2013-003111-22 A Phase II, Randomized, Comparative, Observer-Blind, Multi-Center Study Evaluating the Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophil... 2015-12-22 due-trials
No trial status on register 2013-003155-38 A Phase III, double-blind, randomised, controlled, multi-country, multi-centre study to evaluate the immunogenicity and safety of GSK Biologicals’ quadrivalent influenza vaccine candidate, GSK2282512A... bad-data
Ongoing 2013-003296-34 A Single Blind, Randomised, Placebo Controlled, Repeat Dose, Dose Escalating Study Investigating Safety, Tolerability Pharmacokinetics, Pharmacodynamics and the Beta-Cell Preserving Effect of Otelixiz... not-yet-due
No trial status on register 2013-003427-10 A phase III, open-label, randomised, multicentre study to evaluate the immunogenicity and safety of GlaxoSmithKline Biologicals’ combined DTPa-HBV-IPV/Hib vaccine (Infanrix hexa™) administered to Indi... bad-data
No trial status on register 2013-003428-34 A phase IV, non-randomised, open-label, multicentre study with two parallel groups to assess the immunogenicity and safety of GlaxoSmithKline (GSK) Biologicals’ combined DTPa-HBV-IPV/Hib vaccine admin... bad-data
Reported results 2013-003429-28 A phase IV, observer-blind, randomized, controlled, multicentric study to assess the safety and immunogenicity of GSK Biologicals’ HPV-16/18 L1 VLP AS04 vaccine (Cervarix™) administered intramuscularl... 2017-04-19 due-trials
Listed as ongoing, but also has a completion date 2013-003452-21 BRF117277: A Phase II, Open-Label, Multicentre Study of Dabrafenib plus Trametinib in Subjects with BRAF Mutation-Positive Melanoma that has Metastasized to the Brain 2018-02-14 bad-data
No trial status on register 2013-003459-39 A phase IIIb, open, randomized, controlled, multicenter study to assess the co-administration of Rotarix (GlaxoSmithKline Biologicals’) with Hib-MenCY-TT (GlaxoSmithKline Biologicals’ Meningococcal Gr... bad-data
No trial status on register 2013-003479-36 A phase III, controlled, partially-blind study to assess the reactogenicity, safety and immunogenicity of GSK Biologicals' 10-valent pneumococcal polysaccharide and non-typeable Haemophilus influenzae... bad-data
Reported results 2013-003510-41 A two part, Phase IIa, randomized, placebo-controlled study to investigate the safety, tolerability, pharmacokinetics, pharmacodynamics, and clinical efficacy of oral danirixin (GSK1325756) in symptom... 2016-08-29 due-trials
Reported results 2013-003535-30 A Phase III, double blind, randomized, comparative study of the safety and immunogenicity of GSK Biologicals’ Varilrix HSA-free varicella vaccine and Varilrix™ given as a 2 dose course in the second y... 2016-10-25 due-trials
Other 2013-003595-12 A Phase II Study of Pazopanib (GW786034, NSC# 737754) in Children, Adolescents and Young Adults with Refractory Solid Tumors not-yet-due
Other 2013-003596-35 An Open-Label, Dose-Escalation, Phase I/II Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of the MEK Inhibitor Trametinib in Children and Adolescents Subject... not-yet-due
No trial status on register 2013-003768-30 A phase IV, single-blind, randomized, multicenter study to assess the immunogenicity and safety of GSK Biologicals’ dTpa vaccine (Boostrix™) using a new syringe presentation in healthy adolescents age... bad-data
No trial status on register 2013-003859-37 A phase III, single-group, open-label study to assess the safety and reactogenicity of GSK Biologicals’ combined reduced-antigen-content diphtheria-tetanus-acellular pertussis (dTpa) vaccine Boostrix ... bad-data
No trial status on register 2013-004158-81 A multi-centre, single-blind, parallel group, clinical evaluation of the efficacy bad-data
No trial status on register 2013-004194-27 A Phase III, randomized, multicenter study, double-blind for the immunogenicity and consistency evaluation of 3 lots of GSK Biologicals’ Haemophilus influenzae type b (Hib) conjugate vaccine and singl... bad-data
Listed as ongoing, but also has a completion date and reported results 2013-004297-98 Study 117113: Mepolizumab vs. Placebo as add-on treatment for frequently exacerbating COPD patients characterized by eosinophil level. 2017-01-16 bad-data
Reported results 2013-004298-28 Study 117106: Mepolizumab vs. Placebo as add-on treatment for frequently exacerbating COPD patients. 2017-01-17 due-trials
No trial status on register 2013-004304-19 A Phase III, randomized, open-label, controlled, multicenter study to evaluate immunogenicity and safety of GSK Biologicals' Infanrix hexa™ vaccine when administered to healthy infants as primary vacc... bad-data
Listed as ongoing, but also has a completion date and reported results 2013-004548-44 A 12-Week Study to Evaluate the Efficacy and Safety of Fluticasone Furoate/Vilanterol Inhalation Powder (FF/VI) 100/25 mcg Once Daily Compared with Vilanterol Inhalation Powder (VI) 25 mcg Once Daily ... 2015-07-08 bad-data
Completed, but no date 2013-004586-13 A phase IV, open-label, multi-centre study to assess the long-term persistence of hepatitis A and B antibodies in healthy adult subjects, primed 16 to 20 years earlier with GSK Biologicals’ combined h... bad-data
Completed, but no date 2013-004778-84 A Phase IIIb, open-label, multi-centric study to evaluate the immunogenicity of one dose of GSK Biologicals’ MenACWY-TT conjugate vaccine administered intramuscularly in healthy adolescents aged 10 to... bad-data
No trial status on register 2013-005577-43 A phase III, open-label study to assess the immunogenicity and reactogenicity of GSK Biologicals’ DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course at 3, 4.5 and 6 months of... bad-data
Not reported 2014-000060-17 A phase IIIb, open-label, non-randomised, multicentre study to assess the immunogenicity and safety of GSK Biologicals’ HPV-16/18 L1 VLP AS04 vaccine when administered intramuscularly according to a 2... 2014-07-29 due-trials
No trial status on register 2014-000101-12 A phase III, multi-centre, double-blind, randomised study to assess the non-inferiority of a commercial lot of GlaxoSmithKline (GSK) Biologicals’ 10-valent pneumococcal conjugate (10Pn-PD-DiT) vaccine... bad-data
Listed as ongoing, but also has a completion date 2014-000256-28 A Randomised, Multicentre, Open Label, Phase II study of Prophylactic Octreotide to Prevent or Reduce the Frequency and Severity of Diarrhoea in Subjects Receiving Lapatinib with Capecitabine for the ... 2017-10-19 bad-data
Completed, but no date, and reported results 2014-000313-31 A double-blind (sponsor unblind), placebo controlled, randomised, parallel group study to evaluate the safety, tolerability and pharmacokinetics of multiple doses of GSK2269557 administered as a dry p... bad-data
Listed as ongoing, but also has a completion date and reported results 2014-000314-54 Study 201312: A Multi-Centre, Open-Label, Study of Mepolizumab in a Subset of Subjects with a History of Life Threatening/Seriously Debilitating Asthma Who Participated in the MEA115661 Trial 2017-10-05 bad-data
Other 2014-000499-24 Follow-Up Study to Assess Long-Term Safety and Outcomes in Infants and Children Born to Mothers Participating in Retosiban Treatment Studies not-yet-due
Listed as ongoing, but also has a completion date and reported results 2014-000529-19 A 12 week, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy of Umeclidinium/Vilanterol 62.5/25mcg in Subjects with COPD 2015-03-05 bad-data
Completed, reported early 2014-000551-81 A 6-month, open label, randomised, efficacy study to evaluate fluticasone furoate (FF, GW685698)/vilanterol (VI, GW642444) Inhalation Powder delivered once daily via the Dry Powder Inhaler Ellipta™ co... 2017-07-20 not-yet-due
Reported results 2014-000611-14 A randomized, parallel group study to evaluate the effect of Umeclidinium (UMEC) added to Inhaled corticosteroid/ long-acting beta-agonist combination therapy in subjects with Chronic Obstructive Pulm... 2015-03-24 due-trials
Ongoing, reported early 2014-000643-33 A Placebo Controlled, Double-blind, Multi-centre, Single Dose, Parallel Group, Randomised Clinical Trial of GSK2862277 in Patients undergoing Oesophagectomy Surgery. not-yet-due
No trial status on register 2014-000750-11 Study to compare immunogenicity of GSK Biologicals' 10Pn-PD-DiT 4-dose presentation to the licensed Synflorix™ (10Pn-PD-DiT) vaccine when co-administered with DTPw-combination vaccine in healthy infan... bad-data
Listed as ongoing, but also has a completion date and reported results 2014-000883-16 A Clinical Study to Evaluate Four Doses of Umeclidinium Bromide in Combination with Fluticasone Furoate in COPD Subjects with an Asthmatic Component 2015-08-18 bad-data
Reported results 2014-000884-42 A Randomized, Blinded, Double-dummy, Parallel-group Study to Evaluate the Efficacy and Safety of Umeclidinium (UMEC) 62.5 mcg compared with Tiotropium 18 mcg in Subjects with Chronic Obstructive Pulmo... 2015-06-15 due-trials
Reported results 2014-000885-23 A Randomized, Parallel-group, Open-label Study to Evaluate the Efficacy and Safety of Umeclidinium (UMEC) 62.5 mcg compared with Glycopyrronium 44 mcg in Subjects with Chronic Obstructive Pulmonary Di... 2015-06-02 due-trials
Reported results 2014-000955-10 A Phase III, double-blind, randomized, multicenter study to assess safety and immunogenicity of GlaxoSmithKline Biologicals’ Quadrivalent Split Virion Influenza Vaccine (GSK2321138A) manufactured with... 2015-04-18 due-trials
Listed as ongoing, but also has a completion date 2014-001117-41 A phase IV, open-label, non-randomised, multi-centre study to assess the immunogenicity and safety of Infanrix hexa™ administered as primary vaccination in healthy infants born to mothers given Boostr... 2018-03-07 bad-data
Ongoing, reported early 2014-001118-24 A Phase III, placebo-controlled, observer-blind, randomised, multi-centre study to describe the immunogenicity and safety of GSK Biologicals’ Quadrivalent Split Virion Influenza Vaccine 2014/2015 Infl... not-yet-due
Completed, report not yet due 2014-001119-38 A Phase IV, observer-blind, randomised, cross-over, placebo-controlled, multicentre study to assess the immunogenicity and safety of a single dose of Boostrix™ in pregnant women. 2017-10-24 not-yet-due
Other 2014-001120-30 A phase IV, open-label, non-randomised, multi-centre study to assess the immunogenicity and safety of a booster dose of Infanrix hexa™ in healthy infants born to mothers vaccinated with Boostrix™ duri... not-yet-due
Ongoing, reported early 2014-001197-34 A repeat-dose, open-label, parallel-group study to assess the pharmacokinetics of GSK1278863 and metabolites in subjects not-yet-due
Completed, but no date 2014-001220-30 An Open-Label, Phase II, Study to Evaluate Biomarkers Associated with Response to Subsequent Therapies in Subjects with HER2-Positive Metastatic Breast Cancer Receiving Treatment with Trastuzumab in C... bad-data
Ongoing 2014-001232-11 Study 200622: A randomized, double-blind, placebo-controlled study to investigate the efficacy and safety of mepolizumab in the treatment of adolescent and adult subjects with severe hypereosinophilic... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2014-001821-34 Albiglutide + Insulin Glargine Versus Insulin Lispro + Insulin Glargine in the Treatment of Subjects With Type 2 Diabetes Mellitus: The Switch Study 2017-07-24 bad-data
Listed as ongoing, but also has a completion date 2014-001824-32 A long term, randomised, double blind, placebo-controlled study to determine the effect of albiglutide, when added to standard blood glucose lowering therapies, on major cardiovascular events in patie... 2018-03-12 bad-data
Listed as ongoing, but also has a completion date 2014-001825-33 Study 110933: Albiglutide versus Placebo in insulin-treated Subjects with new-onset type 1 diabetes mellitus 2017-10-18 bad-data
Listed as ongoing, but also has a completion date and reported results 2014-001826-13 Randomized, Double-blind, Multicenter, Phase III Study Comparing the Efficacy and Safety of Retosiban Versus Atosiban Therapy for Women in Spontaneous Preterm Labor 2017-08-25 bad-data
Not reported 2014-001969-27 Albiglutide Versus Placebo as Add-on to Intensified Basal-Bolus Insulin Therapy in Subjects With Type 2 Diabetes Mellitus 2015-06-10 due-trials
Listed as ongoing, but also has a completion date and reported results 2014-001972-70 A randomised, double-blind (sponsor unblinded), placebocontrolled, parallel-group, multicentre study to evaluate the efficacy and safety of GSK2269557 administered in addition to standard of care in a... 2016-05-25 bad-data
Ongoing 2014-002111-41 A Multi-arm Phase 3 Randomized Placebo Controlled Double Blind Clinical Trial to Investigate the Efficacy and Safety of BMS-663068/GSK3684934 in Heavily Treatment Experienced Subjects Infected with Mu... not-yet-due
Reported results 2014-002253-19 A randomized, double-blind, double-dummy, parallel group, multicenter study of once daily Fluticasone Furoate/Vilanterol 100/25 mcg Inhalation Powder, twice daily Fluticasone Propionate/Salmeterol 250... 2016-11-25 due-trials
Reported results 2014-002513-27 A randomised, double-blind, placebo-controlled, parallel-group, multi-centre 24-week study to evaluate the efficacy and safety of mepolizumab adjunctive therapy in subjects with severe eosinophilic as... 2016-06-10 due-trials
Ongoing, reported early 2014-002666-76 An open-label study to characterize the pharmacokinetics and pharmacodynamics of mepolizumab administered subcutaneously in children from 6 to 11 years of age with severe eosinophilic asthma not-yet-due
Reported results 2014-002688-14 A Phase II, randomised, observer-blind, controlled, multi-country study to assess the safety, reactogenicity and immunogenicity of a single intramuscular dose of different formulations of GlaxoSmithKl... 2016-06-21 due-trials
Reported results 2014-002992-27 201496: A Study to Evaluate the Efficacy and Safety of 15mg BID Losmapimod (GW856553) Compared to Placebo in Frequently Exacerbating Subjects with Chronic Obstructive Pulmonary Disease (COPD). 2016-06-30 due-trials
Ongoing 2014-003162-25 Mepolizumab Long-term Access Programme for Subjects who Participated in Study MEA115921 (Placebo-controlled Study of Mepolizumab in the Treatment of Eosinophilic Granulomatosis with Polyangiitis in Su... not-yet-due
Ongoing, reported early 2014-003326-41 Randomized, Double-Blind, Multicenter, Phase III Study Comparing the Efficacy and Safety of Retosiban Versus Placebo for Women in Spontaneous Preterm Labor not-yet-due
Listed as ongoing, but also has a completion date 2014-003453-34 A Phase IIb, Double-Blind, Placebo-Controlled, Dose-Adaptive, Study of the Efficacy and Safety of GSK3196165 in Combination with Methotrexate Therapy, in Subjects with Active Moderate-Severe Rheumatoi... 2017-12-29 bad-data
Reported results 2014-003808-77 A multi-centre, randomised, double-blind, placebo-controlled, crossover study to investigate the efficacy, safety, and tolerability of repeat doses of inhaled GSK2269557 in adults with persistent, unc... 2016-09-28 due-trials
No trial status on register 2014-004714-28 A Phase 2, randomised, observer-blind, controlled, multi country study to assess the safety and immunogenicity of a single intramuscular dose of GSK Biologicals’ investigational recombinant chimpanzee... bad-data
Ongoing 2014-004982-25 A phase I/II open-label, dose escalation study to investigate the safety, pharmacokinetics, pharmacodynamics and clinical activity of GSK525762 in subjects with NUT midline carcinoma (NMC) and other c... not-yet-due
Not reported 2014-005149-40 An open label non randomized access study of Trametinib for patients with advanced unresectable (stage IIIc) or distant metastatic (stage IV) BRAF V600E/K mutation positive cutaneous melanoma 2017-03-01 due-trials
No trial status on register 2014-005282-78 A phase IV, randomised, open-label, controlled study to assess the immunogenicity and safety of the diphtheria, tetanus, pertussis and inactivated poliovirus (DPT-IPV) vaccine Squarekids™ when co-admi... bad-data
Ongoing 2015-000382-31 A Phase III, Open-label, Multicenter Study to Evaluate Long-term Immunogenicity and Boostability of Immune Responses in Adults who Received Different Primary Vaccination Regimens of Pre-exposure Proph... not-yet-due
Ongoing 2015-000400-26 A randomized, double blind (sponsor open), comparative, multicenter study to evaluate the safety and efficacy of subcutaneous belimumab (GSK1550188) and intravenous rituximab coadministration in subje... not-yet-due
Reported results 2015-000841-22 A randomised, double-blind, two-way crossover study to investigate the effect of inhaled fluticasone furoate on short-term growth in paediatric subjects with asthma 2015-12-21 due-trials
Listed as ongoing, but also has a completion date 2015-000965-30 A Phase IIIB, non-randomized, open-label, multi-country, multi-centric cross-vaccination study to evaluate the safety of GSK Biologicals' Herpes Zoster subunit (HZ/su) vaccine when administered intram... 2018-03-01 bad-data
Ongoing 2015-001152-29 A Long-term Access Programme for Subjects with Severe Asthma who Participated in a GSK-sponsored Mepolizumab Clinical Study not-yet-due
No trial status on register 2015-001258-13 A phase III, observer-blind, multi-centre, multi-country, randomized study to evaluate the immunogenicity and safety of thimerosal-free (TF) Fluarix™ (GSK Biologicals) compared with Fluzone® (Sanofi P... bad-data
Reported results 2015-001409-15 Study 201012: A Dose-Finding Study of batefenterol (GSK961081) via Dry Powder Inhaler in Patients with COPD. 2016-07-06 due-trials
No trial status on register 2015-001449-93 A phase II, observer-blind follow-up study with two groups to assess the reactogenicity and immunogenicity of GlaxoSmithKline (GSK) Biologicals’ 10-valent pneumococcal conjugate vaccine (GSK1024850A),... bad-data
No trial status on register 2015-001484-39 A phase II, double-blind, randomized, placebo-controlled study to assess the safety, reactogenicity and immunogenicity of three doses of GlaxoSmithKline (GSK) Biologicals’ oral live attenuated human r... bad-data
No trial status on register 2015-001485-26 A phase III, double-blind, randomised, placebo-controlled, multi-center study to assess the efficacy, safety and immunogenicity of two or three doses of GSK Biologicals’ oral live attenuated human rot... bad-data
No trial status on register 2015-001505-14 A phase III, randomized, controlled, single-blind study to evaluate the non-inferiority of GlaxoSmithKline Biologicals’ 10-valent pneumococcal conjugate vaccine compared to the 7-valent pneumococcal c... bad-data
No trial status on register 2015-001506-34 A phase III, controlled, single-blind study to assess the reactogenicity, safety and immunogenicity of a booster dose of GlaxoSmithKline (GSK) Biologicals’ 10-valent pneumococcal conjugate vaccine or ... bad-data
No trial status on register 2015-001507-31 A phase IIIb, open-label, multicentre study to assess the safety and immunogenicity of GlaxoSmithKline (GSK) Biologicals’ combined diphtheria-tetanus-acellular pertussis (DTPa)- Haemophilus influenzae... bad-data
No trial status on register 2015-001508-71 An open, phase IIIb, randomized, multicentric clinical trial to compare the immunogenicity, safety and reactogenicity of GlaxoSmithKline (GSK) Biologicals’ DTPa-IPV vaccine versus co-administration of... bad-data
No trial status on register 2015-001509-15 A Phase IIIb, open, randomized, controlled, multicenter study of the immunogenicity and safety of GlaxoSmithKline Biologicals' inactivated hepatitis A vaccine (Havrix) [720 El.U/0.5 mL dose] administe... bad-data
No trial status on register 2015-001510-10 A phase III, single group, open study to assess the immunogenicity, safety and reactogenicity of GlaxoSmithKline (GSK) Biologicals’ 10-valent pneumococcal conjugate vaccine in Mexico when co-administe... bad-data
No trial status on register 2015-001511-12 A phase III, single group, open study to assess the immunogenicity, safety and reactogenicity of GlaxoSmithKline (GSK) Biologicals’ 10-valent pneumococcal conjugate vaccine in Taiwan when co-administe... bad-data
No trial status on register 2015-001512-35 An open, multicentric, post-marketing surveillance (PMS) study to assess the safety and reactogenicity of GlaxoSmithKline Biologicals’ DTPa-IPV/Hib vaccine administered at 3, 4, 5 and 18 months of age... bad-data
No trial status on register 2015-001513-27 An open-label primary vaccination study to assess the safety and reactogenicity of GlaxoSmithKline Biologicals’ combined diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influ... bad-data
No trial status on register 2015-001514-97 A Phase 3, observer blind, randomized, non-influenza vaccine comparator-controlled, multi-country and multi-centre study of the efficacy of GSK Biologicals’ quadrivalent, inactivated, split virion, se... bad-data
No trial status on register 2015-001515-12 A phase III, open, randomized, multicentre, multicountry study to compare the reactogenicity and evaluate the safety and immunogenicity of GSK Bio’s combined hepatitis A / hepatitis B vaccine (at leas... bad-data
No trial status on register 2015-001516-35 An open study to evaluate the immunogenicity, safety, and reactogenicity of GlaxoSmithKline Biologicals' commercially available combined hepatitis A / hepatitis B vaccine (TWINRIX ADULT) containing 72... bad-data
No trial status on register 2015-001517-27 An open multicentre, multicountry study to evaluate long-term anti-body persistence and immune memory between Years 11 and 15 after the primary study HAB-084 in which healthy adolescents were vaccinat... bad-data
No trial status on register 2015-001530-25 A Phase IIIb, open, randomized, controlled, multicenter study of the immunogenicity and safety of GlaxoSmithKline Biologicals' inactivated hepatitis A vaccine (Havrix) [720 El.U/ 0.5 mL dose] administ... bad-data
No trial status on register 2015-001531-20 A phase III, single-blinded, randomized, multicentric study to compare the immunogenicity of GlaxoSmithKline Biologicals' thiomersal-free 2-dose Engerix™-B (20 mcg) and 3-dose preservative-free Engeri... bad-data
No trial status on register 2015-001538-25 A Phase I/IIb randomized, double-blind, controlled study of the safety, immunogenicity and proof-of-concept of RTS,S/AS02D, a candidate malaria vaccine in infants living in a malaria-endemic region bad-data
No trial status on register 2015-001539-19 A Phase IIb randomized, double-blind, controlled study of the safety, immunogenicity and proof-of-concept of RTS,S/AS02D, a candidate malaria vaccine, when incorporated into an Expanded Program on Imm... bad-data
No trial status on register 2015-001540-10 A phase III, double-blind, randomised, placebo-controlled, multi-country and multi-center study to assess the efficacy, immunogenicity and safety of two doses of GSK Biologicals’ oral live attenuated ... bad-data
No trial status on register 2015-001541-92 A phase III, double-blind, randomized, placebo-controlled, multi-country and multi-center study to assess the efficacy and safety of two doses of GSK Biologicals’ oral live attenuated human rotavirus ... bad-data
No trial status on register 2015-001542-29 A phase IIIb, randomized, double-blind, placebo-controlled study to explore the existence of horizontal transmission of the RIX4414 vaccine strain between twins within a family. bad-data
No trial status on register 2015-001543-36 A phase III, double-blind, randomised, placebo-controlled, multi-centre study in Japan to assess the efficacy, safety, reactogenicity and immunogenicity of the lyophilised formulation of GlaxoSmithKli... bad-data
No trial status on register 2015-001544-11 A phase II, randomized, double-blind, placebo-controlled study to evaluate the immunogenicity, reactogenicity and safety of two doses of GlaxoSmithKline (GSK) Biologicals’ oral live attenuated human r... bad-data
No trial status on register 2015-001545-81 A Phase IV, double-blind, randomised, placebo-controlled study to evaluate immunogenicity, reactogenicity and safety of GlaxoS-mithKline (GSK) Biologicals’ oral live attenuated HRV vaccine in healthy ... bad-data
No trial status on register 2015-001546-28 Open, multi-centric, post-marketing surveillance (PMS) to evaluate the reactogenicity and safety of two doses of GlaxoSmithKline (GSK) Biologicals’ oral live attenuated human rotavirus (HRV) vaccine, ... bad-data
No trial status on register 2015-001547-37 A Phase I, double-blind, randomised, placebo controlled study to evaluate the reactogenicity and safety of a single oral dose of GlaxoSmithKline (GSK) Biologicals’ live attenuated liquid human rotavir... bad-data
Listed as ongoing, but also has a completion date 2015-001758-14 A Multicenter, Randomized, Double-Blind, Placebo-Controlled, 2018-03-21 bad-data
Ongoing 2015-001778-17 A phase IIIb, open-label, multi-country, multi-centre, long-term follow-up study (ZOE-LTFU) of studies 110390 and 113077 (ZOSTER-006/022) to assess the prophylactic efficacy, safety, and immunogenicit... not-yet-due
Listed as ongoing, but also has a completion date 2015-002361-32 A multi-center, randomized, double-blind, placebo controlled, parallel group study to compare cessation versus continuation of long-term mepolizumab treatment in patients with severe eosinophilic asth... 2017-11-22 bad-data
Ongoing, reported early 2015-002812-33 A Phase 2 Pilot, Multicenter, Single Arm Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of GSK1070806 plus Standard of Care for the Prevention of Delayed Graft Function in ... not-yet-due
Listed as ongoing, but also has a completion date 2015-003089-96 A multi-centre Phase IIa double-blind, placebo-controlled study to investigate the efficacy and safety of GSK3196165 in subjects with inflammatory hand osteoarthritis. 2017-11-29 bad-data
Completed, but no date, and reported results 2015-003094-15 A Phase 2, Non-Randomized, Controlled, Open-Label, Parallel-Group, Extension Study to Evaluate the Immunogenicity and Safety of the Second Dose of GBS Trivalent Vaccine in Healthy Non-pregnant Subject... bad-data
Completed, reported early 2015-003391-74 Persistence of hepatitis B antibodies, immunogenicity and safety of GSK Biologicals’ hepatitis B vaccine, Engerix™-B Kinder (SKF103860) challenge dose, in adolescents vaccinated with four doses of Inf... 2017-07-05 not-yet-due
No trial status on register 2015-003405-42 A phase III, open-label, single-group, multi-centre study to assess the immunogenicity, safety and reactogenicity of GSK Biologicals’ combined reduced antigen content diphtheria, tetanus and acellular... bad-data
Other 2015-003458-42 A phase II observer-blind, multicentre, dose-ranging study of children 6 to less than 36 months of age who are to be primed with a 2-dose series of GSK Biologicals’ AS03-adjuvanted A/Indonesia/05/2005... not-yet-due
Ongoing 2015-003696-30 A randomised, double-blind, placebo-controlled study to evaluate the safety, efficacy and changes in induced sputum and blood biomarkers following daily repeat doses of inhaled GSK2269557 for 12 weeks... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2015-003697-32 A multi-centre, open label, single arm, 32-week treatment study in subjects with severe eosinophilic asthma not optimally controlled with current omalizumab treatment who are switched from omalizumab ... 2017-05-31 bad-data
Completed, but no date, and reported results 2015-004099-31 Long-term persistence of immunity to hepatitis B in adults vaccinated 20 to 30 years ago with Engerix™-B. bad-data
Completed, report not yet due 2015-004386-91 A Phase IIa, Double-Blind, Mechanistic Study of GSK3196165 in Combination with Methotrexate Therapy in Subjects with Active Rheumatoid Arthritis Despite Treatment with DMARDs 2017-10-18 not-yet-due
Ongoing 2015-004400-30 A phase IIIB, open, long term extension study to evaluate the persistence of immune responses and the safety of GSK Biologicals’ Herpes Zoster subunit (HZ/su) vaccine 1437173A, at Months 108 and 120 p... not-yet-due
Reported results 2015-004790-32 A 29-day, randomized, double-blinded, placebo-controlled, parallel-group, multi-center study to evaluate the efficacy, safety and pharmacokinetics of three-times weekly dosing of GSK1278863 in hemodia... 2017-01-21 due-trials
No trial status on register 2015-004864-12 A Multicenter, Randomized, Double-Blind, Parallel Group, 52-Week Comparison of Asthma Control and Measures of Airway Inflammation in Subjects of African Descent Receiving Fluticasone Propionate/Salmet... bad-data
No trial status on register 2015-004865-10 A Randomized, Parallel Group, Double-Blind, Comparative Trial Assessing Lung Function and Other Measures of Asthma Control in Adults and Adolescents, at least 12 Years of Age, with Asthma, Who Have Ei... bad-data
No trial status on register 2015-004866-27 A repeat-dose, open-label, randomized, incomplete block design in pediatric subjects with asthma, ages 4 - 11 years, to compare systemic exposure and pharmacodynamics of fluticasone propionate and sal... bad-data
No trial status on register 2015-004867-35 A 52-week, Randomized, Double-Blind, Parallel-Group Study of Fluticasone Propionate/Salmeterol DISKUS Combination Product (FSC) 250/50 mcg BID and Fluticasone Propionate (FP) DISKUS 250 mcg BID in Tre... bad-data
No trial status on register 2015-004868-11 A randomised, double-blind, double-dummy, parallel group study to evaluate the efficacy and safety of fluticasone furoate/vilanterol trifenatate (FF/VI) inhalation powder delivered once daily compared... bad-data
No trial status on register 2015-004869-88 A multicenter, open-label study to evaluate preventive efficacy for herpes simplex virus infection and safety of 256U87 (valaciclovir hydrochloride) in adult and pediatric hematopoietic stem cell tran... bad-data
No trial status on register 2015-004870-14 A multicentre, randomized, double-blind, double-dummy, active-controlled, parallel-group study to determine the efficacy and safety of nebulized fluticasone propionate 1mg twice daily compared with or... bad-data
No trial status on register 2015-004871-59 A randomised, double-blind, placebo-controlled, parallel group, multicentre study to evaluate the efficacy and safety of fluticasone furoate/vilanterol trifenatate (FF/VI) inhalation powder delivered ... bad-data
No trial status on register 2015-004872-31 The Evaluation of Lamictal as an Add-on Treatment for Bipolar I Disorder in Children and Adolescents, 10 to 17 Years of Age bad-data
No trial status on register 2015-004873-34 A Comparison of Fluticasone Furoate Nasal Spray (FFNS) versus Oral bad-data
No trial status on register 2015-004874-13 An open label study to determine the pharmacokinetic profiles of bad-data
Ongoing 2015-004876-31 An open-label, single arm study to investigate the safety, pharmacokinetics and pharmacodynamics of repeat doses of inhaled nemiralisib in patients with APDS/PASLI not-yet-due
No trial status on register 2015-004878-15 A multi-center, uncontrolled, open-label, evaluation of lamotrigine monotherapy in adult subjects with newly diagnosed epilepsy or recurrent epilepsy (currently untreated). bad-data
No trial status on register 2015-004880-35 A Randomized, Multicenter, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Oral Sumatriptan for the Acute Treatment of Migraine in Children and Adolescents bad-data
No trial status on register 2015-004881-27 Clinical assessment of GW815SF Salmeterol/fluticasone propionate (HFA MDI) in pediatric patients with bronchial asthma -A long term (24-week) study- bad-data
No trial status on register 2015-004882-10 A study to compare GW815SF HFA MDI with concomitant treatment with salmeterol xinafoate DPI plus fluticasone propionate DPI and to assess long-term safety of GW815SF HFA MDI bad-data
No trial status on register 2015-004883-12 A 52-week, Randomized, Double-Blind, Parallel-Group Study of Fluticasone Propionate/Salmeterol DISKUS Combination Product (FSC) 250/50 mcg BID and Fluticasone Propionate (FP) DISKUS 250 mcg BID in Tre... bad-data
No trial status on register 2015-004884-35 A repeat-dose, open-label, 2-session study to assess the systemic exposure to, and pharmacodynamics of, fluticasone propionate HFA inhalation aerosol 88 mcg administered twice-daily for 28 days delive... bad-data
No trial status on register 2015-004885-27 A Comparison of Fluticasone Furoate Nasal Spray versus Oral Fexofenadine in the Treatment of Seasonal Allergic Rhinitis bad-data
No trial status on register 2015-004886-98 A Randomized, Double-Blind, Double Dummy, Comparative, Multicenter Study to Assess the Safety and Efficacy of Topical Retapamulin Ointment, 1%, versus Oral Linezolid in the Treatment of Secondarily-In... bad-data
No trial status on register 2015-004887-13 A Randomized, Double-Blind, Parallel Group study of ADVAIR™ DISKUS™ 100/50 and FLOVENT™DISKUS™ 100, both twice daily, in a Pediatric Population during the Fall Viral Season. bad-data
No trial status on register 2015-004888-37 A Pilot, Randomised, Double-blind, Placebo-controlled, Parallel-group, Multicentre Study to Evaluate the Efficacy and Safety of Once-daily Intranasal Administration of Fluticasone Furoate Nasal Spray ... bad-data
No trial status on register 2015-004889-28 A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Study to Evaluate the Efficacy and Safety of Fluticasone Furoate Nasal Spray for 2 Weeks in Chinese Adult and Adolescent su... bad-data
No trial status on register 2015-004890-34 Phase III study of adefovir dipivoxil tablets in patients with bad-data
No trial status on register 2015-004891-31 A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter, Two-Year Study to Evaluate the Ocular Safety of Once-Daily, Fluticasone Furoate Nasal Spray 110mcg in Adults and Adolescent... bad-data
No trial status on register 2015-004892-61 A 52-week, Randomized, Double-Blind, Parallel-Group Study of Fluticasone Propionate/Salmeterol DISKUS Combination Product (FSC) 250/50 mcg BID and Fluticasone Propionate (FP) DISKUS 250 mcg BID in Tre... bad-data
No trial status on register 2015-004893-14 A Randomised, Multi-centre, Double-blind, Double-dummy, two way cross-over, twelve weeks noninferiority study to evaluate the efficacy, safety and tolerability of combination dry powder Fluticasone Pr... bad-data
No trial status on register 2015-004898-32 Pediatric Asthma Clinical Effectiveness study (PEACE). A Randomized, Double-Blind, Double Dummy, Parallel Group comparative clinical study of Salmeterol/Fluticasone propionate Inhalation Powder (50/10... bad-data
No trial status on register 2015-004899-30 Multi-center, Randomised, Double-blind, Parallel, Placebo Controlled Study Of 0.05% Clobetasone Butyrate Cream in Subjects with Eczema to evaluate the Efficacy and Safety. bad-data
No trial status on register 2015-004900-44 A Multi-center, Randomized, Double-blind, Vehicle-Controlled, Phase 2 Study of the Safety and Efficacy of Benzoyl peroxide/Clindamycin gel and Tazarotene cream when used in combination in the Treatmen... bad-data
No trial status on register 2015-004901-18 Clinical Evaluation of lamotrigine in Epilepsy bad-data
No trial status on register 2015-004902-41 Clinical Evaluation of 506U78 in Japanese Patients with Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma bad-data
No trial status on register 2015-004903-22 A randomized, double-blind, multicenter, superiority Phase III study to assess the safety and efficacy of Topical Retapamulin Ointment 1%, applied twice daily versus Placebo Ointment in Adults and Chi... bad-data
No trial status on register 2015-004905-17 A randomised, double-blind, placebo controlled, parallel group , flexible dose study to evaluate the efficacy and safety of Paxil® Tablets in children and adolescents with Major Depressive Disorder bad-data
No trial status on register 2015-004909-16 A Multicentre, Randomized, Assessor-blind, Comparator-Controlled, Parallel-Group Clinical Trial to Establish the Efficacy and Safety of Duac™(1% clindamycin as clindamycin phosphate and 5% benzoyl per... bad-data
Ongoing, reported early 2015-005120-26 A Phase II, Randomized, Multicenter, Dose-Ranging Study in Adult Subjects Evaluating the Efficacy, Safety, and Tolerability of Single Doses of GSK2140944 in the Treatment of Uncomplicated Urogenital G... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2015-005212-14 A phase IIIB, 24-week randomised, double-blind study to compare ‘closed’ triple therapy (FF/UMEC/VI) with 'open' triple therapy (FF/VI + UMEC), in subjects with chronic obstructive pulmonary disease (... 2017-05-23 bad-data
Listed as ongoing, but also has a completion date 2015-005645-31 A randomised, double-blind (sponsor open) placebo-controlled, parallel group, 8-week treatment study to investigate the safety, 2018-05-04 bad-data
Reported results 2015-005742-58 A phase II, randomised, observer-blind, controlled, study to assess the reactogenicity and safety of a single intramuscular dose of GlaxoSmithKline (GSK) Biologicals’ investigational respiratory syncy... 2016-06-28 due-trials
Completed, report not yet due 2015-005800-27 A randomised, multi-center, double blind (sponsor open), placebo-controlled study to assess the efficacy, safety, tolerability, pharmacokinetics and pharmacodynamics of GSK3117391 in subjects with mod... 2017-11-18 not-yet-due
Ongoing 2016-000117-76 A Phase 1/2, randomized, observer-blind, controlled, multi-center, dose-escalation study to evaluate safety, reactogenicity and immunogenicity of GSK Biologicals’ respiratory syncytial virus (RSV) inv... not-yet-due
Ongoing 2016-000276-23 A multiple treatment session, open label phase 2 clinical study of not-yet-due
No trial status on register 2016-000290-20 Phase IIb randomized, open-label, controlled, multi-center study of the efficacy, safety and immunogenicity of GSK Biologicals’ candidate malaria vaccine RTS,S/AS01E evaluating schedules with or witho... bad-data
Ongoing 2016-000507-86 A 52-week open-label (sponsor-blind), randomized, active controlled, not-yet-due
Ongoing 2016-000541-31 A phase 3 randomized, open-label (sponsor-blind), activecontrolled, parallel-group, multi-center, event driven study in dialysis subjects with anemia associated with chronic kidney disease to evaluate... not-yet-due
Ongoing 2016-000542-65 A phase 3 randomized, open-label (sponsor-blind), active-controlled, parallel-group, multi-center, event driven study in non-dialysis subjects with anemia associated with chronic kidney disease to eva... not-yet-due
Reported results 2016-000585-36 A Randomized, Open-Label, 8-Week Cross-Over Study to Compare Umeclidinium/Vilanterol with Tiotropium/Olodaterol 2017-04-27 due-trials
Other 2016-000598-19 A phase IIIA, randomised, observer-blind, multi-centre study to evaluate the clinical consistency of three production lots of the Porcine circovirus (PCV)-free liquid formulation of GlaxoSmithKline (G... not-yet-due
No trial status on register 2016-000644-34 A phase III, open, randomised, multicentre study to assess the immunogenicity and safety of GlaxoSmithKline (GSK) Biologicals’ combined reduced antigen content diphtheria-tetanus toxoids and acellular... bad-data
No trial status on register 2016-000645-31 A phase II, partially double-blind, randomised, controlled, single-centre study to assess the immunogenicity and reactogenicity of three different formulations of GSK Biologicals’ DTPw-HBV-IPV/Hib can... bad-data
Ongoing 2016-000912-13 A multicentre, randomised, double-blind (sponsor-unblinded), placebo-controlled study to investigate the safety and tolerability, pharmacokinetics, pharmacodynamics, and efficacy of GSK2982772 in subj... not-yet-due
Listed as ongoing, but also has a completion date 2016-001135-12 A Phase II, randomised, observer-blind, controlled, multi-country study to rank different formulations of GSK Biologicals’ investigational RSV vaccine (GSK3003891A), based on immunogenicity, reactogen... 2018-02-05 bad-data
Completed, but no date 2016-001244-19 A Phase II, multicenter, randomized, double-blind (sponsor-unblind), placebo- controlled, parallel group trial to evaluate the efficacy and safety of sirukumab in subjects with severe, poorly controll... bad-data
Ongoing 2016-001304-37 A Phase III, randomized, double-blind, active controlled, parallel not-yet-due
Listed as ongoing, but also has a completion date and reported results 2016-001831-10 An open-label, single arm, repeat dose, multi-centre study to evaluate the use of a safety syringe for the subcutaneous administration of mepolizumab in subjects with severe eosinophilic asthma (Study... 2017-08-08 bad-data
Listed as ongoing, but also has a completion date and reported results 2016-001832-36 An open-label, single arm, repeat dose, multi-centre study to evaluate the use of an autoinjector for the subcutaneous administration of mepolizumab in subjects with severe eosinophilic asthma (Study ... 2017-11-30 bad-data
Ongoing 2016-001833-29 A multicentre, randomised, double-blind (sponsor-unblinded), not-yet-due
Ongoing 2016-002230-69 A Phase 2b, Open-Label, Multi-Center Study Assessing the Immunological Persistence of Antibodies at Approximately 2 years After the last Meningococcal Vaccination in Study V102_15 and the Response to ... not-yet-due
Completed, report not yet due 2016-002294-35 A phase I/II, open-label, 2 arm study to investigate the safety, clinical activity, pharmacokinetics and pharmacodynamics of GSK2879552 administered alone or in combination with azacitidine, in adult ... 2017-12-14 not-yet-due
Listed as ongoing, but also has a completion date 2016-002405-19 An open label, randomised, three arm, single dose, multicentre, parallel group study in healthy subjects to compare the pharmacokinetics of subcutaneous mepolizumab when delivered as a liquid drug pro... 2017-08-11 bad-data
Ongoing 2016-002416-41 A randomized, double-blind, multi-dose, placebo-controlled study to evaluate the efficacy, safety and tolerability of GSK2330672 administration for the treatment of pruritus in patients with primary b... not-yet-due
Ongoing, reported early 2016-002512-40 A Phase II, global, randomized study to evaluate the efficacy and safety of Danirixin (GSK1325756) co-administered with a standard-of-care antiviral (oseltamivir), in the treatment of adults hospitali... not-yet-due
Ongoing 2016-002513-22 A 24-week treatment, multi-center, randomized, double-blind, double-dummy, parallel group study to compare Umeclidinium/Vilanterol, Umeclidimium, and Salmeterol in subjects with chronic obstructive pu... not-yet-due
Ongoing 2016-002551-22 Study HZA114971, A Multicentre Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effects of a One-Year Regimen of Orally Inhaled Fluticasone Furoate 50 mcg once daily ... not-yet-due
Completed, reported early 2016-002671-10 A two-part trial to evaluate the safety, tolerability, clinical effect and systemic exposure potential of topically applied GSK2981278 ointment in subjects with plaque psoriasis 2017-05-05 not-yet-due
Completed, report not yet due 2016-002733-30 A Phase I/II, randomised, observer-blind, controlled multi-country study to assess the safety, reactogenicity and immunogenicity of a single intramuscular dose of GSK Biologicals’ investigational RSV ... 2017-07-14 not-yet-due
Ongoing 2016-002843-40 A Phase IIb, 24 week, randomized, double-blind, 3 arm parallel group study, comparing the efficacy, safety and tolerability of two doses of umeclidinium bromide administered once-daily via a dry powde... not-yet-due
Ongoing 2016-003002-14 An escalating dose, randomized, placebo-controlled incomplete block, 2-period cross-over study to assess the dose response for topical efficacy via airway responsiveness to adenosine-5'-monophosphate ... not-yet-due
Ongoing 2016-003050-32 A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo- Controlled, 104-Week Study to Evaluate the Efficacy and Safety of Belimumab Administered in Combination with Rituximab to Adult Subjects wit... not-yet-due
Ongoing 2016-003074-40 A phase I/II dose escalation and expansion study to investigate the safety, pharmacokinetics, pharmacodynamics and clinical activity of GSK525762 in combination with fulvestrant in subjects with ER+ b... not-yet-due
No trial status on register 2016-003186-25 A Phase 3b, Controlled, Open-Label, Multi-Center Study to Evaluate Safety and Immunogenicity of a Single Dose of GlaxoSmithKline’s Meningococcal ACWY Conjugate Vaccine (Menveo), Administered to Health... bad-data
No trial status on register 2016-003210-27 A phase IIIA, randomized, single-blind, multi-centric study to evaluate the immunogenicity, reactogenicity and safety of three doses of Pediarix, Hiberix and Prevenar 13 when co-administered with two ... bad-data
Ongoing 2016-003417-95 A multi-centre, randomized, double-blind (sponsor open), placebo controlled, repeat-dose, proof of mechanism study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and explore ... not-yet-due
No trial status on register 2016-003479-22 Clinical assessment of fluticasone propionate/ salmeterol xinafoate HFA MDI in 6-month to 4-year-old Japanese patients with bronchial asthma bad-data
Ongoing 2016-003675-21 Randomised, Double-Blind (Sponsor Open), Placebo-Controlled, Multicentre, Dose Ranging Study to Evaluate the Efficacy and Safety of Danirixin Tablets Administered Twice Daily Compared With Placebo for... not-yet-due
Other 2016-004086-87 A randomized, double-blind, parallel group, multicenter, stratified, study evaluating the efficacy and safety of once daily fluticasone furoate/vilanterol inhalation powder compared to once daily flut... not-yet-due
Ongoing 2016-004255-70 A randomised, double-blind, parallel group PhIII study to assess the clinical efficacy and safety of 100 mg SC Mepolizumab as an add on to maintenance treatment in adults with severe bilateral nasal p... not-yet-due
Ongoing 2016-004258-14 A two part Phase IIa Study, to Evaluate the Safety and Tolerability, not-yet-due
No trial status on register 2016-004420-29 A Phase 2, Open-label, Controlled, Multi-Center Extension Study to Evaluate 4-Year Antibody Persistence and Booster Response Fol-lowing MenABCWY Vaccination in Healthy Adolescents and Young Adults who... bad-data
No trial status on register 2016-005117-44 A Phase 3b, Open-Label, Randomized, Multicenter Study to Assess the Safety and Immunogenicity of Novartis Meningococcal group B Vaccine When Administered Concomitantly with Novartis MenACWY Conjugate ... bad-data
No trial status on register 2017-000093-11 A Phase 3b, Open Label, Controlled, Multi-Center, Extension Study to Athe Persistence of Bactericidal Activity at 4 to 7.5 Years After Two Dose Primary Series of GlaxoSmithKline Biologicals Meningococ... bad-data
No trial status on register 2017-000166-30 A Multicenter Post Marketing Surveillance Study to Monitor the Safety of GSK Meningococcal ACWY Conjugate Vaccine (MenACWY-CRM) Administered According to the Prescribing Information to Healthy Subject... bad-data
Other 2017-000184-32 A multi-centre, open-label extension, safety study to describe the longterm not-yet-due
Ongoing 2017-000212-41 An Open-label, Dose-escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of GSK2586881 in Participants with Pulmonary Arterial Hypertension not-yet-due
No trial status on register 2017-000255-50 A phase III, open-label, mono-centre, follow-up extension study to evaluate the persistence of immune response to GSK Biologicals’ HPV vaccine in healthy Chinese female subjects who received three dos... bad-data
No trial status on register 2017-000416-42 A phase IIIb, double-blind, randomized, controlled, multicentre study to assess the immunogenicity and safety of GlaxoSmithKline Biologicals’ HPV-16/18 L1 AS04 vaccine administered intramuscularly acc... bad-data
No trial status on register 2017-000451-14 An open, single group, multi-centric, post marketing surveillance (PMS) to monitor the reactogenicity and safety of oral live attenuated human rotavirus (HRV) vaccine, Rotarix when administered accord... bad-data
No trial status on register 2017-000454-18 A Phase II randomized, observer blind, multicenter study of GlaxoSmithKline (GSK) Biologicals’ combined measles-mumps-rubella-varicella vaccine (MMRV) versus ProQuad, according to a one dose schedule,... bad-data
No trial status on register 2017-000458-20 A post-marketing surveillance (PMS) study to monitor the safety and reactogenicity of GlaxoSmithKline (GSK) Biologicals’ human papillo-mavirus (HPV) vaccine (Cervarix) in 3,000 healthy female Filipino... bad-data
Ongoing 2017-000880-34 A Phase IIB, randomised, observer-blind, placebo-controlled, multi-centre study to evaluate the efficacy, safety, reactogenicity and immunogenicity of the GSK Biologicals’ investigational vaccine GSK3... not-yet-due
Ongoing 2017-001074-42 A Phase IIb, Randomized (Stratified), Double-Blind (Sponsor Open), Parallel-Group, Placebo-Controlled, Dose-Finding Study of Nemiralisib (GSK2269557) Added to Standard of Care (SoC) Versus SoC Alone i... not-yet-due
Ongoing 2017-001150-33 A Phase IV, 12-week, randomised, double-blind, triple dummy study to compare single inhaler triple therapy, fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) with multiple inhaler therapy (bude... not-yet-due
Ongoing 2017-001220-22 A Phase IIIB, randomized, open-label, multicenter clinical trial to assess the immunogenicity and safety of GSK Biologicals’ Herpes Zoster vaccine GSK1437173A when co-administered with Prevenar13 in a... not-yet-due
Ongoing 2017-001356-59 A phase IV, open-label, single-center study to evaluate long term immunogenicity up to 15 years after the first booster immunization with Encepur Adults (Polygeline-free Tick-borne Encephalitis vaccin... not-yet-due
No trial status on register 2017-001514-29 A multi-center, uncontrolled, open-label, evaluation of Lamotrigine monotherapy on newly diagnosed typical absence seizures in children and adolescents bad-data
No trial status on register 2017-001515-36 Valproate dose reduction and its clinical evaluation by introducing lamotrigine in Japanese women with epilepsy – single arm, multicenter, and open-label study bad-data
No trial status on register 2017-001516-11 201832: A Randomised, Double-Blind, Double-Dummy, Crossover Comparison of Fluticasone Furoate/Vilanterol 100/25 mcg Once Daily Versus Fluticasone Propionate 250 mcg Twice Daily in Adolescent and Adult... bad-data
No trial status on register 2017-001574-42 A randomized, open-label, comparative study to evaluate an intermittent dosing regimen of fluticasone propionate 0·05% cream (twice per week) in reducing the risk of relapse when added to regular dail... bad-data
No trial status on register 2017-001575-23 Clinical evaluation of efficacy at 2 weeks of Duac fixed dose combination gel in treatment of facial acne vulgaris in Japanese Subjects. bad-data
Ongoing 2017-001584-20 A Phase I/II, randomized, controlled, observer-blind, multi-center study to assess the reactogenicity, safety and immunogenicity of three GlaxoSmithKline (GSK) Biologicals’ investigational supra-seaso... not-yet-due
No trial status on register 2017-001607-80 An open-label primary vaccination study to assess the safety and reactogenicity of GlaxoSmithKline Biologicals’ Inactivated Poliomyelitis vaccine Poliorix administered as a three-dose primary vaccinat... bad-data
No trial status on register 2017-001608-32 An open-label study to assess the safety and reactogenicity of GlaxoSmithKline Biologicals’ Inactivated Poliomyelitis Vaccine Poliorix administered as a booster dose at 18-24 months of age in healthy ... bad-data
Ongoing 2017-002266-45 An open label, randomised, parallel group clinical study to evaluate the effect of the Connected Inhaler System (CIS) on adherence to Relvar/Breo ELLIPTA therapy, in asthmatic subjects with poor contr... not-yet-due
Ongoing 2017-002270-39 A 28-week, randomized, double-blind, placebo-controlled, parallel-group, multi-center, study in recombinant human erythropoietin (rhEPO) naïve non-dialysis participants with anemia associated with chr... not-yet-due
Ongoing 2017-002919-33 Phase IV, open-label, randomized study to enrol healthy adult volunteers, naïve to any previous meningococcal vaccination or meningococcal disease, aged 18-50 years, to be either vaccinated with GSK M... not-yet-due
Ongoing 2017-002941-31 A Phase 2, randomised, observer-blind, multi-centre study to evaluate the safety, reactogenicity and immunogenicity of GSK Biologicals' GSK3277511A investigational vaccine when administered intramuscu... not-yet-due
Other 2017-003456-23 A phase 2b, randomized, controlled, observer-blind, multi-center study to evaluate safety and immunogenicity of different formulations of GSK Biologicals’ Meningococcal ACWY conjugate vaccine (GSK3536... not-yet-due
Ongoing 2017-003692-61 A phase 2b, randomized, controlled, observer-blind, multi-center, non-inferiority immunogenicity and safety study of two formulations of GSK Biologicals’ Meningococcal ACWY conjugate vaccine (GSK35368... not-yet-due
Ongoing 2017-004369-29 The Clinical Effectiveness of Fluticasone Furoate/Umeclidinium Bromide/Vilanterol in a Single Inhaler (TRELEGYTM ELLIPTATM) when Compared with Non-ELLIPTA Multiple Inhaler Triple Therapies in COPD Pat... not-yet-due
Ongoing 2017-004372-56 A Phase 3 randomized, double-blind, active-controlled, parallel-group, multi-center study in hemodialysis participants with anemia of chronic kidney disease to evaluate the efficacy, safety and pharma... not-yet-due
Ongoing 2017-004810-25 A Phase II, Open Label, Randomized, Two-Arm Study to Investigate the Efficacy and Safety of Two Doses of the Antibody Drug Conjugate GSK2857916 in Participants with Multiple Myeloma Who Had 3 or More ... not-yet-due
Ongoing 2017-005128-12 A Phase II, Randomized, Open-label, Multicenter Study to Assess the Immunogenicity and Safety of GSK Meningococcal MenABCWY Vaccine, and of GSK Meningococcal Group B and MenACWY Conjugate Vaccines Adm... not-yet-due